000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1076|2661|lyfalmen|V0045|1793|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1076||1076|2661||1
000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|25128|34541|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||25128||25128|34541||2
000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|37759|50517|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||37759||37759|50517||2
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|7065|10905|lyfalmen|V0457|8442|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||7065||7065|10905||2
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|18160|26176|lyfalmen|V0475|21138|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||18160||18160|26176||2
000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|23457|32427|lyfalmen|V0540|20307|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||23457||23457|32427||2
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|3637|6186|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||3637||3637|6186||1
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|3542|6890|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||3542||3542|6890||1
000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|9741|14588|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||9741||9741|14588||1
000299|N06AB0311|Fluoxetin Mylan|hylki|20|mg|250|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3819|6437|lyfalmen|||2|250|0|250,0000|Icepharma hf|Mylan AB|Flúoxetín||3819||3819|6437||2
000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GPH|0|0|0|100|IKR|2175|4174|lyfsjukr|||1|5|0|1,6700|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||2175||2175|4174||1
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|3726|6309|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3726||3726|6309||1
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2283|4323|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2283||2283|4323||1
000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|pokar||B05BA02|01.04.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|11926|17595|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||11926||11926|17595||1
000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2349|4414|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2349||2349|4414||1
000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|28858|39259|lyfsjukr|||1|6000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||28858||28858|39259||1
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|2771|4994|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||2771||2771|4994||1
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|75225|97904|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||75225||75225|97904||2
001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|0|MLD|0|0|0|100|DKK|4147|6888|lyfalmen|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4147||4147|6888||1
001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|1116|2717|lyfalmen|V0037|1192|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1116||1116|2717||1
001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3711|6288|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3711||3711|6288||1
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12271|18070|lyfalmen|V0115|11977|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12271||12271|18070||1
001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1539|3299|lyfalmen|V0050|2162|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1539||1539|3299||1
001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|0|MLD|0|0|0|100|DKK|20738|28988|lyfalmen|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||20738||20738|28988||1
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4665|7601|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||4665||4665|7601||1
001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2740|4952|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2740||2740|4952||1
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|16846|24367|lyfsjukr|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||16846||16846|24367||1
001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|13056|19151|lyfalmen|V0637|16851|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||13056||13056|19151||1
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|23351|32293|lyfsjukr|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||23351||23351|32293||1
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|1857|3736|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||1857||1857|3736||1
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3798|6408|lyfalmen|V0444|6018|1|15|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíð||3798||3798|6408||1
001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1660|2419|lyfalmen|V0291|2419|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||900||900|2419||1
001957|N05AX0802|Rison|filmhtfl|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|6375|7106|lyfalmen|V0297|6824|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||4305||4305|7106||1
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|2794|5026|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||2794||2794|5026||2
001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|3098|3864|lyfalmen|V0292|3864|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||1950||1950|3864||1
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1958|3875|lyfalmen|V0004|2484|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1958||1958|3875||1
001986|N05AX0802|Rison|filmhtfl|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|4764|5447|lyfalmen|V0296|5447|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||3100||3100|5447||1
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2882|5147|lyfalmen|V0005|2484|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2882||2882|5147||1
002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|3384|5838|lyfalmen|V0723|5838|1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3384|5838||2
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|19674|28260|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||19674||19674|28260||2
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2390|4470|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2390||2390|4470||1
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|11623|17178|lyfalmen|V0492|7615|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||11623||11623|17178||1
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|TCA|0|0|1|100|IKR|||lyfalmen|V0362|1987|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2411||1
002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|813|2299|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||813||813|2299||2
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|19297|27741|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||19297||19297|27741||1
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|10789|12299|lyfalmen|V0089|2495|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||8078||8078|12299||1
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6033|9484|lyfalmen|V0515|3662|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||6033||6033|9484||1
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|9849|14737|lyfalmen|V0253|5871|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||9849||9849|14737||1
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|18949|27262|lyfalmen|V0516|5396|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||18949||18949|27262||1
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|6901|10679|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||6901||6901|10679||1
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|10190|15206|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||10190||10190|15206||1
003192|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2015||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|6320|12161|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||6320||6320|12161||2
003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4917|7948|lyfalmen|V0356|7160|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4917||4917|7948||1
003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4610|7526|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4610||4610|7526||1
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2393|4474|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2393||2393|4474||1
003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|28222|38454|lyfsjukr|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||28222||28222|38454||1
003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|AGH|0|0|0|100|XEU|1696|3515|lyfalmen|||2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||1696||1696|3515||1
003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|0|G|0|AGH|0|0|0|100|XEU|30544|40699|lyfalmen|||2|500|0|166,6700|Actavis Group hf|Actavis Group hf|Klózapín||29997||29997|40699||1
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1002|2129|lyfalmen|V0151|2060|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||689||689|2129||1
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2389|2664|lyfalmen|V0322|2338|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1078||1078|2664||1
003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1643|3442|lyfalmen|V0469|1889|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1643||1643|3442||1
004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|14619|21302|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||14619||14619|21302||1
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|6113|9594|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||6113||6113|9594||1
004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1
004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|2898|5169|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||2898||2898|5169||1
004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003|31.10.2016|R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|483|1845|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||483||483|1845||1
004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3520|6025|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||3520||3520|6025||1
004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4604|7517|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4604||4604|7517||1
004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|6430|10031|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||6430||6430|10031||1
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|1|PHH|0|0|0|100|DKK|16269|23573|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||16269||16269|23573||1
004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|þpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|5014|4754|lyfalmen|V0381|3920|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||2596||2596|4754||1
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5943|11446|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||5943||5943|11446||1
004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|2508|4632|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||2508||2508|4632||2
004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3345|5785|lyfalmen|V0226|2374|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||3345||3345|5785||2
004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|6288|9835|lyfalmen|V0228|4157|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||6288||6288|9835||2
004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|1596|3377|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir  mótefnavakar||1596||1596|3377||1
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2303|2403|lyfalmen|V0494|1869|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||888||888|2403||1
004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2426|4520|lyfalmen|V0318|4520|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2426||2426|4520||1
004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2357|4425|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir  mótefnavakar||2357||2357|4425||1
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|4346|4491|lyfalmen|V0320|3727|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||2405||2405|4491||1
004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1549|3313|lyfalmen|V0317|3313|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1549||1549|3313||1
004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001|30.09.2016|R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|850|2144|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||700||700|2144||1
004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1789||1
004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|28878|39284|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||28878||28878|39284||3
004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Dextrómetorfan|||||||1
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|6834|10587|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6834||6834|10587||1
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|649|2074|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||649||649|2074||1
004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|4183|6938|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4183||4183|6938||1
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|278|1563|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||278||278|1563||1
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|713|2162|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||713||713|2162||1
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|1220|2860|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1220||1220|2860||1
005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|1293|2960|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||1293||1293|2960||1
005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2700|4897|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2700||2700|4897||2
005096|J07AJ5205|Boostrix|stl|||0,5|ml|10|áf.spr|áfyllt, dreifa|J07AJ52|01.09.2014||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|12932|18980|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||||12932|18980||1
005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6767|5924|lyfalmen|V0148|3045|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3446||3446|5924||1
005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2557|3954|lyfalmen|V0353|3954|2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2015||2015|3954||1
005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|1971|3893|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||1971||1971|3893||1
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2213|3792|lyfalmen|V0337|2832|2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1897||1897|3792||1
005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|14749|21481|lyfalmen|V0356|21481|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||14749||14749|21481||1
005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|2328|4385|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2328||2328|4385||1
005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2
005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|41389|53926|lyfalmen|V0451|47968|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||40455||40455|53926||1
005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1382|3083|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1382||1382|3083||1
005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímþynnir (mucolytica)- guaifenesin|||||||1
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4617|7535|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4617||4617|7535||1
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4753|7723|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4753||4753|7723||1
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1443|3167|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1443||1443|3167||2
005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|2886|5153|lyfalmen|V0020|1449|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||2886||2886|5153||2
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|4541|7431|lyfalmen|V0020|4346|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||4541||4541|7431||2
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3317|5746|lyfalmen|V0020|2173|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3317||3317|5746||2
005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|3741|6330|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Cetrorelix||3741||3741|6330||2
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4203|6965|lyfalmen|V0324|2047|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4203||4203|6965||1
005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|13852|23875|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||13852||13852|23875||1
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6746|10466|lyfalmen|V0325|2047|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6746||6746|10466||1
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2119|4097|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2119||2119|4097||2
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|11860|16695|lyfalmen|V0326|3452|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||11272||11272|16695||1
005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|þpakki||C09CA03|01.01.2001|30.11.2016|R|1|0|0|0|0|0|HES|0|0|0|100|DKK|2850|5103|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||2850||2850|5103||1
005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RPO|0|0|1|100|IKR|1816|2072|lyfalmen|V0169|2072|2|14|0|12,2500|LYFIS ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||648||648|2072||2
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4459|7318|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||4459||4459|7318||1
006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|77453|100722|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||77453||77453|100722||1
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4270|7058|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4270||4270|7058||1
006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|59172|77600|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||59172||59172|77600||1
006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|1781|3632|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB|Flúkloxacillín||1781||1781|3632||1
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|2752|5392|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||2752|5392||1
006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.07.2012|30.09.2016|R|0|0|0|0|G|0|APP|0|0|0|100|GBP|5375|8579|lyfalmen|||1|5|0|10,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||5375||5375|8579||1
006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|10160|15165|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||10160||10160|15165||1
006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|407288|512191|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||407288||407288|512191||1
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|11306|16742|lyfalmen|V0099|3886|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||11306||11306|16742||1
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9516|14278|lyfalmen|V0117|6565|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||9516||9516|14278||1
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14053|20523|lyfalmen|V0118|10378|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14053||14053|20523||1
007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1589|3368|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1589||1589|3368||1
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|17041|24636|lyfalmen|V0195|23413|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||17041||17041|24636||1
007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|74761|97317|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||74761||74761|97317||1
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|191438|243734|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||191438||191438|243734||1
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|2355|4422|lyfalmen|V0374|3311|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2355||2355|4422||1
007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5982|9414|lyfsjukr|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||5982||5982|9414||2
007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|86739|112466|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||86739||86739|112466||3
007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|18031|25998|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||18031||18031|25998||1
007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|5134|8247|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||5134||5134|8247||1
007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|1|0|1|SHG|0|1|0|100|XEU|190965|243145|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||190965|243145||3
007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3798|6408|lyfalmen|V0618|5238|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||3798||3798|6408||1
007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|13647|19964|lyfalmen|V0589|8327|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||13647||13647|19964||1
007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1540|2557|lyfalmen|V0290|2488|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1000||1000|2557||1
007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|3089|5432|lyfalmen|||1|3|0|84,0000|Vistor hf|Merck Sharp & Dohme|Skeiðarinnleg með progestógeni og östrógeni||3089||3089|5432||1
007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALA|0|0|0|100|USD|1213|2850|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Ólópatadín||1213||1213|2850||1
007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|276|1560|lyfalmen|V0502|853|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||276||276|1560||2
008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1
008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|OEL|0|0|1|100|XEU|1158|2774|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón||1158||1158|2774||1
008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|874|2383|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||874||874|2383||1
008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|811|2297|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||811||811|2297||1
008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|2223|4240|lyfalmen|V0226|4240|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2223||2223|4240||1
008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|3350|5791|lyfalmen|V0227|5791|2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||3350||3350|5791||1
008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|4536|7424|lyfalmen|V0228|7424|2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||4536||4536|7424||1
008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|DKK|112797|145926|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||112797||112797|145926||1
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|5494|9469|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5494||5494|9469||2
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|8326|15967|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||8326||8326|15967||2
008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RAT|0|0|1|100|XEU|||lyfalmen|V0575|2148|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||2148||2
008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2231|4251|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2231||2231|4251||1
008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||||2
008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|79838|103738|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||79838||79838|103738||2
008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|82823|107514|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||82823||82823|107514||2
008904|D10AF0101|Dalacin|húðlausn|10|mg/ml|60|ml|1|glas||D10AF01|01.01.1994||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1674|3485|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1674||1674|3485||1
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|5450|8682|lyfalmen|V0145|8028|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||5450|8682||2
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|10807|16055|lyfalmen|V0145|16055|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||10807|16055||2
008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2
009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1353|2660|lyfalmen|V0064|2660|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||1075||1075|2660||2
009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4383|5585|lyfalmen|V0064|5320|2|60|0|60,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||3200||3200|5585||2
009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6114|9596|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6114||6114|9596||2
009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2720|4064|lyfalmen|V0063|4064|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||2095||2095|4064||2
009189|N02BA0111|ASA-ratiopharm|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.09.2014||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|50|0|8,3333|LYFIS ehf|ratiopharm GmbH|Acetýlsalicýlsýra|||||||2
009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6114|9596|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6114||6114|9596||2
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|9260|13926|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||9260||9260|13926||1
009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6114|9596|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6114||6114|9596||2
009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PHH|0|0|0|100|DKK|40261|53681|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||40261||40261|53681||1
009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|4010|6700|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4010||4010|6700||1
009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|881|2393|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||881||881|2393||1
009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|971|2517|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||971||971|2517||1
009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1123|2726|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1123||1123|2726||1
009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1407|3117|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1407||1407|3117||1
009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5141|8257|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5141||5141|8257||2
009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5721|9055|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5721||5721|9055||2
009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5141|8257|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5141||5141|8257||2
009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PHH|0|0|0|100|DKK|145811|186986|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||145811||145811|186986||1
009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|3885|6528|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||3885||3885|6528||1
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|0|1|0|1|GSL|0|0|0|100|DKK|43633|57946|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||43633||43633|57946||2
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7612|10540|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||6800||6800|10540||1
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8248|11620|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||7585||7585|11620||1
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|6557|10206|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||6557||6557|10206||1
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8248|11620|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||7585||7585|11620||1
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|6648|10331|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||6648||6648|10331||1
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7612|9893|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||6330||6330|9893||1
010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|1660|3465|lyfalmen|V0329|1869|1|30|0|15,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||1660||1660|3465||1
010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|156491|200269|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||156491||156491|200269||2
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|5277|8444|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||5277||5277|8444||1
010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|9910|14821|lyfalmen|V0331|2695|1|96|0|96,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||9910||9910|14821||1
010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|13974|20414|lyfalmen|||1|96|0|144,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||13974||13974|20414||1
010290|N06DX0101|Ebixa|mixtúra|5|mg/sk|50|g|1|fl|dæluskammtur|N06DX01|01.08.2010||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|11046|16384|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||11046|16384||1
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|16574|23993|lyfalmen|V0605|4538|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||16574||16574|23993||1
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|8714|13174|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||8714||8714|13174||1
010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4570|7471|lyfalmen|V0724|7471|1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4570|7471||2
010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7113|10971|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||7113||7113|10971||1
010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|963|2506|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||963||963|2506||2
010705|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2
010716|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2282|lyfalmen|V0006|1278|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||800||800|2282||2
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|250333|316982|lyfsjukr|||1|56|0|14,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||250333||250333|316982||3
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|250333|316982|lyfsjukr|||1|56|0|28,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||250333||250333|316982||3
010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|426664|536289|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||426664||426664|536289||1
010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|568479|712667|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||568479||568479|712667||1
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|33990|45750|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||33990||33990|45750||2
010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|2119|4097|lyfsjukr|||1|10|0|5,0000|Vistor hf|Meda AB|Kloxacillín||2119||2119|4097||
010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2700|2557|lyfalmen|V0058|2484|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||1000||1000|2557||2
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|15636|22702|lyfalmen|V0204|8062|1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||15636||15636|22702||1
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|15454|22451|lyfalmen|V0716|11827|1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||15454||15454|22451||1
010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3200|3933|lyfalmen|V0059|3786|2|100|0|200,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||2000||2000|3933||2
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|26623|36432|lyfalmen|V0683|13871|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26623||26623|36432||1
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|26442|36203|lyfalmen|V0684|13871|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26442||26442|36203||1
011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|G|0|TTT|0|0|0|100|SEK|12390|18234|lyfalmen|V0729|18234|1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||12390||12390|18234||2
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3493|5988|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3493||3493|5988||1
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3629|6175|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||3629||3629|6175||1
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|12575|18489|lyfalmen|V0327|2890|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12575||12575|18489||1
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|926|2455|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||926||926|2455||1
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1893|2997|lyfalmen|V0069|2775|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1320||1320|2997||1
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4851|7857|lyfalmen|V0357|7071|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4851||4851|7857||1
011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|4642|7290|lyfalmen|V0691|4305|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4439||4439|7290||1
011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|5987|6745|lyfalmen|V0624|4088|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4043||4043|6745||1
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1492|2932|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1492||1492|2932||2
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PLS|0|0|0|100|DKK|3647|6200|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||3647||3647|6200||1
011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|49755|65689|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||49755||49755|65689||2
011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|1962|3856|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||1962||1962|3856||2
011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|0|0|TCA|0|0|0|100|IKR|1425|2228|lyfalmen|V0152|2060|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||761||761|2228||1
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|3925|4013|lyfalmen|V0323|3018|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||2058||2058|4013||1
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3076|5414|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3076||3076|5414||1
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|1702|3523|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||1702||1702|3523||1
011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|5136|8250|lyfalmen|V0604|2603|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||5136|8250||1
012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|21826|30365|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||21826||21826|30365||1
012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|2873|5135|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||2873||2873|5135||1
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|5244|8398|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||5244||5244|8398||2
012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|7466|8664|lyfalmen|V0622|4957|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5437||5437|8664||1
012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
012864|M01AE0113|Ibuxin|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|LYFIS ehf|ratiopharm Oy|Íbúprófen|||||||2
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|718|2169|lyfalmen|||1|80|0|4,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||718||718|2169||1
012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|3263|5672|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||3263||3263|5672||1
012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|4832|7831|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||4832||4832|7831||2
012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2160|2311|lyfalmen|V0250|2311|2|100|0|16,6667|LYFIS ehf|ratiopharm GmbH|Gabapentín||821||821|2311||2
012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2828|2776|lyfalmen|V0251|2776|2|100|0|22,2200|LYFIS ehf|ratiopharm GmbH|Gabapentín||1159||1159|2776||2
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|4561|7458|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||4561||4561|7458||1
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|7377|11334|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||7377||7377|11334||1
013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1358|2669|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1358||1358|2669||2
013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|4891|7912|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||4891||4891|7912||2
013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|ROB|0|0|0|100|XEU|2140|4126|lyfalmen|V0042|4126|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Nordic (A)|Doxazósín||2140||2140|4126||1
013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005|30.09.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|3833|7442|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||3833||3833|7442||2
013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005|30.11.2016|R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|104593|135723|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||104593|135723||3
013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|254783|281495|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||221800||221800|281495||1
013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005|30.11.2016|R|0|0|0|1|0|1|BER|0|1|0|100|SEK|68367|89230|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||68367|89230||3
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|986|2538|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||986||986|2538||2
013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGH|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1715||1
013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|589|1635|lyfalmen|V0562|1635|2|100|0|33,3300|LYFIS ehf|ratiopharm Oy|Íbúprófen||330||330|1635||2
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1894|3787|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||1894||1894|3787||2
013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|284|1571|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||284||284|1571||1
013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005|30.11.2016|R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3761|6357|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||3761||3761|6357||1
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4768|7743|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4768||4768|7743||1
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1879|3767|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||1879||1879|3767||1
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3583|6112|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||3583||3583|6112||1
013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|143685|184342|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||143685||143685|184342||1
013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|261520|330896|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||261520||261520|330896||1
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1859|3739|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||1859||1859|3739||1
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|5591|8876|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5591||5591|8876||1
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|G|0|UCB|0|0|0|100|DKK|14051|20520|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||14051||14051|20520||1
014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|43709|58042|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||43709||43709|58042||2
014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1957|3658|lyfalmen|V0479|3658|2|60|0|6,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1800||1800|3658||1
014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|2476|4588|lyfalmen|||2|100|0|10,0000|Artasan ehf|Sandoz A/S|Amoxicillín||2476||2476|4588||1
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|14554|21213|lyfalmen|V0357|21213|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||14554||14554|21213||1
014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|284|1571|lyfalmen|V0563|1564|2|30|0|15,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen||284||284|1571||2
014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|1959|3850|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||1959||1959|3850||2
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|64074|83800|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Adefovír||||64074|83800||2
014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|715|1953|lyfalmen|V0564|1953|2|100|0|50,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen||561||561|1953||2
014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|727|2181|lyfalmen|V0596|1829|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||727||727|2181||2
014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009|30.09.2016|R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1079|2167|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||717||717|2167||2
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|20506|28695|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||20506||20506|28695||1
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|53139|69969|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||53139||53139|69969||1
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|35610|47799|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||35610||35610|47799||1
014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|559612|701639|lyfalmen|||1|60|0|60,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||559612||559612|701639||3
015072|V04CX0005|Hexvix|stofn|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.08.2016||R|0|0|0|0|0|1|CUR|0|0|0|100|XEU|47977|63440|lyfsjukr|||1|1|0||PhotoCure ASA|PhotoCure ASA|Carbon monoxide||47977||47977|63440||3
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2111|3657|lyfalmen|V0673|3657|2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||1799||1799|3657||1
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6200|9714|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||6200||6200|9714||1
015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|þpakki||N06AX11|01.07.2003||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|726|2180|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||726||726|2180||1
015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|844|2342|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||844||844|2342||1
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|1408|2282|lyfalmen|V0234|1403|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||800||800|2282||1
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|2010|2282|lyfalmen|V0233|1797|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||800||800|2282||1
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|7282|11203|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7282||7282|11203||1
015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|246331|312005|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||246331||246331|312005||3
015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|70778|92279|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||70778||70778|92279||3
015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4116|6846|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4116||4116|6846||1
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|10464|15583|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||10464||10464|15583||1
015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4116|6846|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4116||4116|6846||1
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|11311|16749|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11311||11311|16749||1
015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4116|6846|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4116||4116|6846||1
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|10353|15430|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||10353||10353|15430||1
015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|54591|71806|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||54591||54591|71806||1
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|17047|24644|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||17047||17047|24644||1
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|34095|45882|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||34095||34095|45882||1
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2482|4278|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||2482||2482|4278||2
015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4706|8111|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||4706||4706|8111||2
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1852|3192|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||1852||1852|3192||2
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2583|4452|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||2583||2583|4452||2
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4517|7786|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||4517||4517|7786||2
015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2
015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1554|3319|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1554|3319||1
015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1745|3582|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||1745||1745|3582||1
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1141|2751|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1141||1141|2751||2
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2483|4280|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2483||2483|4280||2
015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|GBP|1292|2959|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1292||1292|2959||1
016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|848|2348|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||848||848|2348||2
016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|898|2416|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||898||898|2416||2
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2120|4098|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2120||2120|4098||1
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|5286|8456|lyfalmen|V0686|2958|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||5286||5286|8456||1
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8012|12208|lyfalmen|V0687|4890|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||8012||8012|12208||1
016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|0|G|0|AGH|0|0|0|100|XEU|3968|6642|lyfalmen|||2|1000|0|1000,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||3968||3968|6642||1
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1399|3106|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1399||1399|3106||1
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|11509|17021|lyfalmen|V0689|5604|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||11509||11509|17021||1
016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|6381|9963|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||6381||6381|9963||1
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|1|PHH|0|0|0|100|DKK|74613|97130|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||74613||74613|97130||1
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|2919|5198|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||2919||2919|5198||1
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2057|4012|lyfalmen|V0685|1199|1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2057||2057|4012||1
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016527|J01CE0206|Apocillin|mixt.kyr|50|mg/ml|200|ml|1|glerfl||J01CE02|01.06.2015||R|0|0|0|0|0|0|GPA|0|0|1|100|XEU|1017|2580|lyfalmen|||2|200|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Fenoxýmetýlpenicillín||1017||1017|2580||1
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|13629|19939|lyfalmen|V0690|12865|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||13629||13629|19939||1
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||6498||1
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|26623|36432|lyfalmen|V0682|13871|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26623||26623|36432||1
016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|IKR|1026|2232|lyfalmen|V0169|1776|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||764||764|2232||1
016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|112510|145569|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||112510||112510|145569||2
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|5823|9195|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5823||5823|9195||1
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2379|4455|lyfalmen|V0240|4455|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2379||2379|4455||3
016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|4390|7223|lyfalmen|V0433|7223|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||4390||4390|7223||3
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|39896|53219|lyfalmen|V0721|27238|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||39896||39896|53219||1
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|58777|77100|lyfalmen|V0722|38679|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||58777||58777|77100||1
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|21852|30397|lyfalmen|V0720|18390|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||21852||21852|30397||1
016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|60248|78961|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||60248||60248|78961||1
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1386|3088|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1386|3088||1
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|30721|41225|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín||30413||30413|41225||2
016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|2397|4480|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma A/S|Búprenorfín||2397||2397|4480||2
017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1189|2817|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1189||1189|2817||1
017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|205339|261023|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||205339||205339|261023||2
017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|GRP|0|0|0|100|XEU|5243|8397|lyfalmen|||2|500|0|333,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5243||5243|8397||1
017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|GRP|0|0|0|100|SEK|4605|7519|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||4605||4605|7519||1
017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|107489|139324|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||107489||107489|139324||1
017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|26571|36366|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||26571||26571|36366||2
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|87279|113149|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||87279||87279|113149||2
017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|0|0|0|1|0|0|ROC|0|0|0|100|DKK|35786|48021|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||35786||35786|48021||2
017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|0|0|0|1|0|0|ROC|0|0|0|100|DKK|96631|124978|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||96631||96631|124978||2
017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|4359|7180|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma A/S|Búprenorfín||4359||4359|7180||2
017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|7925|12088|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma A/S|Búprenorfín||7925||7925|12088||2
017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|6882|10653|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||6882||6882|10653||1
017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|þpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|913|2437|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||913||913|2437||1
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2090|4057|lyfalmen|||1|30|0|150,0000|Vistor hf|Meda AB|Prednisón||2090||2090|4057||1
017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|IKR|1459|2769|lyfalmen|V0168|2717|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||1154||1154|2769||1
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5213|10061|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||5213||5213|10061||1
017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005|31.10.2016|R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8540|12935|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||8540||8540|12935||1
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|7410|11380|lyfalmen|V0107|3374|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||7410||7410|11380||1
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|908|1811|lyfalmen|V0243|1454|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||458||458|1811||1
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5649|8956|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5649||5649|8956||1
018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|10646|15834|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||10646||10646|15834||2
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|14363|20950|lyfalmen|V0441|18256|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||14363||14363|20950||1
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|675|2110|lyfalmen|V0414|1874|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||675||675|2110||2
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|4550|7443|lyfalmen|V0438|6169|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||4550||4550|7443||1
018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|1371|3059|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||1365||1365|3059||1
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|11825|17456|lyfalmen|V0440|15075|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||11825||11825|17456||1
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|26283|36002|lyfalmen|V0111|11228|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||26283||26283|36002||1
018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|37432|50103|lyfsjukr|||1|3|0||Williams & Halls efh|medac Gesellschaft|BCG bóluefni||37432||37432|50103||2
018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|6955|10753|lyfsjukr|||1|20|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||6955||6955|10753||2
018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|274|1555|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||272||272|1555||1
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|72680|94685|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||72680||72680|94685||1
018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|GBP|43686|58013|lyfsjukr|||1|60|0|30,0000|Vistor hf|Viiv Healthcare UK Ltd|Fosamprenavír||43686||43686|58013||1
018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|856|1682|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||856||856|1682||2
018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|4348|7165|lyfalmen|V0221|6345|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4348||4348|7165||1
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|5175|8303|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||5175||5175|8303||2
019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3147|5512|lyfalmen|V0220|5000|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||3147||3147|5512||1
019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|139096|178635|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||139096||139096|178635||2
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|15731|22833|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||15731||15731|22833||2
019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1733|3566|lyfalmen|V0219|3083|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||1733||1733|3566||1
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|18814|27076|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||18814||18814|27076||2
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|16917|24465|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||16917||16917|24465||2
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22766|31553|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||22766||22766|31553||2
019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|69548|90723|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||69548||69548|90723||2
019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|5344|8536|lyfalmen|V0223|6865|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||5344||5344|8536||1
019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8319|12631|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8319||8319|12631||1
019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|34774|46741|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||34774||34774|46741||2
019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|17387|25112|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||17387||17387|25112||2
019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|0|1|0|1|0|1|THE|0|0|0|100|XEU|576914|723158|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||576914||576914|723158||1
019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|3268|6371|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||3268||3268|6371||1
019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|AGH|0|0|0|100|SEK|299|1553|lyfalmen|V0633|1553|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||271||271|1553||1
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|CAR|0|0|0|100|DKK|25376|48314|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||25376||25376|48314||1
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5306|8484|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5306||5306|8484||2
019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|36584|49030|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||36584||36584|49030||2
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5306|8484|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5306||5306|8484||2
019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1099|2144|lyfalmen|V0496|2093|2|100|0|200,0000|LYFIS ehf|ratiopharm GmbH|Ramipríl||700||700|2144||2
019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|980|2075|lyfalmen|V0648|2075|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ramipríl||650||650|2075||2
019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1543|2832|lyfalmen|V0649|2685|2|100|0|400,0000|LYFIS ehf|ratiopharm GmbH|Ramipríl||1200||1200|2832||2
019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|DAN|0|0|0|100|XEU|2886|5153|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||2886||2886|5153||2
019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|DAN|0|0|0|100|XEU|12679|18632|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||12679||12679|18632||2
019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|139931|179673|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||139931||139931|179673||2
019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|777|2024|lyfalmen|V0159|1972|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||613||613|2024||2
019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|NED|0|1|0|100|XEU|131976|169779|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||131976||131976|169779||2
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|10015|14965|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10015||10015|14965||2
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|10015|14965|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10015||10015|14965||2
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|10015|14965|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10015||10015|14965||2
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|10015|14965|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10015||10015|14965||2
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|10015|14965|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10015||10015|14965||2
019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|254|1530|lyfalmen|||1|12|0|0,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||||254|1530||1
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|1|0|1|0|1|GGL|0|0|0|100|GBP|47686|63072|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||47686||47686|63072||1
019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|964|2363|lyfalmen|V0160|2324|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||859||859|2363||2
020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|2173|4171|lyfalmen|||2|100|0|25,0000|LYFIS ehf|ratiopharm GmbH|Diltíazem||2173||2173|4171||2
020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|1930|3837|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Barnaveiki, kíghósti, mænusótt, stífkrampi||||1930|3837||1
020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|19302|27748|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||19302||19302|27748||1
020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|1821|3687|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||1821||1821|3687||3
020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|LHR|0|0|0|100|XEU|75512|98267|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|Laboratoire HRA Pharma|Mitotanum||75512||75512|98267||0
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|39400|52592|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||39400||39400|52592||1
020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|2723|3651|lyfalmen|||1|84|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||1795||1795|3651||1
020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|5172|4173|lyfalmen|||1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||2174||2174|4173||1
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|18317|26392|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||18317||18317|26392||1
020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|OEL|0|0|1|100|XEU|453|1804|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||453||453|1804||1
020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|OEL|0|0|1|100|XEU|1406|3116|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1406||1406|3116||1
020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|9801|3973|lyfalmen|V0599|3973|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Diltíazem||2029||2029|3973||2
020711|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1
020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|1724|2971|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||1724||1724|2971||1
020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|1|0|0|UCP|0|0|0|100|DKK|46466|61529|lyfalmen|||1|180|0||Vistor hf|UCB Pharma Ltd.|sodium oxybate||||46466|61529||1
020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2017|3477|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2017||2017|3477||2
020924|J01FA1003|Zithromax (Lyf og heilsa)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1335|3018|lyfalmen|V0174|2522|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1335||1335|3018||2
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2271|4306|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2271||2271|4306||2
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|1769|3615|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||1769||1769|3615||2
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|IKR|581|1695|lyfalmen|V0188|1526|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1695||1
021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|HEG|0|0|0|100|XEU|1305|2977|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1305||1305|2977||1
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|IKR|1287|2254|lyfalmen|V0189|2059|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||780||780|2254||1
021341|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|4628|7550|lyfalmen|V0437|7549|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||4628||4628|7550||3
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|13304|19492|lyfalmen|V0490|2189|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||13304||13304|19492||1
021365|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|3618|6160|lyfalmen|V0436|6160|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||3618||3618|6160||3
021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1
021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|25587|35121|lyfalmen|||1|250|0|41,6700|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||25587||25587|35121||3
021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1227|2869|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1227||1227|2869||1
021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|46881|62054|lyfalmen|||1|250|0|83,3300|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||46881||46881|62054||3
021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3344|5783|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3344||3344|5783||1
021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|10378|15465|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||10378||10378|15465||1
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10090|15068|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||10090||10090|15068||1
021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|5516|8773|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5516||5516|8773||1
021625|A07EC0203|Pentasa Sachets|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|11721|17313|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||11721||11721|17313||1
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|12271|18070|lyfsjukr|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||12271||12271|18070||1
021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|17498|25265|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||17498||17498|25265||1
021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|14112|20604|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||14112||14112|20604||1
021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18888|27178|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||18888||18888|27178||1
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7056|10892|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||7056||7056|10892||1
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3561|6082|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||3561||3561|6082||1
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15121|21993|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||15121||15121|21993||1
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|2697|4893|lyfalmen|V0692|2257|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||2697||2697|4893||2
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|4555|7450|lyfalmen|V0693|3029|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4555||4555|7450||2
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|14758|21493|lyfalmen|V0694|9382|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||14758||14758|21493||2
021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|59675|78236|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||59675||59675|78236||3
022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|64264|84040|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||64264||64264|84040||2
022050|J01CF0202|Cloxacillin Villerton|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|XEU|2090|4057|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2090||2090|4057||2
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|86280|111886|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||86280||86280|111886||2
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|3554|6072|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||3554||3554|6072||1
022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|224498|284851|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||224498||224498|284851||2
022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|236122|299308|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||236122||236122|299308||2
022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|þpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9817|16921|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||9817||9817|16921||2
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|IRE|0|0|0|100|XEU|12520|18413|lyfalmen|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||12520||12520|18413||1
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1762|3037|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||1762||1762|3037||2
022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992|31.10.2016|R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1063|2644|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1063||1063|2644||1
022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|þpakki||QP52AA51|01.10.1991||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1113|1918|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1113||1113|1918||2
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2951|2536|lyfalmen|V0056|1829|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||985||985|2536||1
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|5232|3326|lyfalmen|V0057|2096|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1559||1559|3326||1
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1669|2877|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||1669||1669|2877||2
022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|OEL|0|0|1|100|XEU|473|1832|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||473||473|1832||1
022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|OEL|0|0|1|100|XEU|1422|3138|lyfalmen|||1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1422||1422|3138||1
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1080|1861|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1080||1080|1861||2
022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003|30.11.2016|R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3760|6356|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||3760||3760|6356||1
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2129|3207|lyfalmen|V0321|3207|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3207||1
022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.08.2013||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1554|2518|lyfalmen|V0321|1924|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||972||972|2518||1
022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4142||2
022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|18990|27318|lyfalmen|||1|8|0|40,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||18990||18990|27318||1
022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|9495|14249|lyfalmen|||1|4|0|20,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||9495||9495|14249||1
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2661||2
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|IKR|1407|3117|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1407||1407|3117||1
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|IKR|2450|3507|lyfalmen|V0125|2173|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1690||1690|3507||1
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|62169|81390|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl og emtrícítabín||62169||62169|81390||2
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|19989|28693|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||19989||19989|28693||3
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|31209|42232|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||31209||31209|42232||3
023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|3000|2832|lyfalmen|V0125|2173|2|30|0|20,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||1200||1200|2832||2
023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|15462|22462|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||15462||15462|22462||1
023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|6500|4346|lyfalmen|V0125|4346|2|60|0|40,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||2300||2300|4346||2
023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|14000|17009|lyfalmen|V0256|17009|2|100|0|44,4400|LYFIS ehf|ratiopharm GmbH|Gabapentín||11500||11500|17009||2
023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|7500|10815|lyfalmen|V0254|10815|2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Gabapentín||7000||7000|10815||2
023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|15965|23155|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||15965||15965|23155||1
023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|14915|21709|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||14915||14915|21709||1
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SNC|0|0|0|100|NOK|13745|20099|lyfalmen|V0029|5710|1|100|0|100,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||13745||13745|20099||1
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2030|3975|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||2030||2030|3975||2
023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|102221|121390|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||93794||93794|121390||2
023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2419|lyfalmen|V0066|2275|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2419||2
023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2626|lyfalmen|V0449|2505|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2626||2
023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|700|2144|lyfalmen|V0448|1909|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||700||700|2144||2
023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4900|5998|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||3500||3500|5998||2
023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2429|3658|lyfalmen|V0673|3657|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1800||1800|3658||2
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|57774|75832|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||57774||57774|75832||1
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2166|4162|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2166||2166|4162||1
024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1721|3549|lyfalmen|V0222|2959|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||1721||1721|3549||1
024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|0|0|0|0|G|0|TBB|0|0|0|100|DKK|14270|20822|lyfalmen|V0726|15061|1|30|0|30,0000|Vistor hf|Teva B.V.|Rasagilín||14270||14270|20822||1
024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|48338|63897|lyfalmen|||1|5|0|5,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||48338||48338|63897||3
024198|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|plglas|47,5 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1336|2483|lyfalmen|V0048|2483|2|100|0|31,6600|Artasan ehf|Hexal A/S|Metóprólól||946||946|2483||1
024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|0|0|0|0|G|0|TBB|0|0|0|100|DKK|49677|65590|lyfalmen|V0711|38404|1|100|0|100,0000|Vistor hf|Teva B.V.|Rasagilín||49677||49677|65590||1
024231|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|plglas|95 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1793|3321|lyfalmen|V0049|3321|2|100|0|63,3300|Artasan ehf|Hexal A/S|Metóprólól||1555||1555|3321||1
024253|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|3609|5246|lyfalmen|V0054|5246|2|100|0|126,6600|Artasan ehf|Hexal A/S|Metóprólól||2954||2954|5246||1
024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18888|27178|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||18888||18888|27178||1
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5946|9365|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5946||5946|9365||1
024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|304|1599|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||304||304|1599||1
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5946|9365|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5946||5946|9365||1
024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|10019|14971|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10019||10019|14971||1
024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|10035|14993|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10035||10035|14993||1
024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006|31.10.2016|R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|10702|15911|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10702||10702|15911||1
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4287|7081|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4287||4287|7081||1
024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|OPH|0|0|0|100|DKK|42197|56130|lyfalmen|V0715|52413|1|100|0|1,2500|Artasan ehf|Novartis Europharm Ltd|Zoledronsýra||42197||42197|56130||1
024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|10138|15134|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10138||10138|15134||1
024603|V04CL0001|Soluprick  Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1221|2861|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1221||1221|2861||1
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4287|7081|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4287||4287|7081||1
024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5946|9365|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5946||5946|9365||1
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5946|9365|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5946||5946|9365||1
024681|V04CL0002|Soluprick  Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1221|2861|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1221||1221|2861||1
024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2162|4156|lyfalmen|||2|100|0|66,6660|LYFIS ehf|ratiopharm GmbH|Metóprólól||2162||2162|4156||2
025041|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.12.2013|31.10.2016|R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5468|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5468||2
025046|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.12.2013|31.10.2016|R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4993|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4993||2
025052|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.12.2013|31.10.2016|R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3933|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3933||2
025142|D07AB0202|Locoid Crelo|húðfl|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|0|0|0|0|G|0|OEL|0|0|1|100|XEU|482|1844|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||482||482|1844||1
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15121|21993|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||15121||15121|21993||1
025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1480|2282|lyfalmen|V0051|2282|2|100|0|33,3333|LYFIS ehf|ratiopharm GmbH|Metóprólól||800||800|2282||2
025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007|30.09.2016|R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|67093|87618|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||67093||67093|87618||1
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|57933|76033|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||57933||57933|76033||1
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|7493|14386|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||7493||7493|14386||1
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|12162|17920|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||12162||12162|17920||1
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|4103|6828|lyfalmen|V0205|1291|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||4103||4103|6828||2
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|10996|16315|lyfalmen|V0205|3874|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||10996||10996|16315||2
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|35165|47236|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||35165||35165|47236||1
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|5175|8303|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||5175||5175|8303||1
025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18888|27178|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||18888||18888|27178||1
025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|786|2213|lyfalmen|V0597|2213|2|28|0|3,7300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||750||750|2213||2
025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|2632|4385|lyfalmen|V0598|4385|2|98|0|13,0700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||2328||2328|4385||2
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|40323|53760|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||40323|53760||2
025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|35063|47107|lyfalmen|||1|98|0|196,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||35063||35063|47107||1
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|3035|5231|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||3035||3035|5231||
025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||1
026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1524|2995|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1524||1524|2995||1
026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.09.2015||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|820|2082|lyfalmen|V0447|2082|2|100|0|20,0000|Alvogen|Alvogen ehf|Lóperamíð||655||655|2082||1
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|7242|12482|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||7242||7242|12482||1
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15121|21993|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||15121||15121|21993||1
026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|33352|44943|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||33352||33352|44943||1
026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|166763|213045|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||166763||166763|213045||1
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1421|3136|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1421|3136||1
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|5384|8591|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||5384|8591||1
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|2807|5044|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||2807|5044||1
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|11118|16483|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||11118|16483||1
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|16661|24113|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||16661|24113||1
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|22204|30843|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||22204|30843||1
026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1017|2580|lyfalmen|||2|100|0|25,0000|Vistor hf|Meda AB|Nítrófúrantóín||1017||1017|2580||1
026692|L01XE2701|IMBRUVICA|filmhtfl|140|mg|120|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|859819|1075012|lyfsjukr|||1|120|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||859819|1075012||1
026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2
026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4765|3965|lyfalmen|V0099|3965|2|100|0|200,0000|LYFIS ehf|ratiopharm GmbH|Lósartan||2023||2023|3965||2
026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|831|2324|lyfalmen|V0160|2324|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||831||831|2324||2
026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|575|1972|lyfalmen|V0159|1972|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||575||575|1972||2
027051|A10BX1201|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|16079|23312|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||16079||16079|23312||1
027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|3107|lyfalmen|V0672|3095|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1400||1400|3107||2
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|560|1951|lyfalmen|||2|50|0|1,2500|Vistor hf|Meda AB|Nítrófúrantóín||560||560|1951||1
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1971|3893|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||1971||1971|3893||1
027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997|30.09.2016|R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|5091|8188|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Cýpróterón||5091||5091|8188||2
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|10213|6510|lyfalmen|V0341|6510|2|100|0|66,6600|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||3872||3872|6510||1
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|10998|6510|lyfalmen|V0342|6510|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||3872||3872|6510||1
027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1998|3931|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1998||1998|3931||2
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|5137|8251|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||5137||5137|8251||1
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|472|1830|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||472||472|1830||1
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|543|1928|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||543||543|1928||1
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|1|0|0|0|0|OTS|0|0|0|100|DKK|16036|23252|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16036||16036|23252||1
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|18426|26542|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||18426|26542||2
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|1|0|0|0|0|OTS|0|0|0|100|DKK|18185|26210|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18185||18185|26210||1
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|25167|34590|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||25167||25167|34590||2
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|37188|49794|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||37188|49794||2
028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|3359|5804|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||3359||3359|5804||2
028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|17760|25625|lyfalmen|V0387|25625|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||17760||17760|25625||1
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MUN|0|0|1|100|IKR|||lyfalmen|||0|30|0|30,0000|Icepharma hf|Mundipharma|Fexófenadín|||||2626||
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|15871|23025|lyfalmen|V0386|23025|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||15871||15871|23025||1
028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1444|2953|lyfalmen|V0364|2953|2|100|0|100,0000|Icepharma hf|Mylan AB|Fexófenadín||1288||1288|2953||2
028249|C10AA0507|Atorvastatin Hexal|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.10.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2765|2732|lyfalmen|V0114|2732|2|100|0|200,0000|Artasan ehf|Hexal A/S|Atorvastatín||1127||1127|2732||1
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|39575|52813|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||39575||39575|52813||1
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPA|0|0|0|100|XEU|2055|4009|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir  mótefnavakar||2055||2055|4009||2
028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|31943|43161|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||31943||31943|43161||2
028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPA|0|0|0|100|XEU|33015|44516|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||33015|44516||2
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1327|3007|lyfalmen|V0202|3007|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1327||1327|3007||2
028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1487|3227|lyfalmen|V0428|2619|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1487||1487|3227||2
028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|1278|2940|lyfalmen|||1|56|0|0,9334|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||||1278|2940||1
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|5812|3988|lyfalmen|V0245|3585|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2040||2040|3988||1
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|10358|8833|lyfalmen|V0232|7901|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||5560||5560|8833||1
028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|622|2030|lyfalmen|V0266|2030|2|30|0|1,0600|Alvogen|Alvogen|Pramipexól||617||617|2030||1
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|6219|11969|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||6219||6219|11969||2
028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2539|3713|lyfalmen|V0267|3713|2|100|0|7,2000|Alvogen|Alvogen|Pramipexól||1840||1840|3713||1
028632|M05BA0805|Zoledronic Acid Hospira|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.01.2016||R|0|1|0|1|0|1|VOG|0|0|0|100|XEU|2128|4109|lyfsjukr|||2|5|0|1,0000|Alvogen HS|Hospira UK Ltd.|Zoledronsýra||2128||2128|4109||1
028739|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.03.2013|30.09.2016|R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1435|3156|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||1435|3156||2
028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|1841|lyfalmen|V0551|1841|2|7|0|1,7500|Alvogen|Alvogen|Flúkónazól||480||480|1841||1
028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|3259|lyfalmen|V0552|3259|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||1510||1510|3259||1
028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.05.2010||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen|Flúkónazól|||||||1
028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|523|1900|lyfalmen|V0555|1900|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||523||523|1900||1
028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|1965|lyfalmen|V0556|1965|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||570||570|1965||1
029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|HEA|0|0|1|100|IKR|1121|2557|lyfalmen|V0625|1826|1|120|0|30,0000|Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Flútíkasón||1000||1000|2557||1
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|5150|8269|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||5150||5150|8269||2
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|12836|18848|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||12836||12836|18848||2
029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2265|4298|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2265||2265|4298||1
029211|N02AB0309|Abstral|tungur.t|200|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|SEK|28776|39155|lyfalmen|V0802|39155|1|30|0|10,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||28776||28776|39155||2
029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|SEK|28809|39197|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||28809||28809|39197||2
029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|SEK|28809|39197|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||28809||28809|39197||2
029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|þpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|UAK|0|0|0|100|XEU|1142|2752|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1142||1142|2752||1
029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|SEK|9505|14263|lyfalmen|V0801|12941|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||9505||9505|14263||2
029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|UAK|0|0|0|100|GBP|241|1512|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||241||241|1512||1
029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1
029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|SEK|28513|38822|lyfalmen|V0801|38822|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||28513||28513|38822||2
029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|SEK|9592|14383|lyfalmen|V0802|13052|1|10|0|3,3300|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||9592||9592|14383||2
029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|SEK|28776|39155|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||28776||28776|39155||2
029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|SEK|28809|39197|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||28809||28809|39197||2
029381|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|1|0|100|SEK|45607|60443|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||45607||45607|60443||1
029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|GPA|0|0|0|100|XEU|15364|22327|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||15364||15364|22327||1
029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|GPA|0|0|0|100|XEU|3343|5782|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||3343||3343|5782||1
029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9562|14342|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||9562|14342||1
029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9276|13948|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||9276|13948||1
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|4613|7530|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||4613||4613|7530||2
029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|74494|96979|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||74494||74494|96979||1
029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|148987|190936|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||148987||148987|190936||1
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|PHH|0|0|0|100|DKK|6422|10020|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||6422||6422|10020||1
030546|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.09.2015|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1844|1818|lyfalmen|||2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||463||463|1818||2
030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|7227|11128|lyfalmen|V0277|5585|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||7227||7227|11128||1
030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|0|0|HES|0|0|0|100|IKR|2886|5153|lyfalmen|V0276|2282|1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||2886||2886|5153||1
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|12863|22171|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||12863||12863|22171||2
030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|983|2305|lyfalmen|V0051|2282|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||817||817|2305||2
031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1539|3022|lyfalmen|||2|100|0|66,6667|Icepharma hf|Mylan AB|Metóprólól||1338||1338|3022|31.10.2016|2
031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2507||1
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2276|4313|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2276||2276|4313||2
031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2063|4020|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2063||2063|4020||2
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4549|7442|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4549||4549|7442||1
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|17282|24967|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||17282||17282|24967||1
031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1423|3139|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Sótalól||1423||1423|3139||2
032175|N03AX1606|Pregabalin Mylan|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|3618|2891|lyfalmen|V0732|2891|2|56|0|14,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||1243||1243|2891||2
032399|C09CA0106|Losatrix|filmhtfl|25|mg|98|stk|1|þpakki||C09CA01|01.08.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2877|3933|lyfalmen|||2|98|0|49,0000|LYFIS ehf|ratiopharm GmbH|Lósartan||2000||2000|3933||2
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|1|0|0|G|0|OTS|0|0|0|100|DKK|16533|23937|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16533||16533|23937||1
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|11422|19687|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||11422||11422|19687||1
032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1198|2829|lyfalmen|||2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1198||1198|2829||2
032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2100|3094|lyfalmen|V0069|2832|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1390||1390|3094||2
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|16758|24246|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||16758|24246||1
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|33423|45032|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||33423|45032||1
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|959|1653|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||959||959|1653||2
033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|2415|4504|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||2415||2415|4504||2
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|7178|13789|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||7178|13789||2
033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|8230|12508|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||8230||8230|12508||2
033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|4833|7833|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||4833||4833|7833||2
033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|14266|20816|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||14266||14266|20816||2
033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1172|2794|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Dexametasón||1172||1172|2794||1
033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|1251|2059|lyfalmen|V0189|2059|2|100|0|50,0000|LYFIS ehf|ratiopharm Oy|Díklófenak||638||638|2059||2
033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|518|1526|lyfalmen|V0188|1526|2|30|0|15,0000|LYFIS ehf|ratiopharm Oy|Díklófenak||251||251|1526||2
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|14702|11852|lyfalmen|V0185|11852|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||7753||7753|11852||2
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|69062|90109|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||69062||69062|90109||1
034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1944|3821|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||1944|3821||2
034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|RPO|0|0|0|100|XEU|1535|2386|lyfalmen|V0098|2386|2|100|0|100,0000|LYFIS ehf|ratiopharm Oy|Enalapríl og þvagræsilyf||876||876|2386||2
034157|J07AM5104|Diftavax|stl|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPA|0|0|1|100|XEU|585|1986|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur Europe|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||585||585|1986||2
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|13110|19225|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||13110||13110|19225||2
034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|NED|0|0|0|100|XEU|6509|10139|lyfalmen|V0805|10139|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||6509|10139||2
034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|NED|0|0|0|100|XEU|6509|10139|lyfalmen|V0806|10139|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||6509|10139||2
034494|N05CM1801|Dexdor|irþ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|52906|69675|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||52906||52906|69675||1
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1253|2905|lyfalmen|V0367|2905|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1253||1253|2905||1
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2096|4065|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2096||2096|4065||1
034988|L03AB0702|Rebif|stl|44|mcg/,5ml|1,5|ml|4|rörlyk|132 mcg pr. rörlykju|L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|86508|112174|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||86508||86508|112174||2
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|5853|9237|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||5853||5853|9237||1
035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1760|3603|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||1760||1760|3603||1
035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|1958|3875|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||1958|3875||1
035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|12277|18079|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||12277||12277|18079||1
035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1052|2297|lyfalmen|V0050|2162|2|100|0|15,8300|LYFIS ehf|ratiopharm GmbH|Metóprólól||811||811|2297||2
035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|0|0|0|0|G|0|TCA|0|0|0|100|IKR|1844|2105|lyfalmen|V0244|2105|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||672||672|2105||1
035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1045|2619|lyfalmen|V0048|2483|2|100|0|31,6600|LYFIS ehf|ratiopharm GmbH|Metóprólól||1045||1045|2619||2
035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1866|3475|lyfalmen|V0049|3321|2|100|0|63,3300|LYFIS ehf|ratiopharm GmbH|Metóprólól||1667||1667|3475||2
035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6487|10109|lyfalmen|V0080|6050|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||6487||6487|10109||1
035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|4079|5549|lyfalmen|V0054|5246|2|100|0|126,6600|LYFIS ehf|ratiopharm GmbH|Metóprólól||3174||3174|5549||2
035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4409|2695|lyfalmen|V0233|2695|2|18|0|18,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1100||1100|2695||2
035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|0|0|0|0|0|GZE|0|0|0|100|NOK|19804|26206|lyfalmen|V0680|22734|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||18182||18182|26206||1
036108|L03AB0702|Rebif|stl|22|mcg/,5ml|1,5|ml|4|rörlyk|66 mcg pr. rörlykju|L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|86508|112174|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||86508||86508|112174||2
036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5765|9115|lyfalmen|V0081|6050|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5765||5765|9115||1
036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|6509|10139|lyfalmen|V0806|10139|1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||6509|10139||2
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|577|1975|lyfalmen|||1|20|0|8,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||577||577|1975||1
036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|15529|22555|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15529||15529|22555||1
036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|1015|2578|lyfalmen|||1|60|0|3,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||1015||1015|2578||1
036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3490|6015|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||3490||3490|6015||1
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|2003|3937|lyfalmen|||1|125|0|6,2500|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||2003||2003|3937||1
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|607|2016|lyfalmen|||1|30|0|12,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||607||607|2016||1
036754|N03AX1608|Pregabalina Tecnigen|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|8449|5636|lyfalmen|V0735|5494|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||3237||3237|5636||2
037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|6240|6047|lyfalmen|V0532|5837|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||3536||3536|6047||1
037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|10111|8463|lyfalmen|V0533|8386|1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||5291||5291|8463||1
037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|16215|15842|lyfalmen|V0534|15686|1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||10652||10652|15842||1
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1946|3859|lyfalmen|V0434|3859|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1946||1946|3859||2
037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2311|2557|lyfalmen|V0322|2386|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2557||2
037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.02.2013|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3933|lyfalmen|||2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|3933||2
037793|L02BB0308|Bicacta|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.03.2016||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|14428|8029|lyfalmen|V0421|6817|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||4976||4976|8029||1
037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2185||1
037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3289||1
037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5875|9267|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||5875|9267||1
038123|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|5221|10076|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||5221||5221|10076||2
038305|N06AX1611|Duofaxin|forðatfl|150|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2384|4105|lyfalmen|V0335|3175|2|98|0|147,0000|Vistor hf|MediLink A/S|Venlafaxín||2125||2125|4105||1
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|2667|3370|lyfalmen|V0321|3207|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1591||1591|3370||1
038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2232|lyfalmen|V0110|2232|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2232||2
038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|807|2291|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||807||807|2291||2
038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|120875|155973|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||120875||120875|155973||1
039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|11268|16690|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||11268|16690||2
039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|23752|32801|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||23752||23752|32801||2
039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|14342|13706|lyfalmen|||2|50|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||9100||9100|13706||2
039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1329|3010|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1329||1329|3010||2
039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|4646|7575|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||4646||4646|7575||1
039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|þpakki||C01BD07|01.08.2010|30.11.2016|R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|3132|5491|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||3132|5491||1
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|13984|20428|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||13984|20428||1
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2486|4602|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||2486||2486|4602||2
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|316|1581|lyfalmen|V0541|1477|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||291||291|1581||2
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|456|1620|lyfalmen|V0542|1598|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||319||319|1620||2
039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|832|2326|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||832||832|2326||1
039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|1459|3189|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1459||1459|3189||1
039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1630|2232|lyfalmen|V0110|2187|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||764||764|2232||1
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|GBP|5641|4024|lyfalmen|V0182|4002|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||2066||2066|4024||1
039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|GBP|1355|1823|lyfalmen|V0033|1814|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||467||467|1823||1
040313|N02AB0306|Instanyl|nefúði|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|7631|11684|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||7631||7631|11684||1
040421|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4376|8473|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||4376||4376|8473||2
040484|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|SAC|0|0|0|100|IKR|||lyfalmen|||0|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Gervitár og aðrar óvirkar samsetningar|||||1929||1
040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|70047|91354|lyfsjukr|||1|5|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Misóprostól||||70047|91354||1
040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|975|2522|lyfalmen|V0174|2522|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||975||975|2522||1
040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3128|3933|lyfalmen|||2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||2000||2000|3933||2
040891|N06AB1007|Escitalopram Bluefish|filmhtfl|20|mg|28|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|2060|4016|lyfalmen|||2|28|0|56,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2060||2060|4016||2
041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|7544|11564|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7544||7544|11564||2
041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|7544|11564|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7544||7544|11564||2
041693|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.07.2016||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|45160|85848|vetalmen|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||45160||45160|85848||2
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|2795|4817|vetorma|||0|100|0||Vistor hf|Intervet International BV|||2795||2795|4817||1
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|839|2335|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||||839|2335||2
041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|9439|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9439||2
041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|9000|9439|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9439||2
041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1
042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1078|2664|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1078||1078|2664||1
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1984|3911|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1984||1984|3911||1
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3132|5491|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3132||3132|5491||1
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1702|3523|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1702||1702|3523||1
042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2250|4277|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2250||2250|4277||1
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1643|3442|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1643||1643|3442||1
042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1861|3742|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1861||1861|3742||1
042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPA|0|0|0|100|XEU|1786|3639|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||1786||1786|3639||2
042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2568|4715|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2568||2568|4715||2
042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.12.2010|30.09.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1690|3322|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1690||1690|3322||2
042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.12.2010|30.09.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2266|4454|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2266||2266|4454||2
042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.12.2010|30.09.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4533|8771|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4533||4533|8771||2
042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4819|9313|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4819||4819|9313||2
042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1891|3783|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||1891||1891|3783||1
042669|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyflausa|||0|4000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1
042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|2786|5015|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||2786||2786|5015||2
042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MHS|0|0|1|100|XEU|1100|2695|lyfalmen|V0560|2695|2|100|0||Icepharma hf|Mylan Hospital AS|Lídókaín||1100||1100|2695||2
043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|405|1738|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||405||405|1738||2
043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|12318|5396|lyfalmen|V0516|5396|2|100|0|66,6700|Alvogen|Pharmathen S.A.|Levetíracetam||3063||3063|5396||1
043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|2993|5300|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2993||2993|5300||1
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|441|1787|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||441||441|1787||1
043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|1|0|0|0|0|0|UAK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1
044046|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|10|stk|1|þpakki||QJ01CA04|01.02.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|406|798|vetalmen|||0|10|0||Icepharma hf|Zoetis Finland OY|||||406|798||2
044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|0|G|0|LVR|0|0|1|100|CHF|11385|16851|lyfalmen|V0637|16851|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||11385||11385|16851||3
044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|297710|375906|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||297710|375906||1
044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|394809|496670|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||394809|496670||1
044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|4358|7179|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||4358||4358|7179||2
044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|12792|18787|lyfalmen|V0635|13664|1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||12792||12792|18787||1
044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|34077|45860|lyfalmen|V0636|29012|1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||34077||34077|45860||1
045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
045475|A10BX1201|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|5446|8676|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||5446||5446|8676||1
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1050|1899|lyfalmen|V0109|1861|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||522||522|1899||1
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|868|1770|lyfalmen|V0108|1735|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||428||428|1770||1
045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg|10|hgl|1|pakki|lausn / dreifa|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|1615|3403|lyfsjukr|||1|10|0|2,5000|Icepharma hf|Villerton Invest SA|Cefúroxím||||1615|3403||2
045599|J01DC0204|Cefuroxim Villerton|sts/irs|1500|mg|10|hgl|1|pakki|lausn|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2619|4785|lyfsjukr|||2|10|0|5,0000|Icepharma hf|Villerton Invest SA|Cefúroxím||||2619|4785||2
045634|N02AA5907|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGH|0|0|1|100|XEU|311|1609|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema með geðlyfjum||311||311|1609||1
045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|AGH|0|0|0|100|SEK|1549|3313|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Fúrósemíð||1549||1549|3313||1
046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1160|2777|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1160||1160|2777||1
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|665|2096|lyfalmen|V0648|2075|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||665||665|2096||1
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|514|1545|lyfalmen|V0021|1456|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||265||265|1545||1
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|625|1728|lyfalmen|V0022|1593|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||398||398|1728||1
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|801|1962|lyfalmen|V0023|1869|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||568||568|1962||1
046485|L01BC0502|Gemcitabin Hospira|irþ|38|mg/ml|1|hgl|1|pakki||L01BC05|01.12.2015||R|0|0|0|1|0|1|HUK|0|0|0|100|SEK|5918|9326|lyfsjukr|||1|1|0||Icepharma hf|Hospira UK Ltd|Gemcitabín||5918||5918|9326||1
046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSB|0|0|1|100|IKR|1350|2282|lyfalmen|V0625|2282|2|150|0|37,5000|Medical ehf|Teva Sweden AB|Flútíkasón||800||800|2282||2
046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|4372|3874|lyfalmen|V0205|3874|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1957||1957|3874||1
047147|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.08.2015||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|3000|4071|lyfalmen|V0353|3954|2|30|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||2100||2100|4071||2
047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|719|2170|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||719||719|2170||2
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|19608|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|19608||5
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|62907|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|62907||5
047986|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|9843|6868|lyfalmen|V0420|4592|2|30|0|30,0000|Alvogen|Alvogen ehf|Bíkalútamíð||4132||4132|6868||1
047998|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|11820|7992|lyfalmen|V0421|6817|2|30|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||4949||4949|7992||1
048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BGM|0|0|0|100|SEK|3634|6182|lyfsjukr|||1|250|0||Icepharma hf|Baxalta Innovations GmbH|Albúmín||3634||3634|6182||2
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6972|10777|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||6972||6972|10777||1
048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BGM|0|0|0|100|SEK|5895|9294|lyfsjukr|||1|100|0||Icepharma hf|Baxalta Innovations GmbH|Albúmín||5895||5895|9294||2
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2108|2072|lyfalmen|V0324|2047|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||648||648|2072||1
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1257|2911|lyfalmen|V0319|2911|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1257||1257|2911||1
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|3223|2072|lyfalmen|V0325|2047|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||648||648|2072||1
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5351|3593|lyfalmen|V0326|3452|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1753||1753|3593||1
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5766|2992|lyfalmen|V0327|2890|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1316||1316|2992||1
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|883|2396|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geðlyf||883||883|2396||1
048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9932|14851|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||9932||9932|14851||1
048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1402|3110|lyfalmen|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1402||1402|3110||1
048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|0|1|0|1|G|0|ROC|0|0|0|100|DKK|45813|60703|lyfalmen|V0187|11925|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||45813||45813|60703||2
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|1|0|100|NOK|647345|810754|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||647345||647345|810754||1
048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|321|1622|lyfalmen|V0230|1622|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||321||321|1622||1
048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GBL|0|0|0|100|SEK|3185|5564|lyfsjukr|||1|10000|0||Vistor hf|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3185||3185|5564||1
048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|32991|44486|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||32991||32991|44486||3
048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3748|3052|lyfalmen|V0148|3045|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1360||1360|3052||2
049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1562|3330|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||1562||1562|3330||1
049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3521|3308|lyfalmen|V0599|2384|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||1546||1546|3308||1
049091|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|4862|7873|lyfalmen|V0376|7873|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||4862|7873||1
049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|306093|386332|lyfsjukr|||1|1|0|16,6700|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||306093||306093|386332||1
049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|12175|17938|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||12175||12175|17938||2
049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|985|2536|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||985||985|2536||1
049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|3587|6118|lyfalmen|V0655|4759|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||3587||3587|6118||2
049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1154|2075|lyfalmen|V0109|1861|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||650||650|2075||1
049597|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1827|2522|lyfalmen|V0110|2232|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||975||975|2522||1
049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|9665|4415|lyfalmen|V0123|3523|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Terbínafín||2350||2350|4415||1
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|843|2093|lyfalmen|V0496|2093|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||663||663|2093||1
049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1093|2685|lyfalmen|V0649|2685|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1093||1093|2685||1
049834|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGH|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||1523||1
049845|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGH|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||1523||1
049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGH|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1621||1
049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|63669|83288|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||63669||63669|83288||1
049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|137946|177204|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||137946||137946|177204||2
049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|0|1|0|1|G|0|ROC|0|0|0|100|DKK|48193|63714|lyfalmen|V0470|61671|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||48193||48193|63714||2
049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|6898|10675|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||6898||6898|10675||2
049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|17244|24915|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||17244||17244|24915||2
049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|34486|46377|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||34486||34486|46377||2
049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|68846|89835|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||68846||68846|89835||2
049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3274||1
050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2907|5182|lyfalmen|||2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||2907||2907|5182||2
050346|L04AD0104|Ciqorin|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|25500|29952|lyfalmen|||2|50|0|20,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||21500||21500|29952||2
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|54892|72186|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||54892|72186||1
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1
050563|N03AX1606|Pregabalin Mylan|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|965|1726|lyfalmen|V0731|1622|2|56|0|4,6667|Mylan AB|Generics (UK) Ltd.|Pregabalín||396||396|1726||2
050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2466|4575|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||2466||2466|4575||1
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|9805|14676|lyfalmen|V0688|5616|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||9805||9805|14676||1
050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4303|4469|lyfalmen|V0042|4126|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2389||2389|4469||1
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|4615|5034|lyfalmen|V0002|4261|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2800||2800|5034||1
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|4435|3107|lyfalmen|V0006|2282|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1400||1400|3107||1
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|7275|3107|lyfalmen|V0001|2769|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1400||1400|3107||1
051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|889|2191|lyfalmen|V0363|2191|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||734||734|2191||2
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2736|3992|lyfalmen|V0365|3992|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2043||2043|3992||2
051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|17182|24830|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||17182||17182|24830||1
051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1230|1829|lyfalmen|V0056|1829|2|100|0|100,0000|Alvogen|Alvogen|Amlódipín||471||471|1829||1
051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|652|2078|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||652||652|2078||1
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|151|1388|lyfalmen|V0047|1388|2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||151||151|1388||2
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|355|1669|lyfalmen|V0305|947|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||355||355|1669||2
052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007|30.09.2016|R|0|0|0|1|0|1|BMS|0|1|0|100|DKK|258964|327717|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatíníb||258964||258964|327717||1
052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|252|1516|lyfalmen|V0439|1516|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||244||244|1516||2
052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|519|1895|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||519||519|1895||2
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|518|1893|lyfalmen|V0305|1893|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||518||518|1893||2
052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007|30.09.2016|R|0|0|0|1|0|1|BMS|0|1|0|100|DKK|523306|656484|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatíníb||523306||523306|656484||1
052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BMS|0|1|0|100|DKK|453569|569751|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatíníb||453569||453569|569751||1
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2638|4811|lyfalmen|||1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||2638||2638|4811||1
052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír|||||||
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|27652|37733|lyfsjukr|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||27652||27652|37733||1
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22481|31193|lyfsjukr|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||22481||22481|31193||1
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|22862|31675|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||22862||22862|31675||2
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|20046|28113|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||20046||20046|28113||2
052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|0|0|KRK|0|0|0|100|IKR|20582|14119|lyfalmen|V0682|13871|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||9400||9400|14119||2
052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|11729|17324|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíð||11729||11729|17324||1
053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3657|6214|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||3657||3657|6214||1
053155|N02AA5501|Targin|forðatfl|60|mg|28|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|9494|14248|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||9494||9494|14248||2
053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|28276|38522|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||28276||28276|38522||2
053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|4734|7696|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||4734||4734|7696||2
053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1388|3085|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1384||1384|3085||2
053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|4517|7398|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir  mótefnavakar||4517||4517|7398||1
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|23502|32484|lyfalmen|V0453|29389|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||23502||23502|32484||1
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|8554|12954|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||8554||8554|12954||2
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|1|0|0|0|0|OTS|0|0|0|100|DKK|1214|2851|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1214||1214|2851||1
053991|D10AF0101|Dalacin|húðlausn|10|mg/ml|30|ml|1|glas||D10AF01|01.07.1985||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|905|2426|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||905||905|2426||1
054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|þpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5118|2368|lyfalmen|V0490|2234|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||863||863|2368||1
054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPA|0|0|0|100|XEU|3077|5416|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur Europe|Haemophilus influenzae B||3077||3077|5416||2
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1
054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1876|3763|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||1876||1876|3763||1
054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2573|4722|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||2573||2573|4722||1
054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|33304|44882|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||33304||33304|44882||2
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1
054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|SEK|1040|2612|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1040||1040|2612||1
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|345|1655|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||345||345|1655||1
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|TCA|0|0|0|100|XEU|1175|2798|lyfalmen|V0061|2798|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1175||1175|2798||1
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|CES|1|0|0|100|DKK|3765|7313|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||||3765|7313||2
054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|6287|10836|vetorma|||0|20|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||6287||6287|10836||2
054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013|30.09.2016|R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|4596|7506|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4596||4596|7506||1
055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|16029|20557|lyfalmen|V0470|20557|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||14078||14078|20557||2
055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|5651|4171|lyfalmen|V0187|3975|2|50|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||2173||2173|4171||2
055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|CLA|0|0|1|100|USD|1622|3413|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Moxífloxacín||||1622|3413||1
055257|G03AA0903|Benidette|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2013||R|0|0|0|0|0|0|VBA|0|0|0|100|XEU|1050|2257|lyfalmen|V0065|2257|2|63|0|84,0000|Actavis Group PTC ehf|Actavis BV|Desógestrel og ethinylestradíól||782||782|2257||1
055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|7304|11234|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||7304||7304|11234||1
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|IKR|1765|3135|lyfalmen|V0467|2557|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1420||1420|3135||1
055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2143|4130|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2143||2143|4130||1
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2834|2828|lyfalmen|V0112|2557|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1197||1197|2828||1
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|4425|2915|lyfalmen|V0113|2626|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1260||1260|2915||1
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|5897|2915|lyfalmen|V0114|2732|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||1260||1260|2915||1
056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|25384|34865|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||25384||25384|34865||2
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|21354|36806|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||21354||21354|36806||2
056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|0|0|OPE|0|0|0|100|DKK|2669|4854|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||2669||2669|4854||1
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1139|2748|lyfalmen|||1|40|0|10,0000|Vistor hf|Meda AB|Erýtrómýcín||1139||1139|2748||1
056664|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|GPA|0|0|0|100|XEU|2944|3202|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1469||1469|3202||1
056675|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|GPA|0|0|0|100|XEU|2944|3202|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1469||1469|3202||1
056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|2086|4052|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||2086||2086|4052||1
056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|BIB|0|1|0|100|XEU|170259|217393|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||170259||170259|217393||2
057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7024|10848|lyfalmen|V0095|6004|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||7024||7024|10848||1
057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5981|9413|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S|Oktreótíð||5981||5981|9413||1
057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2815|5055|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2815||2815|5055||2
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2990|5296|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2990||2990|5296||1
057401|N06DA0404|Galantamine Portfarma|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|15977|23171|lyfalmen|||2|84|0|84,0000|Alvogen|Alvogen|Galantamín||15977||15977|23171||1
057422|B05XA3102|Tracel|irþ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3874|6513|lyfsjukr|||1|200|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||3874||3874|6513||1
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2106|4079|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2106||2106|4079||1
057492|L01XC1001|Arzerra|irþ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|280370|354340|lyfsjukr|||1|50|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||280370||280370|354340||1
057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|327622|413108|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||327622||327622|413108||1
057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|10035|9100|lyfalmen|V0607|9076|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||5754||5754|9100||2
057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|0|0|100|DKK|92843|120187|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||92843|120187||2
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|15978|23173|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||15978|23173||1
058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|338|1646|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||338||338|1646||1
058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|327247|412642|lyfsjukr|||1|1|0|33,3300|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||327247||327247|412642||1
058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|119685|154493|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||119685||119685|154493||1
058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|128295|221129|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||128295|221129||2
058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|194893|335918|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||194893|335918||2
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|726|2180|lyfalmen|||1|100|0|2,5000|Vistor hf|Meda AB|Trímetóprím||726||726|2180||1
058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|75383|98103|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||75383||75383|98103||1
058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|28875|39280|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||28875||28875|39280||1
058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4138|6876|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||4138||4138|6876||2
058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|826|2317|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||826||826|2317||1
058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1402|3110|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1402||1402|3110||1
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|2374|2952|lyfalmen|V0006|1278|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1287||1287|2952||1
059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|8748|13221|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||8748||8748|13221||3
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|74498|96984|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||74498||74498|96984||1
059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|50493|66623|lyfsjukr|||1|30|0|30,0000|Icepharma hf|Pfizer Limited|Anidulafungin||50493||50493|66623||1
059659|J07CA0601|Infanrix-Polio + Hib|sts|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|24395|33614|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||24395||24395|33614||1
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|20589|28800|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||20589||20589|28800||1
059795|C10AA0506|Atorvaratio|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|5500|2626|lyfalmen|||2|100|0|200,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1050||1050|2626|30.11.2016|2
059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|4336|7149|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||4336|7149||2
059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|7074|10917|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||7074||7074|10917||1
059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|35372|47498|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||35372||35372|47498||1
060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|1642|3083|lyfalmen|V0219|3083|2|5|0|7,5000|LYFIS ehf|ratiopharm GmbH|Fentanýl||1382||1382|3083||2
060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|2912|5000|lyfalmen|V0220|5000|2|5|0|15,0000|LYFIS ehf|ratiopharm GmbH|Fentanýl||2775||2775|5000||2
060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|4199|6345|lyfalmen|V0221|6345|2|5|0|22,5000|LYFIS ehf|ratiopharm GmbH|Fentanýl||3752||3752|6345||2
060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|5027|6865|lyfalmen|V0223|6865|2|5|0|30,0000|LYFIS ehf|ratiopharm GmbH|Fentanýl||4130||4130|6865||2
060337|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7106|11669|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||6061||6061|11669||1
060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|269481|340797|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||269481||269481|340797||1
060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|143311|183877|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||143311||143311|183877||1
060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|16395|23747|lyfalmen|V0713|23747|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||16395||16395|23747||1
060759|A10BB1203|Glimepirid Bluefish|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|907|1593|lyfalmen|V0022|1593|2|90|0|90,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||300||300|1593||2
061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGA|0|1|0|100|DKK|111275|144033|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||||111275|144033||1
061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|83670|108585|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||83670||83670|108585||2
061293|N05AX1206|Aripiprazole ratiopharm|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|10093|8062|lyfalmen|V0204|8062|2|28|0|18,6670|LYFIS ehf|ratiopharm GmbH|Aripiprazól||5000||5000|8062||2
061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|4834|7834|lyfalmen|V0133|6547|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||4834||4834|7834||2
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|4835|7835|lyfalmen|V0133|6547|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Tíbólón||4835||4835|7835||1
061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3282|5698|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3282||3282|5698||1
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|12553|18458|lyfsjukr|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||12553||12553|18458||1
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|17470|25226|lyfsjukr|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||17470||17470|25226||1
062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|363|1680|lyfalmen|V0307|1566|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||363||363|1680||1
062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|0|1|0|1|G|0|GPA|0|0|0|100|XEU|12748|11925|lyfalmen|V0187|11925|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||7806||7806|11925||1
062575|J05AX1501|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AX15|01.09.2015||R|0|0|0|1|0|1|GIL|0|1|0|100|XEU|1686368|2103008|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir||||1686368|2103008||1
062614|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|45160|85848|vetalmen|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||45160||45160|85848||2
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|733|2189|lyfalmen|V0308|1964|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||733||733|2189||1
062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|G|0|AGH|0|0|1|100|XEU|1789|3643|lyfalmen|V0803|3643|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1789||1789|3643||1
062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|14255|24570|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||14255||14255|24570||2
062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|9917|12496|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||8221||8221|12496||1
063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|4530|7416|lyfalmen|||1|10|0|1,6667|Artasan ehf|Novartis Healthcare A/S|Famcíclóvír||4530||4530|7416||1
063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|AGH|0|0|0|100|XEU|1447|2357|lyfalmen|V0276|2282|2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||855||855|2357||1
063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|AGH|0|0|0|100|XEU|4467|5891|lyfalmen|V0277|5585|2|100|0|33,3333|Actavis Group hf|Actavis Group hf|Klózapín||3422||3422|5891||1
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2748||1
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|TCA|0|0|0|100|XEU|1720|3548|lyfalmen|V0123|3523|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1720||1720|3548||1
063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|3287|5705|lyfalmen|V0458|3530|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3287||3287|5705||2
063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|6160|9659|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||6160||6160|9659||1
063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|116208|150168|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||116208||116208|150168||2
063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|770|2240|lyfalmen|V0309|1910|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||770||770|2240||1
063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1613|3401|lyfalmen|V0310|2710|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1613||1613|3401||1
064023|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014|30.11.2016|R|0|0|0|1|0|1|BER|0|1|0|100|SEK|68368|89231|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||68368|89231||3
064034|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014|30.11.2016|R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|104593|135723|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||104593|135723||3
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|741256|927553|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||741256|927553||2
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|343162|432436|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||343162|432436||2
064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996|31.10.2016|R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1788|3641|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1788||1788|3641||1
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|3431621|4273614|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||3431621|4273614||2
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|1347738|1681847|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1347738|1681847||2
064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1774|3335|lyfalmen|V0009|3335|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1565||1565|3335||2
064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|5493|5710|lyfalmen|V0029|5710|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3291||3291|5710||2
064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|937|1842|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||937||937|1842||1
064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5346|9214|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||5346|9214||1
064732|A03BB0101|Buscopan|húðuðtfl|10|mg|100|stk|1|þpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1663|3469|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||1663||1663|3469||1
064733|J07BB0203|Vaxigrip|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPA|0|0|0|100|XEU|794|2034|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur Europe|Inflúensa, hreinsaðir  mótefnavakar||620||620|2034||2
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|39014|52104|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||39014||39014|52104||1
064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|ASS|0|0|1|100|DKK|658|2086|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda AS|Metóklópramíð||658||658|2086||1
064939|G04BD0804|Solifenacin Actavis|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|14282|18256|lyfalmen|V0441|18256|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||12406||12406|18256||1
064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|ASS|0|0|1|100|DKK|378|1701|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||378||378|1701||1
065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|1545|3307|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1545||1545|3307||1
065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
065339|A07EA0604|Cortiment|freyðit|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|12515|18406|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||12515||12515|18406||1
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|9106|13714|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||9106||9106|13714||2
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|41357|55067|lyfalmen|V0451|47968|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||41357||41357|55067||3
065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|954|2072|lyfalmen|V0163|2072|2|70|0|5,6000|LYFIS ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||648||648|2072||2
065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065753|N02AB0303|Fentanyl Actavis|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.05.2016||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1292|2959|lyfalmen|V0222|2959|2|5|0|3,6000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1292||1292|2959||1
065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|2877|5140|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||2877||2877|5140||2
065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|447|1796|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||447||447|1796||1
065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|1350|3039|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1350||1350|3039||1
065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|2510|4635|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||2510||2510|4635||1
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|3556|6917|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||3556||3556|6917||2
066235|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|7735|11827|lyfalmen|V0716|11827|2|28|0|28,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||7735||7735|11827||1
066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4673|7612|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||4673||4673|7612||1
066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|24566|33830|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Hýdróxyetýl sterkja||24566||24566|33830||1
066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|745|2206|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||745||745|2206||2
066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
066593|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|XEU|1142|2752|lyfalmen|V0006|2282|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||1142||1142|2752||3
066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|793|2272|lyfalmen|V0036|2272|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||793||793|2272||2
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1
066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|GPA|0|0|0|100|XEU|3085|5427|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||3085||3085|5427||1
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6973|10778|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6973||6973|10778||1
067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|102720|133393|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtricitabine, tenofovir alafenamide og rilpivirine||||102720|133393||2
067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1979|3904|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||1979|3904||2
068358|L01XC1001|Arzerra|irþ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|96727|125099|lyfsjukr|||1|15|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||96727||96727|125099||1
068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|þpakki||B02BX05|01.04.2011|31.10.2016|R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|72625|94615|lyfsjukr|||1|14|0|7,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||72625||72625|94615||1
068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|1163|2781|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníð||1163||1163|2781||1
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|3969|6643|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníð||3969||3969|6643||1
068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2429|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||2806||1
068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Deslóratadín|||||||
068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2557|4700|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2557||2557|4700||2
068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1987|3915|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||1987||1987|3915||1
068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1857|3736|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||1857||1857|3736||1
068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3304||1
068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3487||1
068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3259||1
068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3438||1
069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|11200|16596|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||11200||11200|16596||1
069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|35353|47473|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||35353||35353|47473||1
069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|318889|402247|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer Pharma AG|Riociguatum||318889||318889|402247||1
069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1
070113|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1
070142|G04BD0704|Tolterodin Actavis|forðahlk|4|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5192|8327|lyfalmen|V0589|8327|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||5192||5192|8327||1
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|8123|12361|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||8123||8123|12361||1
070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|5531|9533|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||5531||5531|9533||1
070971|N06AB0606|Sertralin Hexal|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2921|3080|lyfalmen|V0323|3080|2|100|0|200,0000|Artasan ehf|Hexal A/S|Sertralín||1380||1380|3080||1
071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|46343|61374|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||46343||46343|61374||1
071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|234378|297139|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||234378||234378|297139||1
071458|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
071468|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2014|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1448|1775|lyfalmen|||2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||432||432|1775||2
071479|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.08.2014|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2678|3246|lyfalmen|||2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1501||1501|3246||2
071490|N03AX1108|Topiramat Bluefish|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2014|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|4718|3552|lyfalmen|||2|60|0|20,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1723||1723|3552||2
071501|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|þpakki||N03AX11|01.12.2013|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|8787|13275|lyfalmen|||2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||8787||8787|13275||2
071528|N03AX1608|Pregabalina Tecnigen|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3836|2948|lyfalmen|V0732|2891|2|56|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||1284||1284|2948||2
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|NOK|62017|81198|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||62017||62017|81198||1
071998|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|496|1863|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||496||496|1863||2
072021|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|378|1701|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||378||378|1701||2
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|5556|10711|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||5556||5556|10711||1
072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|5493|5723|lyfalmen|V0029|5710|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3300||3300|5723||1
072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184083|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|184083||5
072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184083|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|184083||5
072735|L01BA0110|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2734|4944|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2734||2734|4944||2
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|440|1786|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||440||440|1786||1
073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|46318|61342|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||46318||46318|61342||1
073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7009|6620|lyfalmen|V0286|6353|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||3952||3952|6620||1
073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|0|G|0|SHS|0|0|0|100|DKK|367|1600|lyfalmen|V0500|1600|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||305||305|1600||1
073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|288647|364634|lyfsjukr|||1|30|0|30,0000|Vistor hf|Actelion Registration Ltd.|Macitentan||||288647|364634||1
073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PHH|0|1|0|100|DKK|532144|667476|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||532144||532144|667476||1
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|2691|4884|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||2691||2691|4884||1
073682|L01XE1301|Giotrif|filmhtfl|50|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|231089|293048|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||231089||231089|293048||1
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|14702|11852|lyfalmen|V0185|11852|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||7753||7753|11852||1
073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|241|1512|lyfalmen|V0047|1388|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||241||241|1512||1
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|758|2224|lyfalmen|V0305|1893|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||758||758|2224||1
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|408|1742|lyfalmen|V0439|1516|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||408||408|1742||1
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1108|2706|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1108||1108|2706||1
073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1479|2455|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||926||926|2455||2
073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|3396|5853|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||3396||3396|5853||2
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|755|2220|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||755||755|2220||1
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|2519|4648|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||2519||2519|4648||1
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|562|1954|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||562||562|1954||1
074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|LYFIS ehf|ratiopharm GmbH|Paracetamól|||||||2
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGH|0|0|0|100|DKK|485|1848|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||485||485|1848||1
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGH|0|0|0|100|DKK|789|2266|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||789||789|2266||1
074608|N03AX1606|Pregabalin Mylan|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|5628|5494|lyfalmen|V0735|5494|2|56|0|56,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||3134||3134|5494||2
074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|320|1621|lyfalmen|||2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||320||320|1621||1
074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|601|2008|lyfalmen|||2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||601||601|2008||1
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|707|2154|lyfalmen|||1|60|0|12,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||707||707|2154||1
074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|377|1699|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||377||377|1699||1
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|1743|3580|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||1743||1743|3580||1
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4347|7164|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4347||4347|7164||1
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|12743|18720|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||12743||12743|18720||1
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4591|7500|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4591||4591|7500||1
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1240|2370|lyfalmen|V0363|2191|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||864||864|2370||1
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|13442|19682|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||13442||13442|19682||1
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|GPA|0|0|1|100|IKR|3144|5508|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||3144||3144|5508||1
075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|GPA|0|0|1|100|IKR|4555|7450|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||4555||4555|7450||1
075140|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|2,5+2,5 mcg|R03AL06|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6768|10496|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6768||6768|10496||1
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|DKK|1956|3873|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun||||1956|3873||1
075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3241|4206|lyfalmen|V0445|4206|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||2198||2198|4206||1
075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|964|1895|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||964||964|1895||1
075865|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|10095|15075|lyfalmen|V0440|15075|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||10095||10095|15075||1
075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|4396|7231|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4396||4396|7231||2
075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|4396|7231|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4396||4396|7231||2
075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|4786|7768|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4786||4786|7768||2
075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|UAK|0|0|0|100|GBP|432|1775|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||432||432|1775||1
075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|TAV|0|0|1|100|XEU|502|1871|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||502||502|1871||1
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|5062|8148|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||5062||5062|8148||1
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15509|22527|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||15509|22527||1
076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15588|22636|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||15588||15588|22636||1
076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15588|22636|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||15588||15588|22636||1
076067|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|10|stk|1|þpakki||QJ01CA04|01.05.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|406|798|vetalmen|||0|10|0||Icepharma hf|Zoetis Finland OY|||||406|798||2
076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1605|2235|lyfalmen|V0143|1229|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||766||766|2235||2
076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2971|3253|lyfalmen|V0143|2458|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3253||2
076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3742|4452|lyfalmen|V0143|3687|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2377||2377|4452||2
076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1667|2432|lyfalmen|V0144|1344|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||909||909|2432||2
076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3208|3580|lyfalmen|V0144|2687|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3580||2
076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|7023|4956|lyfalmen|V0144|4031|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2743||2743|4956||2
076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5
076369|N05AX0805|Risperidon Alvogen|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|GOV|0|0|0|100|IKR|445|1793|lyfalmen|V0045|1793|2|20|0|2,0000|Alvogen|Alvogen ehf|Risperídón||445||445|1793||1
076378|N05AX0805|Risperidon Alvogen|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1691|2488|lyfalmen|V0290|2488|2|60|0|6,0000|Alvogen|Alvogen ehf|Risperídón||950||950|2488||1
076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1660|2419|lyfalmen|V0291|2419|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||900||900|2419||1
076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1198|2829|lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen||1198||1198|2829||1
076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2488|lyfalmen|V0290|2488|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||950||950|2488||2
076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|213449|271109|lyfsjukr|||1|1|0|6,0000|Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||213449||213449|271109||1
076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|142299|182618|lyfsjukr|||1|1|0|4,0000|Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||142299||142299|182618||1
076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|71259|92887|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||71259||71259|92887||1
076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|35839|48088|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||35839||35839|48088||1
076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|2410|4385|lyfalmen|V0598|4385|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2328||2328|4385||1
076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2
076876|M01AE0219|Alpoxen|töflur|500|mg|25|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|GPA|0|0|1|100|SEK|354|1668|lyfalmen|||2|25|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||354||354|1668||1
077213|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|30|stk|1|þpakki||A02BC05|01.09.2015||R|1|0|0|0|0|0|IPC|0|0|0|100|IKR|2559|4703|lyfalmen|V0005|2661|2|30|0|40,0000|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||2559||2559|4703||1
077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|1|0|1|SPP|0|0|0|100|XEU|42143|56061|lyfsjukr|||1|1|0|1,4300|Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||42143||42143|56061||2
077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|367|1686|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||367||367|1686||1
077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|1042|2615|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1042||1042|2615||1
077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2308|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2308||2
077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|874|1869|lyfalmen|V0671|1869|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||500||500|1869||2
077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4379|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4379||2
077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|5723|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|5723||2
077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8062|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8062||2
077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|9852|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|9852||2
077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12357|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12357||2
077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|584|1984|lyfalmen|||1|10|0|0,8333|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||584||584|1984||1
077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|8800|11503|lyfalmen|V0275|11396|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Quetíapín||7500||7500|11503||2
078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|0|0|OPE|0|0|0|100|DKK|8006|12200|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||8006||8006|12200||1
078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2
078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12099|lyfalmen|V0419|12021|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||7933||7933|12099||1
078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|374|1695|lyfalmen|||1|20|0|2,5000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||374||374|1695||1
078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|570|1965|lyfalmen|||1|40|0|5,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||570||570|1965||1
078688|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|MHS|0|0|1|100|XEU|1100|2695|lyfalmen|V0560|2695|2|100|0||Icepharma hf|Mylan Hospital AS|Lídókaín||1100||1100|2695||2
078699|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|MHS|0|0|1|100|XEU|1230|2873|lyfalmen|V0561|2873|2|100|0||Icepharma hf|Mylan Hospital AS|Lídókaín||1230||1230|2873||2
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|7026|5239|lyfalmen|V0069|2775|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||2949||2949|5239||1
079109|J05AX1401|Daklinza|filmhtfl|60|mg|28|stk|1|þpakki||J05AX14|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1136901|1419625|lyfsjukr|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1136901||1136901|1419625||1
079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
079409|N03AX1604|Brieka|hylki|225|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|17951|10028|lyfalmen|V0688|10028|2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||6428||6428|10028||1
079410|N05AX1207|Lemilvo|töflur|10|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|35522|24769|lyfalmen|V0683|24769|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||17138||17138|24769||1
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2752|4968|lyfalmen|V0315|4968|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2752||2752|4968||1
079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSB|0|0|0|100|IKR|9500|6136|lyfalmen|V0184|4772|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Anastrózól||3600||3600|6136||2
079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1
079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|1633|3428|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1633||1633|3428||1
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|393|1721|lyfalmen|V0176|1721|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1721||1
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|638|2059|lyfalmen|V0418|2059|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|2059||1
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|647|2071|lyfalmen|V0177|2071|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|2071||1
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|1168|2788|lyfalmen|V0411|2788|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2788||1
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9628||2
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3158|6162|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3158|6162||2
080162|N03AX1608|Pregabalina Tecnigen|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|6500|4383|lyfalmen|V0733|4282|2|56|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||2327||2327|4383||2
080256|A10BB0903|Gliclazid LYFIS|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4000|3727|lyfalmen|V0020|2173|2|90|0|45,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||1850||1850|3727||2
080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|11820|7992|lyfalmen|V0421|6817|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||4949||4949|7992||2
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|8581|14790|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||8581||8581|14790||2
080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|BLP|0|0|0|100|XEU|7626|5672|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Letrózól||3263||3263|5672||2
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1803|3662|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1803||1803|3662||1
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|4342|7157|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||4342||4342|7157||1
080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1315|2178|lyfalmen|V0143|1229|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||725||725|2178||1
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2122|4101|lyfalmen|||1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2122||2122|4101||1
080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3123|4206|lyfalmen|V0143|3687|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2198||2198|4206||1
080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1328|2337|lyfalmen|V0144|1344|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||840||840|2337||1
080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|11789|17407|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||11789||11789|17407||1
080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|5862|4671|lyfalmen|V0144|4031|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2536||2536|4671||1
080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|0|0|OPE|0|0|0|100|DKK|26687|36513|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||26687||26687|36513||1
080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|23241|32154|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||23241||23241|32154||1
080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|2513|4634|lyfsjukr|||1|1|0|0,3300|Alvogen|Linepharma France|Mifepriston||2509||2509|4634||1
081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PHH|0|1|0|100|DKK|578417|725027|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||578417||578417|725027||1
081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1
081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1
081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|4237|3662|lyfalmen|V0515|3662|2|100|0|16,6700|Alvogen|Pharmathen S.A.|Levetíracetam||1803||1803|3662||1
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|3632|6180|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||3632||3632|6180||1
081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5
081708|G03AC0903|Desogestrel ratiopharm|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.02.2014||R|0|0|0|0|0|0|RAT|0|0|0|100|IKR|1750|2695|lyfalmen|V0590|2498|2|84|0|84,0000|LYFIS ehf|ratiopharm GmbH|Desógestrel||1100||1100|2695||
081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1658|3463|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1658||1658|3463||2
081900|N05AX1209|Aripiprazole Sandoz|töflur|10|mg|14|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|6152|9648|lyfalmen|V0204|4031|2|14|0|9,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||6152||6152|9648||1
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|3864|6499|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||3864||3864|6499||1
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|5442|8671|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5442||5442|8671||1
082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|13419|7661|lyfalmen|V0184|4677|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||4708||4708|7661||1
082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5
082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|22861|31674|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||22861||22861|31674||2
082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|8123|14001|vetorma|||0|10|0||Vistor hf|Virbac S.A|.||8123||8123|14001||1
082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|39920|68806|vetorma|||0|50|0||Vistor hf|Virbac S.A|.||39920||39920|68806||1
082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|522|1899|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||522||522|1899||1
082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|þpakki||N02BE01|01.10.2013||R|1|0|0|0|0|0|RAT|0|0|1|100|XEU|579|1902|lyfalmen|V0229|1902|2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Paracetamól||524||524|1902||2
082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|2106|4079|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2106||2106|4079||1
082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3882|6524|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3882||3882|6524||1
082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2784|5012|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2784||2784|5012||1
082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3031|5352|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3031||3031|5352||1
082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3627|6173|lyfalmen|V0080|6173|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3627||3627|6173||1
083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||R|1|0|0|0|G|0|BGP|0|0|0|100|DKK|2490|4608|lyfalmen|V0706|4608|1|100|0|16,6700|Vistor hf|BGP Products ApS|Hvatablöndur (lípasi, próteasi o.s.frv.)||2490||2490|4608||1
083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4113|6842|lyfalmen|V0701|6686|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4113||4113|6842||1
083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|8548|5282|lyfalmen|V0686|5282|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||2980||2980|5282||1
083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4851|9374|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||4851||4851|9374||2
083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|794|2067|lyfalmen|V0231|1984|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||644||644|2067||1
084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1594|2710|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1111||1111|2710||2
084456|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|54023|71087|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||54023||54023|71087||1
084807|L01XE2301|Tafinlar|hylki|75|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|177753|226713|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||177753||177753|226713||1
084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|34291|46130|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||34291||34291|46130||1
085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|9988|14928|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||9988||9988|14928||1
085171|A10BX0401|Byetta|stl|5|mcg/sk|60|skammtar|1|penni|lausn|A10BX04|01.10.2015||R|0|0|0|0|0|0|AZA|0|0|0|100|SEK|11984|17675|lyfalmen|||1|60|0|20,0000|Vistor hf|AstraZeneca AB|Exenatíð||11984||11984|17675||1
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|XEU|28695|39052|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||28695||28695|39052||2
085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2045|3995|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2045||2045|3995||2
085407|R03AC0206|Ventoline|innönd.l|1|mg/ml|20|lykjur|1|pakki|lausn f. eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|756|2221|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||756||756|2221||1
085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3815|6431|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3815||3815|6431||2
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|16215|23499|lyfalmen|V0412|21059|1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||16215||16215|23499||1
085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|31119|42118|lyfalmen|V0412|42118|1|750|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||31119||31119|42118||1
085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|13641|18950|lyfalmen|V0652|18895|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||12910||12910|18950||1
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|NED|0|0|0|100|XEU|71170|92775|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||71170||71170|92775||2
085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|GPA|0|0|0|100|SEK|15860|23010|lyfalmen|V0579|23010|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||15860||15860|23010||1
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|0|AEB|0|0|0|100|DKK|25400|34885|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||25400||25400|34885||1
085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|GRP|0|0|0|100|XEU|3331|5765|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3331||3331|5765||1
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2106|4079|lyfalmen|V0465|3246|1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||2106||2106|4079||1
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|6217|9738|lyfalmen|V0465|9738|1|9|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||6217||6217|9738||1
085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|307|1603|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||307||307|1603||1
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1436|3157|lyfalmen|V0364|2953|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1436||1436|3157||1
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|3649|4506|lyfalmen|V0365|3992|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||2416||2416|4506||1
086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|47200|62458|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||47200||47200|62458||2
086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|17378|25100|lyfalmen|||1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||17378||17378|25100||1
086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|6081|9550|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||6081||6081|9550||1
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|6600|10265|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||6600||6600|10265||1
086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10070|15041|lyfalmen|V0012|5151|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||10070||10070|15041||1
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|23082|31953|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||23082|31953||1
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|41788|55612|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||41788|55612||1
086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|40806|54370|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||40806||40806|54370||1
086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|13203|19353|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) með prógestógen||||13203|19353||2
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|39141|52265|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||39141||39141|52265||2
087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||
087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|285|1573|lyfalmen|V0060|1558|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||285||285|1573||1
087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|96841|125243|lyfsjukr|||1|60|0|15,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||96841||96841|125243||1
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|193|1446|lyfalmen|V0312|471|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||193||193|1446||1
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|170|1414|lyfalmen|V0312|1414|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||170||170|1414||1
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|1428|3146|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1428||1428|3146||1
087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|26047|15762|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||10594||10594|15762||1
087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|26047|15762|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||10594||10594|15762||1
087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3804||1
087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1631|3425|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1631||1631|3425||1
087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|0|0|0|0|G|0|MEC|0|0|0|100|SEK|696|2138|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||696||696|2138||2
087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.11.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1774|3335|lyfalmen|V0009|3335|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1565||1565|3335||1
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|25354|43700|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||25354||25354|43700||2
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1
087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2959|5784|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||2959||2959|5784||1
088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|19746|34034|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||19746||19746|34034||2
088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BYP|0|0|0|100|DKK|2452|4555|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||2452||2452|4555||2
088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|RGO|0|0|1|100|GBP|836|2331|lyfalmen|||1|120|0|30,0000|Vistor hf|Glaxo Group Limited|Flútíkasón fúróat||836||836|2331||1
088300|L01BA0110|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2527|4659|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2527||2527|4659||2
088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|20454|14119|lyfalmen|V0684|13871|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||9400||9400|14119||2
088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|8728|13194|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||8728||8728|13194||1
088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|3804|6416|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||3804||3804|6416||1
088697|N06AX1611|Duofaxin|forðatfl|75|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2289|3990|lyfalmen|V0334|3175|2|98|0|73,5000|Vistor hf|MediLink A/S|Venlafaxín||2041||2041|3990||1
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|6281|9826|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6281||6281|9826||1
088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|11596|17141|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||11596||11596|17141||1
088882|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|14606|27881|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|Bismuthi subnitras||14606||14606|27881||2
088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|371585|467786|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||371585||371585|467786||1
088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1157|2773|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1157||1157|2773||1
089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|18325|26403|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||18325||18325|26403||2
089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|104056|132628|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||102105||102105|132628||1
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5904||1
089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|96841|125243|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||96841||96841|125243||1
089156|A03AA0406|Mebeverin dura|filmhtfl|135|mg|100|stk|1|þpakki||A03AA04|01.07.2010|31.10.2016|R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3080|5420|lyfalmen|||2|100|0|45,0000|Icepharma hf|Mylan AB|Mebeverín||3080||3080|5420||2
089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|17091|24705|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||17091||17091|24705||1
089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|41019|54640|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||41019||41019|54640||1
089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||
089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|1987|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||1987||2
089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|19390|27869|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||19390||19390|27869||1
089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|77560|100857|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||77560||77560|100857||1
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1265|2922|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1265||1265|2922||2
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|2531|4664|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||2531||2531|4664||2
090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|593|1997|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||593||593|1997||2
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|4547|7439|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||4547||4547|7439||2
090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|101912|132388|lyfalmen|||1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||101912||101912|132388||3
090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1176|2799|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1176||1176|2799||1
090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|664|2094|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||664||664|2094||1
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|CLA|0|0|0|100|USD|14123|20619|lyfsjukr|||1|60|0||Vistor hf|Alcon Nordic A/S|Flúorescein||||14123|20619||1
091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2044|3994|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2044||2044|3994||1
091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3537|6049|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||3537||3537|6049||1
091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|10382|15470|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||10382||10382|15470||1
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|3096|5442|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3096||3096|5442||1
091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|5129|8240|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||5129||5129|8240||1
091627|J01CR0501|Piperacillin/Tazobactam Actavis|irs|2,5|g|1|hgl|1|pakki|2 g/ 0,5 g|J01CR05|01.08.2014|30.09.2016|R|0|1|0|0|0|1|GRP|0|0|0|100|SEK|989|2542|lyfsjukr|||2|1|0|0,1400|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||989||989|2542||1
091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|GRP|0|0|0|100|XEU|5736|9076|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||5736|9076||1
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|CHA|0|0|1|100|DKK|3101|5449|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||3101||3101|5449||1
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|833|1717|lyfalmen|V0021|1456|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||390||390|1717||1
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1439|1993|lyfalmen|V0022|1593|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||590||590|1993||1
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|XEU|909|2432|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||909||909|2432||1
092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2
092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|1065|2557|lyfalmen|V0004|2484|2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||1000||1000|2557||2
092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2200|3933|lyfalmen|V0011|2938|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|3933||2
092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|5475|lyfalmen|V0011|5141|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||3120||3120|5475||2
092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|1510|2557|lyfalmen|V0005|2484|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||1000||1000|2557||2
092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2400|3933|lyfalmen|V0012|2885|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|3933||2
092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5471|5475|lyfalmen|V0012|5048|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||3120||3120|5475||2
092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SNC|0|0|0|100|NOK|3899|6547|lyfalmen|V0009|3335|1|28|0|28,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||3899||3899|6547||1
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1773|3621|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||1773||1773|3621||1
092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|UAK|0|0|1|100|GBP|484|1847|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||484||484|1847||1
092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|UAK|0|0|1|100|GBP|890|2405|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||890||890|2405||1
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|2613|2609|lyfalmen|V0203|2609|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1038||1038|2609||2
092989|C03DA0403|Eplerenon  Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.10.2014|31.10.2016|R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|3520|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||1650||1700|3520||2
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|778|2251|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||778||778|2251||2
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1786|3639|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||1786||1786|3639||2
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|3472|5959|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||3472||3472|5959||2
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3844|6471|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||3844||3844|6471||1
093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|4605|7519|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||4605||4605|7519||1
093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|1|0|1|0|1|ERZ|0|0|0|100|XEU|19218|23755|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||16401||16401|23755||2
093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1145|2756|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1145||1145|2756||1
093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4570|7471|lyfalmen|V0724|7471|1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4570|7471||2
093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|3384|5838|lyfalmen|V0723|5838|1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3384|5838||2
093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|20629|35556|vetorma|||0|100|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||20629||20629|35556||2
093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1873|3758|lyfalmen|||1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1873||1873|3758||1
093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|27546|37599|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||27546||27546|37599||2
093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6661|10349|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||6661||6661|10349||2
093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|17243|24914|lyfalmen|V0588|18387|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||17243||17243|24914||2
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|310743|392116|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||310743||310743|392116||1
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|331336|417727|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||331336||331336|417727||1
094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|3447|5925|lyfalmen|V0236|5310|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||3447||3447|5925||1
094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|4929|7965|lyfalmen|V0236|7965|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||4929||4929|7965||1
094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1390|2732|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1390||1390|2732||1
094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RAT|0|0|1|100|XEU|824|2195|lyfalmen|V0044|2195|2|25|0|1,2500|LYFIS ehf|ratiopharm GmbH|Acíklóvír||737||737|2195||2
094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2500|2006|lyfalmen|V0324|2006|2|98|0|49,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||600||600|2006||2
094652|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2
094757|N04BC0406|Ropinirole Portfarma|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13221|15686|lyfalmen|V0534|15686|2|84|0|112,0000|Alvogen|Alvogen|Rópíníról||10539||10539|15686||1
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|1|0|1|0|1|VII|0|0|0|100|GBP|59278|77734|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||59278||59278|77734||1
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|0|100|XEU|36905|49436|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||36905|49436||1
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|5035|8678|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||5035||5035|8678||2
095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|31488|42585|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||31488||31488|42585||1
095092|M03AX0101|Botox|sts|200|ae/hgl|1|hgl|1|pakki||M03AX01|01.04.2016||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|40531|51573|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||38594||38594|51573||1
095514|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|296422|374304|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration Limited|Pírfenidon||||296422|374304||2
095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|AGH|0|0|0|100|DKK|6092|9566|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6092||6092|9566||1
095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|12786|18779|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||12786||12786|18779||1
095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|12977|19042|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||12977||12977|19042||1
095704|J01MA0204|Ciprofloxacin Alvogen|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|2422|4514|lyfsjukr|||2|200|0|0,8000|Alvogen|Alvogen ehf|Cíprófloxacín||2422||2422|4514|30.11.2016|1
095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|15107|21974|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15107||15107|21974||1
095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|1737|3571|lyfsjukr|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1737|3571||1
095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|2714|4916|lyfsjukr|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||2714|4916||1
095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|1|100|XEU|765|1564|lyfalmen|V0225|1471|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||279||279|1564||1
095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|4482|6686|lyfalmen|V0701|6686|2|40|0|13,3400|Medical ehf|Teva Pharma B.V.|Búdesóníð||4000||4000|6686||2
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|4156|8055|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4156||4156|8055||2
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|5733|11047|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5733||5733|11047||2
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|9534|18258|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9534||9534|18258||2
096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|82930|107649|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||82930||82930|107649||1
096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1865|2268|lyfalmen|V0088|2244|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||790||790|2268||2
096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1941|2518|lyfalmen|V0089|2495|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||972||972|2518||2
096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|RGO|0|0|1|100|GBP|1324|3003|lyfalmen|||1|5|0||Vistor hf|Glaxo Group Limited|Retapamúlín||1324||1324|3003||1
096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|11565|17099|lyfalmen|V0347|15027|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||11565||11565|17099||1
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|584346|732401|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||584346||584346|732401||2
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|541643|679291|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||541643||541643|679291||2
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|570150|714745|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||570150||570150|714745||2
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|625129|783124|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||625129||625129|783124||2
096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|11698|17282|lyfalmen|V0349|16271|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||11698||11698|17282||1
096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1023|2589|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíð||1023||1023|2589||2
096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNO|0|0|0|100|NOK|9915|14827|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||9915||9915|14827||1
097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|57162|98524|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||57162||57162|98524||2
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|6291|12106|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||6291|12106||2
097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
097269|J01FF0103|Dalacin (Lyf og heilsa)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1696|3515|lyfalmen|V0461|3515|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||1696||1696|3515||2
097498|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|417|1754|lyfalmen|V0333|809|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||417||417|1754||1
097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8645|13079|lyfalmen|V0334|3175|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||8645||8645|13079||1
097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|16083|23317|lyfalmen|V0335|3175|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||16083|23317||1
097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|27190|37149|lyfalmen|||1|1|0||Vistor hf|Amgen Europe B.V.|Evolocumab||27190||27190|37149||1
097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4819|9313|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4819||4819|9313||2
097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|16923|24473|lyfalmen|V0809|24473|1|1|0|1000,0000|Vistor hf|Merck Sharp & Dohme|Etónógestrel||16923||16923|24473||1
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2066|2218|lyfalmen|V0023|1869|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||754||754|2218||1
097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2357|4425|lyfsjukr|||2|2000|0|8,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2357|4425||2
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|854|1900|lyfalmen|V0329|1869|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||523||523|1900||1
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2608|3441|lyfalmen|V0678|3441|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1642||1642|3441||1
098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|4344|3441|lyfalmen|V0679|3441|2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1642||1642|3441||1
098074|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4437|8588|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||4437||4437|8588||2
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|480|1841|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||480||480|1841||2
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|480|1841|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||480||480|1841||2
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2
098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1022|1731|lyfalmen|V0243|1731|2|50|0|4,1600|LYFIS ehf|ratiopharm GmbH|Lamótrigín||400||400|1731||2
098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1812|2006|lyfalmen|V0244|1879|2|50|0|8,3300|LYFIS ehf|ratiopharm GmbH|Lamótrigín||600||600|2006||2
098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|5116|3658|lyfalmen|V0245|3658|2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Lamótrigín||1800||1800|3658||2
098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|9166|8062|lyfalmen|V0232|8062|2|100|0|66,6600|LYFIS ehf|ratiopharm GmbH|Lamótrigín||5000||5000|8062||2
098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|2815|3920|lyfalmen|V0381|3920|2|10|0|2,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1990||1990|3920||2
098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|12561|18469|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||12561||12561|18469||2
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|1|ASZ|0|0|0|100|SEK|55942|73514|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||55942||55942|73514||1
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1989|2013|lyfalmen|V0284|2013|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||605||605|2013||2
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3717|3630|lyfalmen|V0285|3520|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||1780||1780|3630||2
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6652|6353|lyfalmen|V0286|6353|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||3758||3758|6353||2
099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2
099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3451|2141|lyfalmen|V0685|2141|2|100|0|8,3300|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||698||698|2141||1
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1371|1825|lyfalmen|V0247|1716|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||468||468|1825||1
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2476|3178|lyfalmen|V0248|3065|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1451||1451|3178||1
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4467|3486|lyfalmen|V0249|3315|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1675||1675|3486||1
099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|136081|174885|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||136081||136081|174885||1
099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|262294|331859|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||262294||262294|331859||1
099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|524569|658055|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||524569||524569|658055||1
099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|477|1837|lyfalmen|V0414|1837|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||477||477|1837||1
100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|4372|7048|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||4372||4372|7048||1
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|9020|13596|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||9020|13596||2
100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1561|3095|lyfalmen|V0672|3095|2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1391||1391|3095||1
100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|322|1564|lyfalmen|V0563|1564|2|30|0|15,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||279||279|1564||2
100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|1849|1720|lyfalmen|V0685|1199|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||392||392|1720||2
100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|0|GPA|0|0|1|100|XEU|3818|6436|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Lymecycline||3818||3818|6436||1
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|8525|10825|lyfalmen|V0254|10815|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||7007||7007|10825||1
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|12472|18347|lyfalmen|V0256|17009|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||12472||12472|18347||1
101148|QI10AB0301|Alpha Ject  5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|53686|86542|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||53686||53686|86542||1
101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5189||5189|10015||2
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|1053|2090|lyfalmen|V0330|1869|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||661||661|2090||1
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|2163|2783|lyfalmen|V0331|2695|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1164||1164|2783||1
101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2038|2290|lyfalmen|V0088|2290|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||806||806|2290||1
101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2587|2546|lyfalmen|V0089|2546|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||992||992|2546||1
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|9684|18543|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||9684||9684|18543||1
101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4800|7787|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||4800||4800|7787||2
101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|14240|20780|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||14240||14240|20780||2
102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|887|2401|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||887||887|2401||1
102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1298|2967|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1298||1298|2967||1
102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|4703|7654|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||4703||4703|7654||2
102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|325|1628|lyfalmen|V0230|1622|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||325||325|1628||1
102353|N06AX2108|Aritavi|sþ-hylki|60|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|2530|3395|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||1609||1609|3395|30.11.2016|1
102404|R03DX0701|Daxas|filmhtfl|500|mcg|30|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|SEK|5469|8708|lyfalmen|||1|30|0|30,0000|Vistor hf|Takeda GmbH|Roflumílast||5469||5469|8708||1
102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|16052|14391|lyfalmen|V0684|13871|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||9598||9598|14391||2
102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2617|4783|lyfalmen|V0041|2445|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2617||2617|4783||1
102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|12406|18256|lyfalmen|V0441|18256|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||12406||12406|18256||1
103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1558|lyfalmen|V0060|1558|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||274||274|1558||2
103114|L01BA0110|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2051|4003|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2051||2051|4003||2
103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|0|1|0|1|UAB|0|0|0|100|NOK|86948|112731|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|UAB Sicor Biotech|Lipegfilgrastim||86948||86948|112731||1
103610|L01DB0105|Doxorubicin Actavis|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|GRP|0|0|0|100|XEU|3258|5665|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||3258||3258|5665||1
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2501|2843|lyfalmen|V0088|2244|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|2843||1
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|3172|3430|lyfalmen|V0089|2495|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3430||1
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2416|3617|lyfalmen|V0069|2775|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3617||1
103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|1289|1814|lyfalmen|V0033|1814|2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír||460||460|1814||1
103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|5373|3834|lyfalmen|V0182|3811|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||1928||1928|3834||1
103678|N06AX1604|Venlafaxin (Portfarma)|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3473|3658|lyfalmen|V0334|3240|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1800||1800|3658||1
103687|N06AX1604|Venlafaxin (Portfarma)|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|6528|4215|lyfalmen|V0335|3240|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||2205||2205|4215||1
103791|M01AE0115|Alvofen Express|hylki|400|mg|10|stk|1|þpakki||M01AE01|01.01.2015||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1
103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RAT|0|0|0|100|XEU|1404|3113|lyfalmen|V0222|2959|2|5|0|3,6000|LYFIS ehf|ratiopharm GmbH|Fentanýl||1404||1404|3113||2
103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|1|0|1|BAA|0|0|0|100|SEK|241529|306033|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Blöndur||241529||241529|306033||2
103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|95819|123951|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd|Axitinib||95819||95819|123951||1
103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3095|6042|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3095||3095|6042||1
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1909||1
103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|7782|11892|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||7782||7782|11892||2
104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2208|4220|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2208||2208|4220||1
104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|5292|8464|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5292||5292|8464||1
104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|8270|12563|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||8270||8270|12563||1
104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|6102|9579|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6102||6102|9579||1
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|3162|5533|lyfalmen|V0017|4818|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3162||3162|5533||1
104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|4097|6820|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4097||4097|6820||1
104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|3543|6057|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||3543||3543|6057||2
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|85910|111418|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||85910|111418||1
105306|A02BC0505|Nexium (Lyf og heilsa)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|23.09.2007||R|1|0|0|0|0|0|HOL|0|0|0|100|SEK|10069|15039|lyfalmen|V0012|5151|3|100|0|133,3300|Lyf og heilsa|Lyf og heilsa|Esómeprazól||10069||10069|15039||
105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|1005|2564|lyfalmen|V0545|1866|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||1005||1005|2564||2
105363|C03DA0403|Eplerenon  Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|3383|lyfalmen|V0107|3374|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||1600||1600|3383||2
105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|10493|15623|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||10493||10493|15623||1
105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|13191|19337|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||13191||13191|19337||1
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1701|3522|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||1701||1701|3522||1
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2011|3948|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2011||2011|3948||1
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1435|3156|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1435||1435|3156||2
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|2748|3156|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1435||1435|3156||2
106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2745|4959|lyfalmen|V0191|4324|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||2745||2745|4959||2
106390|L01XE1801|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01XE18|01.03.2016||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|355975|448372|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||355975||355975|448372||1
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|13700|20037|lyfsjukr|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||13700||13700|20037||1
106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|7576|11608|lyfsjukr|||1|5|0|0,3125|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||7576||7576|11608||1
106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|2819|3396|lyfalmen|V0107|3374|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||1610||1610|3396||2
107002|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|125955|162291|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||125955||125955|162291||1
107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1224|2865|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1224||1224|2865||1
107265|C03DA0403|Eplerenon  Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.10.2014|31.10.2016|R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9000|9439|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||6000||6000|9439||2
107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3624|6169|lyfalmen|V0438|6169|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||3624||3624|6169||1
107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PIR|0|0|0|100|XEU|16681|21397|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Healthcare UK Limited|Sevóflúran||14688||14688|21397||2
107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|719|2170|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||719||719|2170||1
107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|20582|14119|lyfalmen|V0683|13871|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||9400||9400|14119||2
107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|8574|16437|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||8574|16437||2
108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|1808|3669|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||1808||1808|3669||2
108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2
108347|J05AX1401|Daklinza|filmhtfl|30|mg|28|stk|1|þpakki||J05AX14|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1136901|1419625|lyfsjukr|||1|28|0|14,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1136901||1136901|1419625||1
108413|C10A00001|Praluent|stl|75|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|58677|76974|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||58677|76974||1
108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|42630|56677|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||42630||42630|56677||1
108455|N04BD0203|Rasagilin WH|töflur|1|mg|30|stk|1|þpakki||N04BD02|01.04.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|12957|15257|lyfalmen|V0726|15061|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||10227||10227|15257||2
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|7619|11667|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||7619||7619|11667||1
108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|57891|75980|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||57891||57891|75980||3
108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1091|2682|lyfalmen|||1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1091||1091|2682||1
109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18888|27178|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||18888||18888|27178||1
109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15121|21993|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||15121||15121|21993||1
109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|1281|2944|lyfalmen|V0584|2944|2|28|0|7,4700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||1281||1281|2944||2
109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|4481|7161|lyfalmen|V0585|7161|2|98|0|26,1300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||4345||4345|7161||2
109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|2342|4404|lyfalmen|V0586|4404|2|28|0|14,9300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||2342||2342|4404||2
109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|7598|11638|lyfalmen|V0587|11637|2|98|0|52,2700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||7598||7598|11638||2
109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|13458|18388|lyfalmen|V0588|18387|2|98|0|104,5300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||12502||12502|18388||2
110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||||2
110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|351|1664|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||351||351|1664||2
110177|N06AX2108|Aritavi|sþ-hylki|60|mg|90|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|7111|8715|lyfalmen|V0694|8616|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||5474||5474|8715||1
110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1513|3263|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1513||1513|3263||1
110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5
110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2419|lyfalmen|V0291|2419|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2419||2
110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2700|3864|lyfalmen|V0292|3864|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1950||1950|3864||2
110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4210|5447|lyfalmen|V0296|5447|2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||3100||3100|5447||2
110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|6824|lyfalmen|V0297|6824|2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4100||4100|6824||2
110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1198|2829|lyfalmen|V0065|2257|1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1198||1198|2829||1
110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5
110421|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|áf.spr||H01CC01|01.12.2015||R|0|0|0|1|0|0|MLD|0|0|0|100|DKK|20738|28988|lyfalmen|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||20738||20738|28988||1
110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3063|5396|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3063||3063|5396||1
110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|71760|93521|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||71760||71760|93521||1
111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|0|0|0|0|0|AIP|0|0|0|100|XEU|13138|15681|lyfalmen|||2|1|0||Actavis ehf|Allergan Pharmaceuticals Ltd.|Plast lyfjalykkja (IUD) með prógestógen||10535||10535|15681||1
111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2297|4138|lyfalmen|V0373|4138|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2149||2149|4138||1
111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|CAS|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Casen Recordati S.L.|Natríumpicosúlfat|||||||1
111795|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.09.2014||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2
111863|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.04.2015|30.11.2016|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2943|5231|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||2943||2943|5231||2
111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|566|1960|lyfalmen|V0229|1902|1|100|0|33,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||566||566|1960||1
112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|16923|24473|lyfalmen|V0809|24473|1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||16923||16923|24473||1
112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|158304|202524|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer Pharma AG|Riociguatum||158304||158304|202524||1
112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1700|3520|lyfalmen|||2|100|0|5,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1700||1700|3520||2
113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1
113143|N05AX1205|Aripiprazol Krka|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|40598|25267|lyfalmen|V0717|24749|2|56|0|112,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||17500||17500|25267||2
113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyfalmen|V0655|4759|2|5|0||LYFIS ehf|ratiopharm Oy|Amorolfín|||||4759||2
113331|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.11.2013|30.11.2016|R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1456|3185|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1456||1456|3185||2
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6032|9483|lyfalmen|V0024|8034|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6032||6032|9483||1
113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|16654|24103|lyfalmen|V0024|24103|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||16654||16654|24103||1
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|5433|8658|lyfalmen|V0025|6997|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5433||5433|8658||1
113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|1802|3661|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||1802||1802|3661||2
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|2315|4367|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2315||2315|4367||1
113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|14394|20992|lyfalmen|V0025|20992|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||14394||14394|20992||1
113648|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4578|7472|lyfalmen|V0681|7472|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4571||4571|7472||1
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|3977|6654|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3977||3977|6654||1
113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|389496|490062|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||389496||389496|490062||1
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|468|1825|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||468||468|1825||1
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|592|1995|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||592||592|1995||1
113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|902|2422|lyfalmen|||1|40|0|20,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||902||902|2422||1
114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|732|2188|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||732||732|2188||1
114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1
114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|17078|24687|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||17078|24687||2
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|27479|37514|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||27479|37514||2
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3215|5606|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3215||3215|5606||1
114512|D06BB0401|Condyline|húðlausn|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|1720|3548|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||1720||1720|3548||2
114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|8598|13015|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||8598||8598|13015||1
114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|4450|7305|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||4450||4450|7305||2
114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|13775|lyfalmen|V0420|13775|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||9150||9150|13775||2
114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|4716|8128|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||4716||4716|8128||2
114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1917|2444|lyfalmen|V0278|2444|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||918||918|2444||2
114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2527|2503|lyfalmen|V0279|2503|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||961||961|2503||2
114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|7351|3823|lyfalmen|V0280|3823|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1920||1920|3823||2
114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|9062|3125|lyfalmen|V0282|2909|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1413||1413|3125||2
114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5276|8442|lyfalmen|V0457|8442|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8442||2
115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12222|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12222||2
115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|17396|21138|lyfalmen|V0475|21138|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||14500||14500|21138||2
115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20307|lyfalmen|V0540|20307|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20307||2
115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|74317|96755|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||74317||74317|96755||1
115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1482|3220|lyfalmen|||1|10|0|2,5000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1482||1482|3220||1
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|6886|10658|lyfsjukr|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||6886||6886|10658||1
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|936|2396|lyfalmen|V0158|2396|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||883||883|2396||2
115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1955|2282|lyfalmen|V0276|2282|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||800||800|2282||2
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|8889|13415|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||8889||8889|13415||1
115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1482|3220|lyfalmen|||1|10|0|3,6700|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1482||1482|3220||1
115348|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|142|1376|lyfalmen|V0505|1376|1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||142||142|1376||1
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|8120|12357|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||8120||8120|12357||1
115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|40364|53811|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||40364||40364|53811||1
115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|2703|4901|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2703||2703|4901||1
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|2733|4942|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||2733||2733|4942||1
116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|1429|3147|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1429||1429|3147||1
116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.03.2012|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|2096|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2096||2
116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.03.2012|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|2096|lyfalmen|||2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2096||2
116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||||2
116449|N05AH0313|Olanzapin Sandoz|filmhtfl|5|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|15368|11085|lyfalmen|||2|250|0|125,0000|Artasan ehf|Sandoz A/S|Olanzapín||7196||7196|11085||1
116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1
116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1
116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|589|1892|lyfalmen|V0562|1635|2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||517||517|1892||
116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|294|1585|lyfalmen|V0563|1564|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||294||294|1585||1
116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|706|2136|lyfalmen|V0564|1953|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||694||694|2136||1
116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|12311|18125|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||12311||12311|18125||1
116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|4155|6173|lyfalmen|V0081|6173|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3627||3627|6173||1
116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|4798|7784|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||4798||4798|7784||1
116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|5141|8257|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5141||5141|8257||1
116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|13198|19346|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||13198||13198|19346||1
116769|N06DX0108|Memantine Alvogen|munndr.t|20|mg|56|stk|1|þpakki||N06DX01|01.05.2014|30.11.2016|R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|9958|8018|lyfalmen|||2|56|0|56,0000|Alvogen|Alvogen IPco S.á.r.l.|Memantín||4968||4968|8018||1
116841|D07AC1302|Ovixan|húðlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|528|1907|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||||528|1907||1
117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|7602|14593|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||7602||7602|14593||2
117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1253|2905|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1253||1253|2905||1
117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3432|5904|lyfalmen|V0435|5802|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3432||3432|5904||2
117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|0|ASZ|0|0|0|100|SEK|10368|13594|lyfalmen|V0275|11396|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||9019||9019|13594||1
117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|18324|23124|lyfalmen|V0273|21009|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||15943||15943|23124||1
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1151|2765|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1151||1151|2765||2
117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|29052|35119|lyfalmen|V0272|33747|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||25585||25585|35119||1
117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|36647|49110|lyfalmen|V0261|43233|1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||36647|49110||1
117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|41742|55554|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||41742||41742|55554||1
117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|7563|13036|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||7563||7563|13036||2
117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|4844|9361|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||4844||4844|9361||2
117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|9002|17249|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||9002||9002|17249||2
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1407|3117|lyfalmen|V0278|2444|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1407||1407|3117||1
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2307|3709|lyfalmen|V0279|2503|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1837||1837|3709||1
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7880|3145|lyfalmen|V0282|2909|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1427||1427|3145||1
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1360|3052|lyfalmen|V0283|2619|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1360||1360|3052||1
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|14273|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|14273||5
118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|TCA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7351|4773|lyfalmen|V0280|3823|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2610||2610|4773||1
118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4191|8122|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4191||4191|8122||2
118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|17057|24658|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||17057||17057|24658||1
118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2357|4425|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2357||2357|4425||2
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|APP|0|0|0|100|XEU|380|1704|lyfalmen|||1|120|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||380||380|1704||1
118967|C03DA0405|Eplerenon Actavis|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.09.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|5682|3374|lyfalmen|V0107|3374|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Eplerenón||1594||1594|3374||1
119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|999|2556|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||999||999|2556||1
119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|3173|5548|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||3173||3173|5548||2
119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|749|1910|lyfalmen|V0309|1910|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||530||530|1910||2
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|GBP|273345|345603|lyfsjukr|||1|30|0|20,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||273345||273345|345603||1
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|GBP|244502|309730|lyfsjukr|||1|30|0|40,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||244502||244502|309730||1
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|907|2429|lyfalmen|||1|10|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Cýklópentólat||907||907|2429||1
120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|1|0|100|XEU|33391|44992|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||33391||33391|44992||2
120596|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|10|stk|1|þpakki||QJ01CA04|01.02.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|778|1529|vetalmen|||0|10|0||Icepharma hf|Zoetis Finland OY|||||778|1529||2
120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10373|10678|lyfalmen|V0118|10590|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6900||6900|10678||2
120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|22813|31613|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||22813||22813|31613||1
121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|352503|444053|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||352503||352503|444053||2
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|3590|6122|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3590||3590|6122||1
121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|MBV|0|0|0|100|DKK|5976|9406|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Rókúrón, brómíð||5976||5976|9406||1
121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1
121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|skammtar|1|stauk|dreifa|R03AC02|01.12.1972||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|432|1775|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||432||432|1775||1
121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|396|1726|lyfalmen|||2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||396||396|1726||1
121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|NAA|0|0|0|100|DKK|1328|3008|lyfalmen|V0314|2571|1|100|0|25,0000|Artasan ehf|Novartis Healthcare A/S|Klómípramín||1328||1328|3008||1
121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|264|1544|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||264||264|1544||1
121912|L01BA0110|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2886|5153|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2886||2886|5153||2
122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSB|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Medical ehf|Teva Sweden AB|Flútíkasón|||||||
122354|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|13444|14329|lyfalmen|V0682|13871|2|56|0|18,6600|Artasan ehf|Sandoz GmbH|Aripiprazól||9553||9553|14329||1
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|8144|14037|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||8144||8144|14037||1
122471|L01XE1301|Giotrif|filmhtfl|30|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|231089|293048|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||231089||231089|293048||1
122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|459|1812|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||459||459|1812||2
123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGH|0|0|1|100|DKK|669|2101|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||669||669|2101||1
123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGH|0|0|1|100|DKK|1105|2701|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1105||1105|2701||1
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|24872|42869|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||24872||24872|42869||2
123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|SEK|16103|23345|lyfalmen|||1|90|0|90,0000|Vistor hf|Takeda GmbH|Roflumílast||16103||16103|23345||1
123493|C10AA0506|Atorvaratio|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|0|0|TSB|0|0|0|100|IKR|7844|11977|lyfalmen|V0115|11977|2|100|0|400,0000|Medical ehf|Teva Sweden AB|Atorvastatín||7844||7844|11977||2
123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|24809|42761|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||24809||24809|42761||2
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|XEU|229|1496|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||229|1496||1
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|AVS|0|0|0|100|NOK|18937|27245|lyfalmen|V0579|23010|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||18937||18937|27245||1
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1416|2783|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1416|2783||2
124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SNC|0|0|0|100|NOK|25098|34503|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||||25098|34503||1
124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|7284|11206|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||7284||7284|11206||2
124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|778|2251|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||778||778|2251||1
124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|8866|13384|lyfalmen|V0464|13384|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||8866||8866|13384||1
125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|795|2275|lyfalmen|V0066|2275|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||795||795|2275||1
125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|9872|14768|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Melphalan||9872||9872|14768||1
125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4400|3520|lyfalmen|V0285|3520|2|100|0|25,0000|Medical ehf|Teva Sweden AB|Quetíapín||1700||1700|3520||2
126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|19712|28312|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||19712||19712|28312||3
126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|6570|10223|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||6570||6570|10223||3
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|26220|35922|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||26220||26220|35922||2
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|52440|69085|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||52440||52440|69085||2
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|104881|136081|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||104881||104881|136081||2
126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|1|0|1|BGB|0|1|0|100|DKK|105577|136947|lyfsjukr|||1|1|0||Icepharma hf|Bayer Pharma AG|Aflibercept||105577||105577|136947||2
126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|26714|36547|lyfalmen|||1|100|0|75,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||26714|36547||2
126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|2930|5213|lyfalmen|||1|3|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||2930|5213||1
126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|5750|9095|lyfalmen|V0409|9095|2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||5750||5750|9095||2
127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|3235|5246|lyfalmen|V0011|5246|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2954||2954|5246||1
127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1
128003|N05CF0205|Zovand|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|IKR|1644|2653|lyfalmen|V0313|2653|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||1070||1070|2653||2
128034|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|10|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|519|1895|lyfalmen|V0206|1305|2|10|0|6,6700|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||519||519|1895||1
128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|5731|9069|lyfalmen|V0279|2503|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||5731||5731|9069||2
128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|11248|21510|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíðar í blöndu með öðrum lyfjum||11248||11248|21510||1
128146|N06DX0108|Memantine Alvogen|munndr.t|10|mg|56|stk|1|þpakki||N06DX01|01.05.2014|30.11.2016|R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|4024|4122|lyfalmen|||2|56|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Memantín||2137||2137|4122||1
128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|959|2500|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||959||959|2500||1
128625|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|SEK|3030|5351|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3030||3030|5351||1
129024|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|2500|2282|lyfalmen|V0003|1865|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2282||2
129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|NED|0|0|0|100|XEU|22548|31278|lyfalmen|V0282|2909|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22548||22548|31278||2
129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|248|1522|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||248||248|1522||1
129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|1|0|0|0|0|WEH|0|0|0|100|XEU|17593|22734|lyfalmen|V0680|22734|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||15659||15659|22734||2
129291|A02BC0113|Omeprazol Sandoz|sþ-hylki|40|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|4426|2587|lyfalmen|||2|100|0|200,0000|Artasan ehf|Sandoz A/S|Ómeprazól||1022||1022|2587|31.10.2016|1
129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|MAB|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Meda AB|Natríumhýdrógenkarbonat|||||2752||1
129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|2604|4765|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2604||2604|4765||1
129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|14847|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|14847||2
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1631|3425|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||1631||1631|3425||2
130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|248578|314800|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||248578||248578|314800||1
130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|13451|25690|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||13451||13451|25690||1
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1275|2935|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1275||1275|2935||2
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|8849|13360|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||8849|13360||1
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|42453|68434|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||42453|68434||1
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2337|4397|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||||2337|4397||2
131155|H05BX0104|Cinacalcet Mylan|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|35354|47475|lyfalmen|V0722|38679|2|28|0|42,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||35354||35354|47475||2
131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|781|2255|lyfalmen|||2|100|0|33,3333|Vistor hf|Meda AB|Fenýtóín||781||781|2255||1
131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|SLO|0|0|0|100|SEK|1287|2952|lyfalmen|||2|100|0|15,0000|Vistor hf|Meda AB Solna|Fenemal||1287||1287|2952||1
131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|SLO|0|0|0|100|SEK|1457|3186|lyfalmen|||2|100|0|50,0000|Vistor hf|Meda AB Solna|Fenemal||1457||1457|3186||1
131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|SLO|0|0|0|100|SEK|2073|4034|lyfalmen|||2|100|0|100,0000|Vistor hf|Meda AB Solna|Fenemal||2073||2073|4034||1
131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
132260|N06DA0404|Galantamine Portfarma|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|3110|5461|lyfalmen|||2|28|0|14,0000|Alvogen|Alvogen|Galantamín||3110||3110|5461||1
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4106|2776|lyfalmen|V0581|2776|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1159||1159|2776||1
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2553|2776|lyfalmen|V0580|2776|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1159||1159|2776||1
132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|367440|462631|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||367440||367440|462631||
132494|M01AX0503|Glucosamin LYFIS|mixtduft|1178|mg|30|skpokar|1|pakki||M01AX05|01.05.2016||L|0|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Glúkósamín|||||||2
132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|7834|11963|lyfalmen|||1|28|0|28,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||7834||7834|11963||1
132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|MAB|0|0|1|100|SEK|1036|2606|lyfalmen|||2|100|0|25,0000|Vistor hf|Meda AB|Kódein||1036||1036|2606||1
132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|4864|7875|lyfalmen|V0681|7472|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4864||4864|7875||1
132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5129|9901|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||||5129|9901||2
132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3245|lyfalmen|V0335|3240|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3245||2
132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|466|1822|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||466||466|1822||1
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1
132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|þpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|892|2408|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||892||892|2408||1
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|18951|27265|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||18951||18951|27265||1
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|25199|34631|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||25199||25199|34631||1
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|34265|46097|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||34265|46097||1
133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|SPR|0|0|0|100|DKK|212833|270343|lyfsjukr|||1|2|0||Lyfjaver ehf|ViroPharma SPRL|C1 hemill||212833||212833|270343||3
133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1
133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1
133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|6635|10313|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||6635||6635|10313||1
133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|5195|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||5195||1
133919|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.04.2014|31.10.2016|R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1869|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1869||2
133949|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.02.2015||R|0|0|0|0|G|0|STI|0|0|0|100|NOK|2442|4542|lyfalmen|||1|5|0|13,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||2442||2442|4542||3
133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1661|3467|lyfalmen|V0333|3467|2|30|0|11,2500|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1661||1661|3467||2
134019|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.04.2014|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3245|lyfalmen|||2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3245||2
134085|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.04.2014|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3245|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3245||2
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2553|4694|lyfalmen|V0378|3548|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2553||2553|4694||2
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|6876|10645|lyfalmen|V0378|10645|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||6876||6876|10645||2
134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGH|0|0|0|100|XEU|2108|4082|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||2108||2108|4082||1
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|46649|61761|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||46649||46649|61761||1
134844|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|G|0|BAB|0|0|1|100|DKK|||lyfalmen|V0362|1987|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||7527||2
134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|93642|121197|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||93642||93642|121197||2
134906|A02BC0307|Gasterix|sþ-hylki|30|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4200|2970|lyfalmen|V0007|2970|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Lansóprazól||1300||1300|2970||2
134939|A02BC0307|Gasterix|sþ-hylki|15|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2560|3933|lyfalmen|||2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Lansóprazól||2000||2000|3933||2
135090|C02KX0501|Adempas|filmhtfl|1,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|318889|402247|lyfsjukr|||1|84|0|28,0000|Vistor hf|Bayer Pharma AG|Riociguatum||318889||318889|402247||1
135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDE|0|0|0|100|NOK|8431|12785|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8431||8431|12785||1
135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|705|2151|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Verapamíl||705||705|2151||2
135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|993|2547|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||993||993|2547||1
136168|G03AB0401|Trinovum|töflur|||63|stk|1|þpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|892|2408|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||892||892|2408||1
136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|G|0|PHH|0|0|0|100|DKK|31461|42551|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Limited|Sirolimus||31461||31461|42551||1
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|MAB|0|0|0|100|SEK|4836|7837|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Ísóníazíð||4836||4836|7837||1
136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|54023|71087|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||54023||54023|71087||1
136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|2511|4637|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||2511||2511|4637||1
136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|356|1566|lyfalmen|V0307|1566|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||280||280|1566||2
136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|0|AGH|0|0|1|100|IKR|||lyflausa|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól|||||||1
137110|L01XA0302|Oxaliplatin Hospira|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|4600|7512|lyfsjukr|||2|20|0||Alvogen HS|Hospira UK Ltd.|Oxalíplatín||4600||4600|7512||1
137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|39000|43233|lyfalmen|V0261|43233|2|100|0|100,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||32000||32000|43233||2
137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|16739|24220|lyfsjukr|||2|25|0|1,2500|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||16739||16739|24220||1
137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|4866|7878|lyfsjukr|||2|10|0|0,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||4866||4866|7878||1
137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|4250|7030|lyfsjukr|||2|10|0|1,0000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||4250||4250|7030||1
137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|4804|7793|lyfsjukr|||2|10|0|1,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||4804||4804|7793||1
138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|11272|6125|lyfalmen|V0689|5604|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3592||3592|6125||2
138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2266|4299|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2266||2266|4299||2
138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1292|2959|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1292||1292|2959||2
138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13330|19528|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||13330||13330|19528||1
138619|L01BA0110|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2837|5085|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2837||2837|5085||2
139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|2157|4138|lyfalmen|V0373|4138|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||2149||2149|4138||1
139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|0|0|100|XEU|95516|123568|lyfsjukr|||1|56|0||Celgene AB|Celgene Europe Limited|Apremilast||95516||95516|123568||2
139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|V0807|4370|0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||4370||1
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|959|2500|lyfalmen|V0266|2030|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||959||959|2500||1
140330|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|12501|18387|lyfalmen|V0588|18387|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||12501||12501|18387||1
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|8632|13062|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8632||8632|13062||1
140500|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|4397|7233|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||4397||4397|7233||2
140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|61498|116845|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||61498||61498|116845||1
140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|43352|57591|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||43352||43352|57591||1
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|941|2476|lyfalmen|V0413|2283|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||941||941|2476||1
141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|2930|5213|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||2930|5213||1
141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3042|5367|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3042||3042|5367||1
141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|12122|17865|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||12122|17865||2
141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|BVB|0|0|1|100|DKK|33855|45579|lyfalmen|||1|50|0|8,3300|Lyfjaver ehf|Shire Services BVBA|Hýdrókortisón||33855||33855|45579||3
141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3130|5489|lyfalmen|V0193|4471|1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3130|5489||2
141751|J01EE0106|Co-Trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2009||R|0|0|0|0|0|0|UAK|0|0|1|100|XEU|700|2144|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||700||700|2144||1
141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2909||1
141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|4675|7615|lyfalmen|V0492|7615|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||4675||4675|7615||2
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5150|8269|lyfalmen|V0267|3713|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||5150||5150|8269||1
142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1374|3003|lyfalmen|V0127|2821|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1324||1324|3003||2
142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|18018|25980|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||18018|25980||5
142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|3320|3816|lyfalmen|V0384|2917|2|10|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1915||1915|3816||2
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|650|2075|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||650||650|2075||1
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2309|4359|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2309||2309|4359||1
142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1750|3589|lyfalmen|||2|100|0|16,6700|LYFIS ehf|ratiopharm GmbH|Carvedílól||1750||1750|3589||2
142878|A10BB1203|Glimepirid Bluefish|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|593|1456|lyfalmen|V0021|1456|2|90|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||200||200|1456||2
143139|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16503||1
143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1299|2968|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1299||1299|2968||1
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1756|3597|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1756||1756|3597||1
143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|12827|8733|lyfalmen|V0687|8733|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||5487||5487|8733||1
143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|2792|5023|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||2792||2792|5023||
143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|453|1631|lyfalmen|V0542|1631|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||327||327|1631||1
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|854|2356|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Trópíkamíð||854||854|2356||1
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1058|2637|lyfalmen|V0173|2244|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1058||1058|2637||1
143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|5115|8221|lyfalmen|V0387|7321|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||5115||5115|8221||1
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|5172|8299|lyfalmen|V0386|6579|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||5172||5172|8299||1
143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|OEL|0|0|1|100|XEU|453|1804|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||453||453|1804||1
143787|N06AX1611|Duofaxin|forðatfl|225|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|1259|2795|lyfalmen|||2|28|0|63,0000|Vistor hf|MediLink A/S|Venlafaxín||1173||1173|2795||1
143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|AGH|0|0|0|100|DKK|2271|4306|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||2271||2271|4306||1
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1336|3019|lyfalmen|V0174|2522|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1336||1336|3019||1
144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1617|3406|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1617||1617|3406||1
144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|21524|29983|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||21524||21524|29983||1
144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|53946|70990|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||53946||53946|70990||1
144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2796|5029|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||2796||2796|5029||1
144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|35969|48253|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||35969||35969|48253||1
144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|7918|11637|lyfalmen|V0587|11637|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||7597||7597|11637||1
144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|17985|25935|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||17985||17985|25935||1
144808|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|OEL|0|0|1|100|XEU|474|1833|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||474||474|1833||1
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|60786|79641|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||60786||60786|79641||1
145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1389|2730|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||1389||1389|2730||1
145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2107|4141|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2107||2107|4141||1
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|MAB|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Meda AB|Pýrvín|||||||1
145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3242|6321|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||3242||3242|6321||1
145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|4521|8748|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4521||4521|8748||1
145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7781|11890|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7781||7781|11890||2
145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|4507|7384|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||4507||4507|7384||1
145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|23811|32875|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||23811||23811|32875||1
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|22322|30992|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||||22322|30992||1
146229|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.12.2015||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|6657|10343|lyfsjukr|||2|25|0||Alvogen HS|Hospira UK Ltd.|Írinótekan||6657||6657|10343||1
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|13815|20195|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13815||13815|20195||2
146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|267|1548|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||267||267|1548||1
147263|L01BC0102|Arabine|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.09.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2481|4595|lyfsjukr|||2|20|0||Alvogen|Hospira Nordic AB|Cýtarabín||||2481|4595||1
147426|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.04.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4103|5211|lyfalmen|V0691|4305|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2928||2928|5211||1
147578|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3052||1
148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|1|0|0|ROA|0|0|0|100|DKK|87205|113056|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||87205||87205|113056||2
148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|936|2244|lyfalmen|V0577|2244|2|20|0|6,6667|Alvogen|Orion Corporation|Pívmecillínam||773||773|2244||1
148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1392|3096|lyfalmen|||2|30|0|10,0000|Alvogen|Orion Corporation|Pívmecillínam||1392||1392|3096||1
148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|4787|7449|lyfalmen|||2|100|0|33,3300|Alvogen|Orion Corporation|Pívmecillínam||4554||4554|7449||1
148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|GBP|47959|63418|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||47959||47959|63418||1
148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|GBP|47959|63418|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||47959||47959|63418||1
148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|AGH|0|0|0|100|SEK|322|1547|lyfalmen|V0601|1547|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||266||266|1547||1
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|891|2407|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||891||891|2407||1
148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|81299|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|81299||5
148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|10628|15809|lyfsjukr|||2|10|0||Alvogen|Hospira Nordic AB|Vínkristín||10628||10628|15809||1
148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|22735|31514|lyfsjukr|||1|1|0||Alvogen|Hospira Nordic AB|Raltítrexed||22735||22735|31514||1
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|2818|5517|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||2818||2818|5517||2
149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1906|3804|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1906||1906|3804||1
150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|3679|6244|lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen||3679||3679|6244||1
150448|L01XX4501|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XX45|01.10.2016||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|149484|191555|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomibum||149484||149484|191555||1
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|34363|46221|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||34363|46221||1
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|4963|8012|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||4963||4963|8012||1
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|775|2247|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||775||775|2247||1
151250|J05AX6701|Viekirax|filmhtfl|137,5|mg|56|stk|1|þpakki|12,5mg/75mg/50mg|J05AX67|01.10.2015||R|0|0|0|1|0|1|ABV|0|1|0|100|DKK|1533834|1913298|lyfsjukr|||1|56|0||Vistor hf|AbbVie Ltd.|Ombitasvir, paritaprevir og ritonavir||1533834||1533834|1913298||1
151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|9859|14750|lyfalmen|V0606|4540|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||9859|14750||1
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|32457|43811|lyfalmen|V0607|9076|1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||32457||32457|43811||1
151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|329|1633|lyfalmen|V0633|1553|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||329||329|1633||1
151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|3503|6002|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||3503|6002||2
151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3748|3052|lyfalmen|V0148|3045|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1360||1360|3052||2
151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|0|0|VAL|0|0|0|100|IKR|10143|14738|lyfalmen|V0682|13871|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||9850||9850|14738||2
151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|0|LTH|0|0|1|100|SEK|918|2444|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||918||918|2444||1
151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1768|3475|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1768|3475||2
151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1216|2854|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1216||1216|2854||1
151975|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|2282|lyfalmen|V0006|2282|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||800||800|2282||2
152197|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|plglas|23,75 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|906|2162|lyfalmen|V0050|2162|2|100|0|15,8300|Artasan ehf|Hexal A/S|Metóprólól||713||713|2162||1
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1481|3219|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1481||1481|3219||1
152318|D01BA0204|Terbinafine (Lyf og heilsa)|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|HOL|0|0|0|100|XEU|1719|3523|lyfalmen|V0123|3523|3|28|0|28,0000|Lyf og heilsa|Lyf og heilsa|Terbínafín||1702||1702|3523||2
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1
152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2272|4308|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2272||2272|4308||1
152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3646|6199|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3646||3646|6199||1
152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|6667|10357|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||6667||6667|10357||1
152635|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1
152636|A02BC0113|Omeprazol Sandoz|sþ-hylki|10|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2769|4261|lyfalmen|V0002|4261|2|100|0|50,0000|Artasan ehf|Sandoz A/S|Ómeprazól||2238||2238|4261||1
152653|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|1427|2144|lyfalmen|V0033|1814|2|10|0|1,6667|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||700||700|2144||2
152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|14603|21280|lyfalmen|||3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||14603||14603|21280||2
152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|5140|4002|lyfalmen|V0182|4002|2|42|0|7,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||2050||2050|4002||2
152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|12712|8751|lyfalmen|||2|90|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||5500||5500|8751||2
152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|854|2356|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||854||854|2356||1
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1250|2901|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1250||1250|2901||1
153190|S01EC0402|Brinzolamide ratiopharm|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.04.2016||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1176|2006|lyfalmen|V0444|2006|2|5|0|25,0000|LYFIS ehf|ratiopharm GmbH|Brinzólamíð||600||600|2006||2
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|25773|35357|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||25773|35357||1
153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1579|3354|lyfalmen|V0561|2873|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1579||1579|3354||1
153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1105|2701|lyfalmen|V0560|2695|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1105||1105|2701||1
153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|TCA|0|0|1|100|XEU|||lyfalmen|V0575|2148|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín|||||3383||1
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|166657|212913|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||166657||166657|212913||2
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|XEU|559|1950|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||559|1950||1
153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|25058|34452|lyfalmen|V0452|34452|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||25058||25058|34452||1
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|3003|5314|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3003||3003|5314||1
153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGH|0|0|1|100|XEU|500|1869|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||500||500|1869||1
153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGH|0|0|1|100|XEU|849|2349|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||849||849|2349||1
154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|VBT|0|0|1|100|XEU|495|1862|lyfalmen|||2|30|0|30,0000|Medical ehf|Teva B.V.|Deslóratadín||495||495|1862||2
154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|17953|18358|lyfalmen|V0183|18358|2|1|0|27,9070|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||12480||12480|18358||1
154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|7319|11254|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||7319||7319|11254||1
154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993|31.10.2016|R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|866|2372|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||866||866|2372||1
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|15776|22895|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||15776||15776|22895||1
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|18025|25990|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||18025||18025|25990||1
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22549|31279|lyfsjukr|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||22549||22549|31279||1
154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20572|28778|lyfsjukr|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||20572||20572|28778||1
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20853|29134|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||20853||20853|29134||1
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25274|34726|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||25274||25274|34726||1
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|13450|19693|lyfsjukr|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||13450||13450|19693||1
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2561|4705|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2561||2561|4705||1
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|19876|28538|lyfsjukr|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||19876||19876|28538||1
154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1183|2809|lyfalmen|V0336|2235|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1183||1183|2809||1
154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2721|3175|lyfalmen|V0334|3175|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1449||1449|3175||1
154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5397|3175|lyfalmen|V0335|3175|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1449||1449|3175||1
155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|2305|2789|lyfalmen|V0604|2789|2|30|0|15,0000|LYFIS ehf|ratiopharm GmbH|Memantín||1169||1169|2789||2
155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|1371|1716|lyfalmen|V0247|1716|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||389||389|1716||1
155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|2476|3065|lyfalmen|V0248|3065|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||1369||1369|3065||1
155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|4467|3315|lyfalmen|V0249|3315|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||1551||1551|3315||1
155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|13757|20116|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||13757||13757|20116||1
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1206|2840|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1206||1206|2840||1
155410|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1500|2282|lyfalmen|V0466|1958|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2282||2
155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|9408|6119|lyfalmen|V0253|5871|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3588||3588|6119||1
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|520|1896|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||520||520|1896||1
155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|1300|2498|lyfalmen|V0590|2498|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||957||957|2498||1
155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen|||||||2
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4573|7475|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4573||4573|7475||1
156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|16000|23203|lyfalmen|V0383|23203|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||16000||16000|23203||2
156439|L04AC1001|Cosentyx|stl|150|mg|2|áf.spr|1|þpakki||L04AC10|01.07.2015|30.11.2016|R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|131637|145656|lyfsjukr|||1|2|0||Vistor hf|Novartis Europharm Ltd|Secukinumab||112580||112580|145656||1
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|4190|6948|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||4190||4190|6948||2
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|4690|7636|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||4690||4690|7636||2
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|303|1598|lyfalmen|||2|15|0|3,7500|Vistor hf|Meda AB|Nítrófúrantóín||303||303|1598||1
156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|7621|11670|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||7621||7621|11670||2
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|523|1900|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||523||523|1900||1
156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|9131|17494|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||9131||9131|17494||2
157015|QP54AB5207|Equest Pramox vet|hlaup|||14,4|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.08.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|2212|3813|vetorma|||0|14,4|0||Icepharma hf|Zoetis Finland OY|||2212||2212|3813||2
157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2
157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33164|44705|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33164|44705||1
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1185|2812|lyfalmen|V0239|2812|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1185||1185|2812||1
157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|5219|8364|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||5219||5219|8364||1
158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|818|2306|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||||818|2306||1
158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|0|ASA|0|0|0|100|SEK|20311|28448|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||20311|28448||1
158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|739|2198|lyfalmen|V0239|1406|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||739||739|2198||1
158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|35357|47479|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||35357|47479||1
158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|46537|61619|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||46537||46537|61619||1
158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3123|4206|lyfalmen|V0143|3687|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2198||2198|4206||1
158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|0|0|100|DKK|279974|353848|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||279974|353848||2
158725|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|720|1889|lyfalmen|V0469|1889|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||515||515|1889||2
159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1638|3083|lyfalmen|V0219|3083|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1382||1382|3083||1
159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|2809|5000|lyfalmen|V0220|5000|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||2775||2775|5000||1
159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|4032|6347|lyfalmen|V0221|6345|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3754||3754|6347||1
159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|4372|6865|lyfalmen|V0223|6865|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4130||4130|6865||1
159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3218|2832|lyfalmen|V0581|2776|2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||1200||1200|2832||2
159341|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.06.2015||R|0|0|0|0|G|0|LYF|0|0|0|100|IKR|27000|20450|lyfalmen|V0421|20450|2|90|0|270,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||14000||14000|20450||2
159454|L01XX3202|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.12.2015||R|0|1|0|1|0|1|IPC|0|1|0|100|SEK|106086|137580|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomíb||106086||106086|137580||1
159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2
159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|369|1688|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||369||369|1688||2
159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1119|2721|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1119||1119|2721||2
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|106619|138242|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||106619||106619|138242||1
159845|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|100|stk|1|þpakki||A02BC05|01.10.2015||R|1|0|0|0|0|0|IPC|0|0|0|100|IKR|8980|13541|lyfalmen|V0012|5151|2|100|0|133,3300|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||8980||8980|13541||1
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3267|6369|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3267||3267|6369||2
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|IKR|5300|3278|lyfalmen|V0010|2090|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1524||1524|3278||1
160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGH|0|0|0|100|DKK|5859|4586|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2474||2474|4586||1
160343|G03AA1206|Cleodette|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|2284|4324|lyfalmen|V0191|4324|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2284||2284|4324||1
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|656|2083|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||656||656|2083||1
160531|C10AC0101|Questran|mixtduft|4|g|50|skammtar|1|skpoki||C10AC01|01.05.2016||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|2888|5156|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2888||2888|5156||1
160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|G|0|BOI|0|0|1|100|DKK|935|2467|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||935||935|2467||1
161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|531|1911|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||531||531|1911||1
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|717|2167|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||717||717|2167||1
161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|1115|2715|lyfalmen|V0169|2072|1|14|0|12,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||1115||1115|2715||1
161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1975|3899|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||1975||1975|3899||1
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|472|1830|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||472||472|1830||1
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|47968|63429|lyfalmen|V0452|34452|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||47968||47968|63429||1
161592|J01DD0101|Cefotaxim Villerton|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|5064|8151|lyfsjukr|||2|100|0|2,5000|Icepharma hf|Villerton Invest SA|Cefotaximum||||5064|8151||2
161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|23166|32059|lyfalmen|||1|90|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||23166||23166|32059||1
161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|9564|14344|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||9564||9564|14344||1
162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|114063|147501|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||114063||114063|147501||1
162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|424834|534013|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||424834||424834|534013||1
162276|A10BB0904|Zodediab|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2658|4389|lyfalmen|V0020|4346|2|180|0|90,0000|Alvogen|Alvogen IPco S.á.r.l.|Glíklazíð||2331||2331|4389||1
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1574|3347|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1574||1574|3347||1
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|4399|8516|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||4399||4399|8516||2
162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2016|2495|lyfalmen|V0041|2495|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||955||955|2495||2
162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|445|1786|lyfalmen|V0500|1600|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||440||440|1786||2
162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|745|2206|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||745||745|2206||2
162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|918|2006|lyfalmen|V0502|1706|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||600||600|2006||2
162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.08.2012|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1770|lyfalmen|||2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1770||2
162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.08.2012|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1899|lyfalmen|||2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1899||2
162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.08.2012|31.10.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2232|lyfalmen|||2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2232||2
162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|1084|2672|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1084||1084|2672||1
163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|7874|12018|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||7874||7874|12018||1
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|955|2495|lyfalmen|V0671|1869|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||955||955|2495||1
163239|L01BA0110|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3238|5637|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3238||3238|5637||2
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1105|2701|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1105||1105|2701||1
163324|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1514|3264|lyfalmen|V0213|3264|2|100|0|25,0000|Acare ehf|Medical Valley Invest AB|Lósartan||1514||1514|3264||2
163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|4917|7948|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||4917||4917|7948||1
163389|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AD01|01.09.2015||L|0|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||2
163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|9347|14046|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||9347||9347|14046||2
163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|1891|3783|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1891||1891|3783||1
163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|408372|513539|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||408372||408372|513539||2
163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1539|3299|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1539||1539|3299||1
163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|474|1713|lyfalmen|||2|30|0|20,0000|LYFIS ehf|ratiopharm Oy|Íbúprófen||387||387|1713||2
163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RPO|0|0|1|100|XEU|1306|2463|lyfalmen|||2|100|0|66,6700|LYFIS ehf|ratiopharm Oy|Íbúprófen||932||932|2463||2
164125|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.02.2014||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3085|5427|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3085||3085|5427||1
164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|VON|0|0|0|100|DKK|30762|41667|lyfsjukr|||1|100|0||Williams & Halls efh|Nova Laboratories Limited|Merkaptópúrín||30762||30762|41667||2
164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7485|14371|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||7485||7485|14371||1
164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995|31.10.2016|R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2293|4337|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Selegilín||||2293|4337||2
164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010|31.10.2016|R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|7558|11583|lyfalmen|||2|100|0|200,0000|Icepharma hf|Mylan AB|Selegilín||7558||7558|11583||2
164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|318889|402247|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer Pharma AG|Riociguatum||318889||318889|402247||1
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|822|2312|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||822||822|2312||2
164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1010|2571|lyfalmen|V0314|2571|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1010||1010|2571||2
164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|4406|7245|lyfalmen|V0014|7245|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4406|7245||2
165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1
165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGH|0|0|0|100|XEU|1185|2812|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||1185||1185|2812||1
165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|5382|10381|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||5382||5382|10381||2
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|135312|173929|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||135312||135312|173929||2
165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|23908|32998|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||23908||23908|32998||2
165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|34811|46788|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||34811||34811|46788||2
165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|492|1858|lyfalmen|V0506|1858|1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||492||492|1858||1
165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|142|1376|lyfalmen|V0505|1376|1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||142||142|1376||1
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1
165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|158304|202524|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer Pharma AG|Riociguatum||158304||158304|202524||1
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3260|5668|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3260||3260|5668||1
165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|46440|61496|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||46440||46440|61496||2
165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|4656|9004|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|Butylscopolamine og metamizolum||||4656|9004||2
166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3647|7090|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||3647|7090||1
166120|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.04.2013||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|326330|411501|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||326330||326330|411501||2
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1219|2858|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1219||1219|2858||1
166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PLS|0|0|0|100|DKK|12161|17919|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||12161||12161|17919||1
166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1557|2639|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1060||1060|2639||2
166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2948|5238|lyfalmen|V0428|5238|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||2948||2948|5238||2
166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|112956|146124|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||112956||112956|146124||1
166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|0|0|0|0|0|0|UAK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1
167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|350|1662|lyfalmen|V0333|809|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||350||350|1662||1
167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1396|2484|lyfalmen|V0005|2484|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||947||947|2484||1
168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|138086|177379|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||138086||138086|177379||2
168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|13864|lyfalmen|V0420|13775|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||9215||9215|13864||1
168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|350|1662|lyfalmen|V0119|1662|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||350|1662||1
168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|4452|3754|lyfalmen|V0007|2911|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||1870||1870|3754||1
168423|R06AX2701|Aerius|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.10.2015||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|2673|4860|lyfalmen|V0458|3177|1|90|0|90,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||2673||2673|4860||1
168589|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2175|4174|lyfalmen|V0621|1173|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||2175||2175|4174||1
168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|1858|3738|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||1858||1858|3738||2
168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2041|3990|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2041||2041|3990||2
168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2518|4646|lyfalmen|||1|0,4|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2518||2518|4646|31.10.2016|2
168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2430|4525|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2430||2430|4525||2
168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2379|4455|lyfalmen|V0240|4455|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2379||2379|4455||1
168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4391|7224|lyfalmen|V0433|7223|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||4391||4391|7224||1
168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|21726|30238|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||21726||21726|30238||1
169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|9924|6125|lyfalmen|V0688|5616|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3592||3592|6125||2
169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|108630|140744|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||108630||108630|140744||1
169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|16079|23312|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||16079||16079|23312||2
169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|3919|6575|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||3919||3919|6575||1
169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|1168|2788|lyfalmen|V0411|2788|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1168||1168|2788||1
169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|647|2071|lyfalmen|V0177|2071|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||647||647|2071||1
169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|638|2059|lyfalmen|V0418|2059|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||638||638|2059||1
169784|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|393|1721|lyfalmen|V0176|1721|2|10|0|2,5000|Alvogen|Alvogen ehf|Cíprófloxacín||393||393|1721||1
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2071|4031|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2071||2071|4031||1
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2229|4248|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2229||2229|4248||1
170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|15466|22468|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||15466|22468||2
170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|38297|51197|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||38297|51197||2
170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|4115|6844|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4115||4115|6844||1
170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|76595|99636|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||76595||76595|99636||2
170486|C10A00001|Praluent|stl|75|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|168985|215808|lyfalmen|||1|6|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||168985|215808||1
170489|G04BD0705|Tolterodine Sandoz|forðahlk|4|mg|28|stk|1|plglas||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2694|4889|lyfalmen|V0618|4889|1|28|0|28,0000|Artasan ehf|Sandoz A/S|Tólteródín||||2694|4889||1
170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|10529|15673|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||10529||10529|15673||2
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1695|3513|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||1695||1695|3513||1
170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|8900|13430|lyfsjukr|||2|1600|0|6,6700|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||8900||8900|13430||1
170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|21410|29838|lyfsjukr|||2|1600|0|20,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||21410||21410|29838||1
170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|32114|43377|lyfsjukr|||2|2400|0|30,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||32114||32114|43377||1
170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|27890|38034|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||27890|38034||1
170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2613|2609|lyfalmen|V0203|2609|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1038||1038|2609||1
170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Le Vet B.V.|||1158||1158|2276||2
170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|44794|59414|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||44794||44794|59414||2
171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2135|4196|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2135||2135|4196||1
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2567|4714|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||2567||2567|4714||1
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2592|4748|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||2592||2592|4748||1
171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|0|G|0|GBP|0|0|0|100|DKK|1658|3463|lyfalmen|||1|30|0|20,0000|Icepharma hf|BGP Produtcs B.V.|Mebeverín||1658||1658|3463||2
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2200|4209|lyfalmen|V0247|1716|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2200||2200|4209||1
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3823|6442|lyfalmen|V0248|3065|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3823||3823|6442||1
171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|34917|46922|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||34917||34917|46922||2
172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|23278|32201|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||23278||23278|32201||2
172289|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|88269|114402|lyfalmen|V0484|114402|1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||||88269|114402||2
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|7078|10923|lyfalmen|V0249|3315|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7078||7078|10923||1
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|12881|18910|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||12881||12881|18910||1
172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|53540|70476|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||53540||53540|70476||2
172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|33707|lyfalmen|||3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33707||2
172567|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|14859|25611|vetorma|||0|200|0||Icepharma hf|Zoetis Finland OY|Doramectinum||14859||14859|25611||2
172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|17532|25312|lyfalmen|||1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||17532||17532|25312||1
172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|7788|11900|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||7788||7788|11900||1
172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|4771|7747|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||4771||4771|7747||2
172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|8872|13392|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||8872||8872|13392||2
172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2119|2030|lyfalmen|V0284|2013|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||617||617|2030||1
172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|15378|22347|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||15378||15378|22347||2
172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|477205|599148|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||477205||477205|599148||1
172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|19799|28432|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||19799||19799|28432||2
173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|294|1585|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||294||294|1585||1
173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|8285|10378|lyfalmen|V0118|10378|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||6682||6682|10378||1
173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2404|4489|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||2404||2404|4489||2
173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3216||1
173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|4349|7166|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||4349||4349|7166|30.11.2016|2
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|10317|15381|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||10317||10317|15381||1
173895|N05AX1207|Lemilvo|töflur|15|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|32456|24769|lyfalmen|V0684|24769|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||17138||17138|24769||1
173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|11261|16680|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||11261||11261|16680||1
173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGH|0|0|0|100|DKK|1527|3282|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1527||1527|3282||1
174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|439|1785|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||439||439|1785||1
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|448|1797|lyfalmen|||1|14|0|7,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||448||448|1797||1
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|1117|2718|lyfalmen|V0368|2093|1|5|0|25,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1117||1117|2718||1
174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5172|lyfalmen|||2|30|0|3,1200|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5172||
174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|9338|14033|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||9338||9338|14033||1
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|3704|6279|lyfalmen|V0368|6279|1|15|0|75,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3704||3704|6279||1
174935|L01XE1301|Giotrif|filmhtfl|20|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|231089|293048|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||231089||231089|293048||1
175058|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|1262|2917|lyfalmen|||2|10|0|1,2500|Medical ehf|Teva Pharma B.V.|Quetíapín||1262||1262|2917||2
175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|6654|6213|lyfalmen|V0389|6213|1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3656||3656|6213||1
175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|4160|8063|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||4160||4160|8063||2
175370|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|12376|18215|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||12376|18215||1
175600|G03AA0904|Denise|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2014||R|0|0|0|0|0|0|RAT|0|0|0|100|IKR|1477|2419|lyfalmen|V0065|2257|2|63|0|84,0000|LYFIS ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||900||900|2419||2
175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|1864|2094|lyfalmen|V0033|1814|1|10|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||664||664|2094||1
175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5
176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|3882|6524|lyfalmen|V0278|2444|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3882||3882|6524||2
176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|3247|5650|lyfalmen|V0429|5650|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3247||3247|5650||2
176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|0|RAD|0|0|1|100|DKK|2151|4141|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2151||2151|4141||1
176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5142|9926|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||5142||5142|9926||2
177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6363|9939|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||6363||6363|9939||2
177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|644|2067|lyfalmen|V0231|1984|2|300|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||644||644|2067||1
177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|3571|6945|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||3571||3571|6945||2
177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|5882|9276|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Kolkisín||5882||5882|9276||1
178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|26714|36547|lyfalmen|||1|100|0|50,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||26714||26714|36547||2
178273|L01XE2501|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|770459|963874|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||770459||770459|963874||1
178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4998|3727|lyfalmen|V0320|3727|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1850||1850|3727||2
179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|110547|143128|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||110547||110547|143128||1
179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|7541|11560|lyfalmen|||1|28|0|21,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||7541|11560||2
179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|13947|20377|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||13947||13947|20377||1
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|91038|117904|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||91038||91038|117904||2
180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|3866|6502|lyfalmen|||1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||3866||3866|6502||1
180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|2191|3383|lyfalmen|V0148|3383|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1600||1600|3383||2
180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|622|2037|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||622||622|2037||1
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2
181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|7627|11678|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||7627||7627|11678||1
181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1
181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|4774|7751|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||4774||4774|7751||1
182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5256||2
182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|9378|14088|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||9378||9378|14088||1
182435|A10BB0903|Gliclazid LYFIS|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8700|4346|lyfalmen|V0020|4346|2|180|0|90,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||2300||2300|4346||2
182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|12601|18524|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||12601||12601|18524||2
182707|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.2016||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|4180|7205|vetorma|||0|50|0||Icepharma hf|Zoetis Finland OY|Doramectinum||||4180|7205||2
182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|16094|30704|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||16094|30704||2
182862|N04BC0507|Pramipexole Sandoz|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|26963|29012|lyfalmen|V0636|29012|2|100|0|84,0000|Artasan ehf|Sandoz A/S|Pramipexól||20757||20757|29012||1
182893|M05BA0806|Zoledronic Acid Accord|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.07.2016||R|0|1|0|1|0|1|AHL|0|0|0|100|IKR|9983|4515|lyfsjukr|||2|5|0|1,0000|Alvogen|Accord Healthcare Limited|Zoledronsýra||2423||2423|4515||1
183093|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|SEK|2813|5052|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||2813||2813|5052||1
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4206|8150|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||4206||4206|8150||1
183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1485|2214|lyfalmen|V0234|1403|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||751||751|2214||2
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|4516|7396|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||4516|7396||1
183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5432|10476|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||5432||5432|10476||2
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|APP|0|0|0|100|DKK|927|2456|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Flúdrókortisón||927||927|2456||1
184046|L01XE2701|IMBRUVICA|filmhtfl|140|mg|90|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|644864|807669|lyfsjukr|||1|90|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||644864|807669||1
184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|526|1904|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||526||526|1904||1
184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|IKR|1517|2416|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||898||898|2416||1
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|2643|4818|lyfalmen|V0017|4818|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||2643|4818||2
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|41807|55636|lyfalmen|V0185|11852|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||41807||41807|55636||1
184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|þpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1090|2681|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og ensímblokkar||1090||1090|2681||1
185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|LYFIS ehf|ratiopharm GmbH|Krómóglíkatsýra|||||||2
186052|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|20|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1038|2609|lyfalmen|V0206|2609|2|20|0|13,3400|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||1038||1038|2609||1
186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|14199|12880|lyfalmen|V0419|12880|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||8500||8500|12880||1
186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|750|2213|lyfalmen|V0597|2213|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||750||750|2213||1
186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|10240|9261|lyfalmen|V0607|9261|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Memantín||5871||5871|9261||2
186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|4860|7870|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||4860||4860|7870||1
187032|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|100|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|1|0|0|0|GPA|0|0|1|100|XEU|3101|5449|lyfalmen|V0210|5449|2|100|0|66,6600|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||3101||3101|5449||1
187154|N06AX1611|Duofaxin|forðatfl|225|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|3542|5725|lyfalmen|||2|98|0|220,5000|Vistor hf|MediLink A/S|Venlafaxín||3302||3302|5725||1
187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2459|4565|lyfalmen|V0462|4565|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4565||2
187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|4550|7842|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||4550||4550|7842||2
187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|3224|5618|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||3224||3224|5618||1
188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2539||2
188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|PHH|0|0|0|100|DKK|60205|78906|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Limited|Tigecýklín||60205||60205|78906||1
188405|N02CC0403|Rizatriptan Portfarma|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1226|2071|lyfalmen|V0621|1173|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||647||647|2071||1
188479|N04BD0201|Azilect|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TBB|0|0|0|100|NOK|14294|20855|lyfalmen|V0726|14057|1|28|0|28,0000|Vistor hf|Teva B.V.|Rasagilín||14294||14294|20855||1
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|0|G|0|DEA|0|0|0|100|XEU|2283|4323|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2283||2283|4323||1
188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|4540|7429|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||4540||4540|7429||1
188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|3088|5431|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||||3088|5431||2
189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|1|0|1|PSA|0|0|0|100|DKK|7530|11545|lyfsjukr|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||7530||7530|11545||1
189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|33870|45598|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||33870||33870|45598||1
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|NAA|0|0|0|100|DKK|5585|8868|lyfsjukr|||1|10|0||Artasan ehf|Novartis Healthcare A/S|Deferoxamín||5585||5585|8868||1
189235|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|áfspr||H01CC01|01.12.2015||R|0|0|0|1|0|0|MLD|0|0|0|100|DKK|4147|6888|lyfalmen|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4147||4147|6888||1
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|2206|4217|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2206||2206|4217||1
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|801|2283|lyfalmen|V0413|2283|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||801||801|2283||1
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|388|1715|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||388||388|1715||1
189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|359|1675|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||359||359|1675||1
190000|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3424|3094|lyfalmen|V0693|3029|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||1390||1390|3094||2
190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|0|G|0|APP|0|0|0|100|DKK|1332|3014|lyfalmen|||1|90|0|45,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól||1332||1332|3014||1
190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|211|1471|lyfalmen|||2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||211||211|1471||1
190425|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|6024|9472|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||6024|9472||2
190728|M01AB0101|Confortid|eþ-stíll|50|mg|10|stk|1|þpakki||M01AB01|01.08.2012||R|0|0|0|0|G|0|AGH|0|0|1|100|DKK|1226|2868|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1226||1226|2868|30.11.2016|1
190889|G03XB0201|Esmya|töflur|5|mg|28|stk|1|þpakki||G03XB02|01.05.2016||R|0|1|0|1|G|0|CLP|0|0|0|100|XEU|18459|26587|lyfalmen|||1|28|0|28,0000|Vistor hf|Gedeon Ricther Plc.|Ulipristal||18459||18459|26587||1
190894|N04BC0507|Pramipexole Sandoz|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.09.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|10291|13664|lyfalmen|V0635|13664|2|100|0|20,8000|Artasan ehf|Sandoz A/S|Pramipexól||9070||9070|13664||1
191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3262||1
191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3013|5328|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3013||3013|5328||1
191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|5454|6565|lyfalmen|V0117|6565|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||3912||3912|6565||1
191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2839|5088|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||2839||2839|5088||1
191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2961|5256|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||2961||2961|5256||1
191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1
191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|407|1741|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||407||407|1741||1
191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|18499|10007|lyfalmen|V0689|10007|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||6413||6413|10007||1
192030|QD06AA0202|Cyclospray vet.|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|0|ERO|0|0|0|100|XEU|891|1751|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||891||891|1751||1
192296|H05BX0103|Cinacalcet Sandoz|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|33016|27259|lyfalmen|V0721|27238|2|28|0|28,0000|Artasan ehf|Sandoz A/S|Cinacalcet||18947||18947|27259||1
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|2984|5288|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2984||2984|5288||1
192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|3734|5650|lyfalmen|V0429|5650|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||3247||3247|5650||1
192558|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|492|1858|lyfalmen|V0506|1858|1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||492||492|1858||1
192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1253|2905|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1253||1253|2905||1
192644|C10BA0501|Atozet|filmhtfl|90|mg|30|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5095|8193|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5095||5095|8193||1
192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5570|8847|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5570||5570|8847||2
192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|IRE|0|1|0|100|XEU|137357|176472|lyfsjukr|||2|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Dexametasón||137357||137357|176472||1
193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2121|2214|lyfalmen|V0233|1797|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||751||751|2214||2
193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|724|2177|lyfalmen|V0447|2082|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||724||724|2177||1
193411|H05BX0104|Cinacalcet Mylan|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|22419|31115|lyfalmen|V0721|27238|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||22419||22419|31115||2
193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|17378|25100|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||17378||17378|25100||1
193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2443||1
193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|31889|51405|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||31889||31889|51405||1
194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|2031|2006|lyfalmen|V0556|1965|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||600||600|2006||1
194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4262|8256|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4262||4262|8256||2
194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5059|5151|lyfalmen|V0012|5151|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2885||2885|5151||1
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1287|2952|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1287||1287|2952||2
195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13002||2
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|45104|59807|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||45104||45104|59807||2
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|109646|142007|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||109646||109646|142007||1
195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|786|2262|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||786||786|2262||1
195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|511|1884|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||511||511|1884||1
195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|686|2125|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Fenýlprópanólamín||686||686|2125||1
195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|873|2382|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB|Fenýlprópanólamín||873||873|2382||1
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1644|3443|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||1644||1644|3443||2
196106|C10AA0107|Simvastatin LYFIS|filmhtfl|40|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2950|2350|lyfalmen|V0110|2232|2|100|0|133,3333|LYFIS ehf|LYFIS ehf|Simvastatín||850||850|2350||2
196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1681|3494|lyfalmen|||2|100|0|75,0000|LYFIS ehf|ratiopharm GmbH|Allópúrinol||1681||1681|3494||2
196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|5491|8738|lyfalmen|||1|100|0|0,8333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||5491||5491|8738||1
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|17182|24830|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||17182|24830||1
197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|564|1731|lyfalmen|V0119|1662|2|100|0|25,0000|LYFIS ehf|ratiopharm GmbH|Allópúrinol||400||400|1731||2
197320|L04AB0204|Inflectra|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2015||R|0|1|0|1|0|1|SCO|0|1|0|100|XEU|49370|65202|lyfsjukr|||2|1|0|26,6700|Scope Pharma ehf|Hospira UK Limited|Infliximab||49370||49370|65202||1
197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|fl|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990|31.10.2016|R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|701|2145|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||701||701|2145||1
197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990|31.10.2016|R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2294|4338|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2294||2294|4338||1
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1283|2946|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1283||1283|2946||1
197927|L01XE3101|Ofev|hylki|100|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|170059|217144|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||170059||170059|217144||1
198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1
198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2212|2832|lyfalmen|V0069|2832|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Lósartan||1200||1200|2832||2
198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|5562|8836|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||5562||5562|8836||1
199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|28067|38258|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||28067||28067|38258||1
199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|6509|10139|lyfalmen|V0805|10139|1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||6509|10139||2
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|490|1855|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||490||490|1855||1
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|73002|95092|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||73002|95092||1
199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3619|6162|lyfalmen|V0126|6162|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||3619||3619|6162||1
199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|41403|55126|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||41403||41403|55126||2
199915|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|áfspr||QP52AF02|01.04.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|956|1648|vetorma|||0|3|0||Icepharma hf|Zoetis Finland OY|||956||956|1648||2
199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|2001347|2494754|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2001347||2001347|2494754||1
370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|485|1848|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||485||485|1848||2
370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|25704|48936|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||25704||25704|48936||1
370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1425|2847|lyfalmen|||2|20|0|7,5000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2847||2
371058|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.06.2016||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|5195|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||5195||1
371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|7001|10817|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||7001||7001|10817||1
371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1
371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1
371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||8152||1
371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|TCA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3095|5440|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3095||3095|5440||1
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2701|4898|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2701||2701|4898||2
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|0|G|0|APP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Artasan ehf|Aspen Pharma Trading Limited|Estríól|||||2301||1
373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4993|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4993||2
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|6981|10789|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||6981||6981|10789||1
373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|100171|130223|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||100171||100171|130223||2
373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3012|5326|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3012||3012|5326||1
373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3618|6160|lyfalmen|V0436|6160|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3618||3618|6160||1
373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4627|7549|lyfalmen|V0437|7549|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4627||4627|7549||1
373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|4906|6698|lyfalmen|V0420|4592|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíð||4009||4009|6698||2
373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|344|1507|lyfalmen|V0541|1507|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||237||237|1507||1
373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1225|2867|lyfalmen|V0126|1541|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1225||1225|2867||1
374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|6570|10223|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||6570||6570|10223||3
374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|272532|344592|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||272532||272532|344592||1
374194|L01XE2501|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|192615|245197|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||192615||192615|245197||1
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|396|1726|lyfalmen|V0500|1600|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||396||396|1726||2
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4534|7421|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||4534||4534|7421||1
374279|L04AD0104|Ciqorin|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|6800|6961|lyfalmen|||2|50|0|5,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||4200||4200|6961||2
374319|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.11.2013|30.11.2016|R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|16312|23632|lyfalmen|||2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||16312||16312|23632||2
374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|2970|5268|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2970||2970|5268||1
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|8402|12745|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||8402||8402|12745||1
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|leysir, dreifa|J07CA06|01.04.2015||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3525|6032|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||3525||3525|6032||2
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|5574|8853|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5574||5574|8853||1
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|6578|10234|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6578||6578|10234||1
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|7704|11784|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7704||7704|11784||1
374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|9198|13841|lyfalmen|V0383|11602|2|50|0|12,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||9198||9198|13841||2
374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|5331|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2720||2720|5331||2
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|21733|30247|lyfalmen|V0459|30247|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||21733||21733|30247||1
376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|4880|7897|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||4880||4880|7897||1
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|14045|20512|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||14045||14045|20512||1
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|72154|94019|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||72154||72154|94019||1
376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014||R|1|1|0|1|0|1|RRL|0|0|0|100|DKK|675775|846113|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration Limited|Vismodegibum||675775||675775|846113||2
377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|9867|17007|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||9867||9867|17007||2
377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|166945|213271|lyfalmen|||1|6|0||Vistor hf|Amgen Europe B.V.|Evolocumab||166945||166945|213271||1
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|8137|6279|lyfalmen|V0182|4002|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||3704||3704|6279||1
378432|L01XX4701|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|441957|555309|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Science International Limited|Idelalisib||441957||441957|555309||2
378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1533|3291|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1533||1533|3291||1
378543|N03AX1606|Pregabalin Mylan|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|5226|4282|lyfalmen|V0733|4282|2|56|0|28,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||2253||2253|4282||2
378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|12682|18636|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||12682||12682|18636||
379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1374|3072|lyfalmen|V0677|2429|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1374||1374|3072||1
379521|QP54AB5208|Cydectin TriclaMox|mixtúra|51|mg/ml|1|l|1|glas|1 mg/ml + 50 mg/ml|QP54AB52|01.03.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6460|11134|vetorma|||0|1|0||Icepharma hf|Zoetis Finland OY|||6460||6460|11134||2
379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|121283|156480|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||121283|156480||1
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|77733|101076|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||77733||77733|101076||1
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|102248|132806|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||102248||102248|132806||1
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|132046|169867|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||132046||132046|169867||1
379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|112015|144954|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||112015||112015|144954||1
379796|N04BC0406|Ropinirole Portfarma|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4520|5837|lyfalmen|V0532|5837|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||3383||3383|5837||1
379875|N05BA0105|Stesolid|innhl|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGH|0|0|1|100|DKK|1609|3395|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1609||1609|3395||1
379883|N05BA0105|Stesolid|innhl|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGH|0|0|1|100|DKK|2090|4057|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||2090||2090|4057||1
380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2
380162|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|3|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|16210|23492|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||16210||16210|23492||
380374|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1260|2915|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1260||1260|2915||2
380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|22917|31744|lyfalmen|V0653|31744|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||22917|31744||1
380486|N06AB0606|Sertralin Hexal|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1537|2386|lyfalmen|V0322|2386|2|100|0|100,0000|Artasan ehf|Hexal A/S|Sertralín||876||876|2386||1
380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20000|23891|lyfalmen|V0195|23891|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||16500||16500|23891||2
380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|4261|4864|lyfalmen|V0606|4864|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Memantín||2676||2676|4864||2
381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2458|4237|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2458||2458|4237||2
381589|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.06.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|34868|46860|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||34868|46860||1
382162|N04BC0406|Ropinirole Portfarma|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|6199|8386|lyfalmen|V0533|8386|2|84|0|56,0000|Alvogen|Alvogen|Rópíníról||5235||5235|8386||1
382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5
382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|3913|6566|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||3913||3913|6566||1
383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4781|7761|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||4781||4781|7761||1
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|998|1720|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||998||998|1720||2
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1
383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1265|2922|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1265||1265|2922||1
383445|J05AG0101|Viramune|forðatfl|400|mg|30|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|30741|41640|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||30741||30741|41640||1
384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2282|lyfalmen|V0006|1278|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||800||800|2282||2
384125|A10BX1201|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|5446|8676|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||5446||5446|8676||1
384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|15|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Terbínafín|||||||1
385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5886|9282|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||5886||5886|9282||1
386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|328358|414024|lyfsjukr|||1|1|0|50,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||328358||328358|414024||1
386465|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4936|8190|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||4227||4227|8190||1
386959|C03DA0402|Eplerenone Portfarma|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|22471|11425|lyfalmen|V0111|11228|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||7443||7443|11425||1
387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|7458|11446|lyfalmen|V0670|11446|1|15|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníð og brinzolamið||7458||7458|11446||1
387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|115359|149113|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||115359||115359|149113||2
387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|719|1964|lyfalmen|V0308|1964|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||569||569|1964||2
387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|90308|116981|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||90308||90308|116981||1
387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4468|8647|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4468||4468|8647||
387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016||R|0|0|0|0|0|1|DIC|0|0|0|100|IKR|6709|10415|lyfsjukr|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10415||2
387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|5213|8356|lyfalmen|||2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||5213||5213|8356||2
388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|118174|152614|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||118174||118174|152614||1
388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|2184|4187|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||2184||2184|4187||1
388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|2383|4460|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||2383||2383|4460||1
388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1
388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|4290|7085|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4290||4290|7085||1
388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.06.2011|31.10.2016|R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|1366|1902|lyfalmen|||2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||524||524|1902||1
388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|52359|38679|lyfalmen|V0722|38679|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||28400||28400|38679||2
388877|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.04.2016||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|14859|25611|vetorma|||0|200|0||Icepharma hf|Zoetis Finland OY|Doramectinum||14859||14859|25611||2
388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|7588|11625|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||7588||7588|11625||2
389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|MAB|0|0|0|100|SEK|1971|3893|lyfalmen|V0410|3893|1|84|0|84,0000|Vistor hf|Meda AB|Noretísterón og östrógen||1971||1971|3893||1
389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|MAB|0|0|0|100|SEK|1402|3110|lyfalmen|||1|84|0|84,0000|Vistor hf|Meda AB|Noretísterón og östrógen||1402||1402|3110||1
389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MAB|0|0|0|100|SEK|538|1921|lyfalmen|V0128|1921|1|84|0|84,0000|Vistor hf|Meda AB|Estradíól||538||538|1921||1
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MAB|0|0|0|100|SEK|427|1768|lyfalmen|||1|84|0|42,0000|Vistor hf|Meda AB|Estradíól||427||427|1768||1
389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|0|0|100|DKK|373611|470306|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||373611|470306||2
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|658|2086|lyfalmen|V0367|1453|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||658||658|2086||1
389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|2539|3713|lyfalmen|V0267|3713|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||1840||1840|3713||2
389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|34884|46880|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||34884|46880||2
389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|13346|19550|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13346||13346|19550||1
390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|63862|83532|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||63862||63862|83532||1
390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974|30.09.2016|R|0|0|0|0|G|0|BRS|0|0|1|100|DKK|2460|4566|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2460||2460|4566||1
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|5431|8656|lyfalmen|V0429|5650|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||5431||5431|8656||1
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2152|4142|lyfalmen|V0037|2383|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2152||2152|4142||1
391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|18165|26183|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||18165|26183||2
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|10501|15634|lyfalmen|V0196|6258|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||10501||10501|15634||1
391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|208111|259617|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||204209||204209|259617||1
391376|J05AE1401|Olysio|hylki|150|mg|28|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|1086480|1356915|lyfsjukr|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||1086480|1356915||1
391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|269418|196373|lyfsjukr|||2|30|0||Alvogen|Accord Healthcare Limited|Imatiníb||153358||153358|196373||1
391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1698|3518|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||1698||1698|3518||2
392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|498|1866|lyfalmen|V0545|1866|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||498||498|1866||1
392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|157424|201430|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||157424||157424|201430||2
392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|0|1|0|0|SAO|0|0|0|100|XEU|11256|16673|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||11256||11256|16673||2
392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3545|5000|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2775||2775|5000||1
392438|N07XX0901|Tecfidera|hylki|120|mg|14|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|36687|49161|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||36687||36687|49161||2
392563|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.03.2013||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|8326|12640|lyfalmen|V0388|12640|1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||8326||8326|12640||1
393248|C10AA0107|Simvastatin LYFIS|filmhtfl|20|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2250|2006|lyfalmen|V0109|1899|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Simvastatín||600||600|2006||2
393642|V07AB0013|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3157||1
393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|BVB|0|0|1|100|DKK|55670|73170|lyfalmen|||1|50|0|33,3300|Lyfjaver ehf|Shire Services BVBA|Hýdrókortisón||55670||55670|73170||3
393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
393939|S01EE0403|Travoprost Portfarma|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|USD|1847|3555|lyfalmen|V0669|3555|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1725||1725|3555||1
393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|115776|148737|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||115057||115057|148737||1
395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|4980|8035|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||4980||4980|8035||1
395732|C09CA0305|Valsartan ratiopharm|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3895|3520|lyfalmen|V0679|3441|2|98|0|196,0000|LYFIS ehf|ratiopharm GmbH|Valsartan||1700||1700|3520||2
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|15102|21967|lyfalmen|V0356|21481|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||15102||15102|21967||3
395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|139668|179346|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||139668||139668|179346||2
396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|3855|6487|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||3855||3855|6487||1
396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3154|5522|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3154||3154|5522||1
396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|16585|31636|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||16585||16585|31636||2
396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2300|2529|lyfalmen|V0006|1278|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||980||980|2529||2
396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4381|8482|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||4381||4381|8482||1
397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2037|2375|lyfalmen|V0250|2311|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||868||868|2375||1
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|21006|29327|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||21006||21006|29327||2
397520|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.08.2015||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|2737|2832|lyfalmen|V0337|2832|2|30|0|7,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1200||1200|2832||2
397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|4298|7096|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||4298||4298|7096||2
397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|24717|34021|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||24717||24717|34021||2
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5511||1
398490|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|40|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|1|0|0|0|GPA|0|0|1|100|XEU|2049|4001|lyfalmen|V0210|2180|2|40|0|26,6800|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||2049||2049|4001||1
398759|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|15832|14872|lyfalmen|V0622|14872|2|90|0|162,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||9947||9947|14872||1
398821|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3933|lyfalmen|V0012|2885|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3933||2
399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|0|1|0|1|GSD|0|1|0|100|GBP|121792|157113|lyfsjukr|||1|1|0||Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||121792||121792|157113||1
399309|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|24578|33845|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||24578|33845||1
399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|211|1471|lyfalmen|V0225|1471|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||211||211|1471||1
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|2049|2414|lyfalmen|V0244|2105|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||896||896|2414||1
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|7026|10851|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||7026||7026|10851||1
399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|27890|38034|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||27890|38034||1
399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1
399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|88814|115091|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||88814||88814|115091||2
400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|984|2535|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||984||984|2535||1
400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3965|6638|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3965||3965|6638||1
400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|45761|60638|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||45761||45761|60638||1
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|174|1420|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||174||174|1420||1
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|299|1592|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||299||299|1592||1
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|151|1388|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||151||151|1388||1
400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|4198|6959|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||4198||4198|6959||1
400574|N07XX0901|Tecfidera|hylki|240|mg|56|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|146747|188150|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||146747||146747|188150||2
401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|1815|2383|lyfalmen|V0037|2383|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||874||874|2383||2
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|7509|11516|lyfalmen|V0459|10082|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||7509||7509|11516||1
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|642|2064|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||642||642|2064||1
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|942|2477|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||942||942|2477||1
402203|D07AC1302|Ovixan|húðlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1099|2693|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1099||1099|2693||1
402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|0|1|0|1|SPD|0|0|0|100|DKK|865912|1082590|lyfsjukr|||1|180|0||Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||865912||865912|1082590||1
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1548|3042|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1548||1548|3042||
402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|10964|16271|lyfalmen|V0349|16271|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||10964||10964|16271||3
402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|5748|3383|lyfalmen|V0552|3259|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||1600||1600|3383||1
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4001|7761|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||4001||4001|7761||1
403524|N05AX1206|Aripiprazole ratiopharm|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|24606|14119|lyfalmen|V0683|13871|2|56|0|37,3300|LYFIS ehf|ratiopharm GmbH|Aripiprazól||9400||9400|14119||2
403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4284|7077|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||4284||4284|7077||1
403856|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|28791|39174|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||28791|39174||1
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|861|2366|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||861||861|2366||1
403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|14258|20805|lyfalmen|||1|6|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||14258||14258|20805||1
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||1867||2
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|50710|66897|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||50710||50710|66897||1
404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|937|2470|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||937||937|2470||1
404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|533|1914|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||533||533|1914||2
404997|A10BX1001|Lyxumia|stl|||2|áf-penni|1|pakki|10 og 20 mcg|A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|8333|12650|lyfalmen|||1|2|0|1,5000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||8333||8333|12650||1
405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1398|3105|lyfalmen|||2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1398||1398|3105||2
405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2463|4245|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2463||2463|4245||2
405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2066||1
405535|C03DA0403|Eplerenon  Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.11.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9000|9439|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||6000||6000|9439||2
405597|J07BD5203|Priorix|sts|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|13943|20372|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||13943||13943|20372||1
405677|J01DD0401|Rocephalin|irþ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|2842|5092|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||2842||2842|5092||2
405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|14293|20853|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||14293||14293|20853||1
405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|382|1706|lyfalmen|V0502|1706|2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||382||382|1706||1
406106|C10A00001|Praluent|stl|150|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|168985|215808|lyfalmen|||1|6|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||168985|215808||1
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15442|22435|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||15442||15442|22435||1
406356|L01XX4601|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XX46|01.07.2016||R|0|0|0|1|0|0|AZA|0|1|0|100|SEK|593727|744068|lyfalmen|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||593727||593727|744068||1
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|46573|61665|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||46573||46573|61665||1
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|53678|70651|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||53678||53678|70651||1
406678|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|glas|12,5+50 mg|N04BA02|01.10.2015||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1367|3062|lyfalmen|||1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1367||1367|3062||1
406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|56306|73975|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||56306||56306|73975||1
407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|0|G|0|AGH|0|0|1|100|XEU|||lyfalmen|V0803|3643|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin|||||3643||1
407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|14391|27473|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|||||14391|27473||2
407923|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1320|2997|lyfalmen|V0319|2911|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1320||1320|2997||2
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|131|1361|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||131||131|1361||1
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|268|1549|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||268||268|1549||1
408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|0|0|OPE|0|0|0|100|DKK|26687|36513|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||26687||26687|36513||1
408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|13252|19421|lyfalmen|||1|100|0|12,5000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||13252||13252|19421||2
408156|A10BB0904|Zodediab|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2744|3831|lyfalmen|V0020|2173|2|90|0|45,0000|Alvogen|Alvogen IPco S.á.r.l.|Glíklazíð||1926||1926|3831||1
408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1520|2710|lyfalmen|V0310|2710|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1111||1111|2710||2
408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977|30.11.2016|R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1381|3081|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1381||1381|3081||1
409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2553|4400|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2553||2553|4400||2
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|2999|5308|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||2999||2999|5308||1
409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2847|5099|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2847||2847|5099||1
409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7948|12120|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||7948||7948|12120||1
409488|N03AX1609|Pregabalin Sandoz GmbH|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|3038|4407|lyfalmen|||2|56|0|14,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||2344||2344|4407|30.11.2016|1
409547|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|49623|65522|lyfalmen|V0728|65522|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||49623||49623|65522||1
409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|46407|61455|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||46407||46407|61455||1
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|6446|10053|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||6446||6446|10053||1
409809|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5650|4209|lyfalmen|V0234|4209|2|18|0|36,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||2200||2200|4209||2
409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|13441|19681|lyfalmen|V0651|19681|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||13441||13441|19681||1
409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|6098|6923|lyfalmen|V0196|6258|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||4172||4172|6923||2
410077|N02CC0402|Maxalt Smelt|frþ.tfl|5|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2871|5132|lyfalmen|V0620|4515|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||2871||2871|5132||1
410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|2885|4604|lyfalmen|V0093|4604|2|100|0|133,3300|Alvogen|Orion Corporation|Spírónólaktón||2487||2487|4604||1
410469|L04AB0202|Remsima|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2014||R|0|1|0|1|0|1|CHH|0|1|0|100|DKK|42947|57078|lyfsjukr|||2|1|0|26,6700|Alvogen|Celltrion Healthcare Hungary Kft.|Infliximab||42947||42947|57078||1
410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|796|2276|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||796||796|2276||1
410649|C09CA0305|Valsartan ratiopharm|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|0|0|RAT|0|0|0|100|IKR|820|2309|lyfalmen|||2|14|0|7,0000|LYFIS ehf|ratiopharm GmbH|Valsartan||820||820|2309||2
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|476|1836|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||476||476|1836||2
411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1297|2966|lyfalmen|V0557|2966|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1297||1297|2966||1
411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RAT|0|0|1|100|XEU|376|1635|lyfalmen|V0230|1622|2|100|0|16,6667|LYFIS ehf|ratiopharm GmbH|Paracetamól||330||330|1635||2
411324|N06AX2107|Duloxetine Mylan|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|1973|2426|lyfalmen|V0692|2257|2|28|0|14,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||905||905|2426||2
411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|5051|8133|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||5051||5051|8133||2
411616|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|5583|4923|lyfalmen|V0624|4088|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2719||2719|4923||1
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|18532|26688|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||18532||18532|26688||1
411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyfalmen|V0554|1975|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól|||||1975||1
411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4832|7831|lyfalmen|||1|6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4832||4832|7831||1
412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|15327|21390|lyfalmen|V0183|18358|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||14683||14683|21390||1
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|2469|4579|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2469||2469|4579||1
412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|2417|4750|vetalmen|||0|100|0||Vistor hf|Merial|||2417||2417|4750||1
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|80139|104119|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||80139||80139|104119||2
412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TBB|0|0|0|100|NOK|43158|57345|lyfalmen|V0711|43013|1|112|0|112,0000|Vistor hf|Teva B.V.|Rasagilín||43158||43158|57345||1
412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|41544|55304|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||41544||41544|55304||1
412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2392|4473|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||2392||2392|4473||2
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2468|4577|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||2468||2468|4577||2
413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|ROP|0|0|0|100|DKK|26222|35925|lyfsjukr|||1|50|0||Williams & Halls efh|Provepharm SAS|Metýltíónín||26222||26222|35925||2
413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
414097|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.05.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1762|1789|lyfalmen|||2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||442||442|1789|30.9.2016|2
414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|12394|6510|lyfalmen|V0342|6380|2|98|0|130,6700|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||3872||3872|6510||2
414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|115208|148925|lyfsjukr|||1|12|0|24,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||115208||115208|148925||1
414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|2963|5259|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíð||2963||2963|5259||2
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|954|2494|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||954||954|2494||1
415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|þpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1357|3048|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1357||1357|3048||1
415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|158304|202524|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer Pharma AG|Riociguatum||158304||158304|202524||1
415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|109259|141526|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||109259||109259|141526||1
415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|6608|5871|lyfalmen|V0253|5871|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||3408||3408|5871||1
416371|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1479|2907|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1479||1479|2907||2
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|7391|7888|lyfalmen|V0088|2244|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||4873||4873|7888||1
416589|N03AX1604|Brieka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3931|3476|lyfalmen|V0686|2958|2|56|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1668||1668|3476||1
416630|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.10.2014|31.10.2016|R|1|0|0|1|0|0|BLP|0|0|0|100|IKR|7200|7787|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||4800||4800|7787||2
416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3379|5831|lyfalmen|||1|300|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||3379||3379|5831||1
416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2248|4275|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2248||2248|4275||2
416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|786|2262|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||786||786|2262||2
417674|J01DH0203|Meropenem Mylan|stl/irs|1|g/hgl|10|hgl|1|pakki|lausn|J01DH02|01.07.2016||R|0|0|0|0|0|1|MHS|0|0|0|100|DKK|12685|18640|lyfsjukr|||2|10|0|5,0000|Icepharma hf|Mylan Hospital AS|Meropenem||12685||12685|18640||2
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|1|0|1|0|1|VII|0|0|0|100|GBP|30333|41124|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||30333||30333|41124||1
417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|PHH|0|1|0|100|DKK|77372|100619|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuþáttur IX||77372||77372|100619||1
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|25089|34492|lyfalmen|V0460|34492|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||25089|34492||1
418119|N05AX1207|Lemilvo|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|23042|14277|lyfalmen|V0682|13871|2|56|0|18,6670|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||9515||9515|14277||1
418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|104848|136040|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||104848||104848|136040||3
418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|4864|7875|lyfalmen|V0014|7245|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4864||4864|7875||1
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2149|4138|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2149||2149|4138||1
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|5538|8803|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||5538||5538|8803||1
419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|38751|51771|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||38751||38751|51771||1
419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5109|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5109||2
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|31032|42008|lyfalmen|||1|100|0|7,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mecaptamín||31032||31032|42008||3
419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|10669|15865|lyfalmen|||1|100|0|2,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mecaptamín||10669||10669|15865||3
419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|528|1907|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||528||528|1907||1
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|9388|14102|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||9388||9388|14102||1
420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|124217|160129|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||124217||124217|160129||2
420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|2282|lyfalmen|V0006|2282|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||800||800|2282||2
420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|2242|3864|lyfalmen|V0479|3658|2|60|0|6,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1950||1950|3864||2
420568|A10BB1203|Glimepirid Bluefish|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|960|1869|lyfalmen|V0023|1869|2|90|0|135,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|1869||2
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|793|2272|lyfalmen|V0036|2272|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||793||793|2272||1
421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|26348|50158|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||26348||26348|50158||1
421962|A06AB0202|Toilax|sþ-tfl|5|mg|25|stk|1|glas||A06AB02|01.12.2016||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1
422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|471|1829|lyfalmen|V0596|1829|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||471||471|1829||1
422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2382|4459|lyfalmen|V0049|3255|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||2382||2382|4459||1
422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3917|6572|lyfalmen|V0054|5141|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||3917||3917|6572||1
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|49903|65876|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||49903||49903|65876||2
422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|2410|4498|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2410||2410|4498||3
422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|7439|11420|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||7439||7439|11420||2
423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2512|4638|lyfalmen|V0192|3885|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||2512|4638||2
423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
423527|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4596|3933|lyfalmen|V0011|2938|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3933||2
423703|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.05.2014||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|571|1966|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Nafazólín í blöndum með öðrum efnum||571||571|1966||1
423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|17012|24596|lyfsjukr|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||17012||17012|24596||1
423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|DKK|4576|7479|lyfalmen|V0373|4138|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||4576||4576|7479||2
425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|755|2220|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||755||755|2220||2
425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|3395|5853|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||3395||3395|5853||1
425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2248|3577|lyfalmen|V0213|3264|2|100|0|25,0000|Actavis Group hf|Actavis hf|Lósartan||1741||1741|3577||1
425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|0|G|0|TTT|0|0|0|100|SEK|12390|18234|lyfalmen|V0729|18234|1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||12390||12390|18234||2
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|473|1832|lyfalmen|||1|20|0|5,0000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||473||473|1832||1
426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|618|2031|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||618||618|2031||1
426859|N03AX1407|Levetiracetam Teva|filmhtfl|250|mg|50|stk|1|þpakki||N03AX14|01.02.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|2129|1731|lyfalmen|||2|50|0|8,3300|Medical ehf|Teva Pharma B.V.|Levetíracetam||400||400|1731|30.11.2016|2
427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1
427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|6618|10289|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||6618||6618|10289||1
427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|6445|10051|lyfalmen|V0658|10051|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||6445||6445|10051||1
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2951||1
427803|R03AK0604|Relanio|innönddu|300|mcg/sk|180|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014|30.09.2016|R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|19495|21138|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||14500||14500|21138||2
428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1942||1
428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33164|44705|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33164|44705||1
428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|25104|31579|lyfalmen|||3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||22786||22786|31579||2
429093|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|glas|með skammtadælu|G03CA03|01.06.2016||R|0|0|0|0|G|0|TAT|0|0|0|100|DKK|946|2483|lyfalmen|||2|64|0||Vistor hf|Takeda Oy|Estradíól||946||946|2483||1
429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2769|4992|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2769||2769|4992||2
429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|75189|97858|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||75189||75189|97858||1
429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3531|6041|lyfalmen|V0093|4604|1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||3531||3531|6041||1
429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|7962|12139|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||7962||7962|12139||3
430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|818|2306|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||818||818|2306||1
430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1658|3463|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1658||1658|3463||2
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3983|6782|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||3485||3485|6782||1
430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|75305|98005|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||75305||75305|98005||1
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|15567|4677|lyfalmen|V0184|4677|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||2540||2540|4677||2
430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|0|G|0|TTT|0|0|0|100|SEK|4847|7852|lyfalmen|V0730|7852|1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||4847||4847|7852||2
430729|A11DA0101|Tiacur|stl|50|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|17933|25863|lyfalmen|||1|10|0|10,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||17933|25863||2
430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2
430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|773|2244|lyfalmen|V0173|2244|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||773||773|2244||1
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|862|2367|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||862||862|2367||1
431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1
431193|N02AB0306|Instanyl|nefúði|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|7631|11684|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||7631||7631|11684||1
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|1101|2696|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1101|2696||1
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|3383|5837|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3383||3383|5837||1
431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17279|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17279||2
431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|1|0|1|TPA|0|1|0|100|DKK|288751|364764|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||288751||288751|364764||1
431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1614|3402|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1614||1614|3402||1
432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4900|3245|lyfalmen|V0693|3245|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1500||1500|3245||2
432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|DKK|12574|18487|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||12574|18487||1
432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|2698|5289|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||||2698|5289||2
433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1859||1
433194|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1297|2966|lyfalmen|V0557|2966|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1297||1297|2966||1
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|8610|13031|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||8610||8610|13031||1
433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1954|3870|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||1954||1954|3870||1
433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|363060|457183|lyfsjukr|||1|96|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||363060||363060|457183||1
434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BYP|0|0|0|100|DKK|136530|175443|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||136530||136530|175443||2
434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|5015|2189|lyfalmen|V0490|2189|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||733||733|2189||2
434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|62850|96185|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||59668||59668|96185||1
434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||15098||15098|28814||2
434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|6566|10218|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||6566||6566|10218||1
434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3931|3658|lyfalmen|V0010|3658|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1800||1800|3658||2
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|629|2046|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||629||629|2046||1
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|4493|7365|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||4493||4493|7365||1
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|5167|8292|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5167||5167|8292||1
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|XEU|7991|12179|lyfalmen|V0315|4968|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||7991||7991|12179||2
435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|3530|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3530||1
436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|169595|216567|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||169595||169595|216567||2
436022|C09DA0308|Diovan Comp 80/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|2754|4971|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||2754||2754|4971||1
436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2
436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|33581|45232|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||33581||33581|45232||1
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|843|2341|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||843||843|2341||1
436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|RAP|0|0|0|100|XEU|57038|74901|lyfsjukr|||1|60|0|0,7500|Raptor Pharmaceuticals Europe B.V.|Raptor Pharmaceuticals Europe B.V.|Mecaptamín||57038||57038|74901||3
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|634|2053|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||634||634|2053||1
437223|V10XX0301|Xofigo|stl|1000|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|498116|625155|lyfsjukr|||1|6|0||Icepharma hf|Bayer Pharma AG|radium-223 dichloride||498116||498116|625155||2
437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|LYFIS ehf|ratiopharm GmbH|Deslóratadín|||||||
437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|16395|23747|lyfalmen|V0712|23747|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||16395||16395|23747||1
437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|917|2443|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||917||917|2443||1
437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|48758|64428|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||48758||48758|64428||2
438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|0|HRA|1|0|0|100|XEU|18474|35219|vetalmen|||0|1|0||Vistor hf|Dechra Limited|Clodronic acid||18474||18474|35219||1
438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1699|3519|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1699||1699|3519||1
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1142|2752|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Hýdrókortisón og sýkingalyf||1142||1142|2752||1
438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|6286|4470|lyfalmen|V0605|4447|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||2390||2390|4470||2
438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|188281|239807|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||188281||188281|239807||2
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|128113|164975|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||128113||128113|164975||1
439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4369|7194|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||4369||4369|7194||1
439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|16650|24098|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||16650||16650|24098||1
439672|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|G|0|WEH|0|0|0|100|XEU|44420|19108|lyfalmen|||2|500|0|250,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||13025||13025|19108||2
439680|A10BX0401|Byetta|stl|10|mcg/sk|60|skammtar|1|penni|lausn|A10BX04|01.10.2015||R|0|0|0|0|0|0|AZA|0|0|0|100|SEK|11984|17675|lyfalmen|||1|60|0|40,0000|Vistor hf|AstraZeneca AB|Exenatíð||11984||11984|17675||1
439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2148|4137|lyfalmen|V0658|3350|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||2148||2148|4137||1
439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1
440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|1066|2418|lyfalmen|V0163|2072|1|70|0|5,6000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||899||899|2418||1
440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|141312|181391|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||141312||141312|181391||1
440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5468|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5468||2
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGH|0|0|0|100|DKK|1097|2690|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1097||1097|2690||1
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGH|0|0|0|100|DKK|1730|3562|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1730||1730|3562||1
440731|N05AX1209|Aripiprazole Sandoz|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|27196|24749|lyfalmen|V0717|24749|2|56|0|112,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||17123||17123|24749||1
441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|800|2282|lyfalmen|V0046|1939|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||800||800|2282||1
441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|858|2361|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||858||858|2361||1
441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|818|2306|lyfalmen|V0046|1939|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||818||818|2306||1
441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|94146|121835|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, rilpívírin og tenófóvír||94146||94146|121835||2
441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAP|0|0|0|100|DKK|817|2305|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||817||817|2305||2
442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2073|2619|lyfalmen|V0283|2619|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1045||1045|2619||2
442586|N03AX1608|Pregabalina Tecnigen|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|1624|1675|lyfalmen|V0731|1622|2|56|0|4,6667|Williams & Halls efh|Williams & Halls ehf|Pregabalín||359||359|1675||2
442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|64725|84623|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||64725||64725|84623||3
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|8889|13415|lyfalmen|V0460|11497|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||8889|13415||1
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|2612|4776|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||2612||2612|4776||1
443181|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1048|2060|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1048||1048|2060||2
443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|20734|28983|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||20734||20734|28983||1
443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|19137|27521|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||19137||19137|27521||1
443500|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.05.2013|30.09.2016|R|0|0|0|1|0|1|GRP|0|0|0|100|XEU|2993|5300|lyfsjukr|||2|45|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||2993||2993|5300||1
443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|19712|28312|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||19712||19712|28312||3
443861|N06AB0311|Fluoxetin Mylan|hylki|20|mg|30|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|563|1854|lyfalmen|V0038|1854|2|30|0|30,0000|Icepharma hf|Mylan AB|Flúoxetín||489||489|1854||2
443903|N06AB0311|Fluoxetin Mylan|hylki|20|mg|100|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1528|2754|lyfalmen|V0039|2754|2|100|0|100,0000|Icepharma hf|Mylan AB|Flúoxetín||1143||1143|2754||2
443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|2700|4897|lyfalmen|||2|14|0|14,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||2700||2700|4897||2
444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|6241|9771|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||6241||6241|9771||1
444098|L01BA0110|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2393|4474|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2393||2393|4474||2
444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|730|2185|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||730||730|2185||2
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|DKK|2433|4529|lyfalmen|V0061|2798|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2433||2433|4529||2
444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|17870|25777|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||17870||17870|25777||2
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|1678|3490|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1678||1678|3490||2
444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RPO|0|0|0|100|IKR|2018|3958|lyfalmen|||2|100|0|33,3300|LYFIS ehf|ratiopharm Oy|Betahistín||2018||2018|3958||2
444722|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.07.2016||R|0|0|0|0|G|0|GPA|0|0|1|100|XEU|907|2429|lyfalmen|V0677|2429|2|140|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Mómetasón||907||907|2429||1
444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|4283|7076|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||4283||4283|7076||1
445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|14254|20800|lyfalmen|V0705|20800|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||14254||14254|20800||1
445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|3915|6569|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||3915||3915|6569||1
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1236|2882|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1236||1236|2882||1
445357|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.03.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1869|lyfalmen|V0329|1869|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1869||2
445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|12474|14738|lyfalmen|V0684|13871|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||9850||9850|14738||2
445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDE|0|0|0|100|NOK|5142|8258|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5142||5142|8258||1
446268|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|3965|6638|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||3965|6638||2
446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|13544|19822|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíð||13544||13544|19822||1
447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|18000|9852|lyfalmen|V0694|9573|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||6300||6300|9852||2
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|9381|14092|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||9381||9381|14092||1
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|5381|8587|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5381||5381|8587||1
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|6607|10274|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||6607||6607|10274||1
447145|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.09.2014|30.09.2016|R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|762|2229|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||||762|2229||2
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|8167|12422|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8167||8167|12422||1
447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|2887|5154|lyfalmen|||2|100|0|66,6700|LYFIS ehf|ratiopharm GmbH|Carvedílól||2887||2887|5154||2
447753|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|1262|1869|lyfalmen|V0330|1869|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1869||2
447785|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|3300|5723|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||3300||3300|5723||2
448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|1940|3851|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||1940|3851||2
448245|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1621|3412|lyfalmen|V0202|3007|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1621||1621|3412||1
448897|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|49623|65522|lyfalmen|V0727|65522|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||49623||49623|65522||1
449125|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3933|lyfalmen|V0323|3080|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|3933||2
449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|891|2407|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||891||891|2407||1
449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|4919|3465|lyfalmen|V0686|2958|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1660||1660|3465||2
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|807|2191|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||734||734|2191||2
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGH|0|0|0|100|DKK|4102|6826|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||4102||4102|6826||1
449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|2693|4887|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||2693||2693|4887||2
449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|G|0|DAN|0|0|0|100|XEU|3968|6642|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||3968||3968|6642||2
450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|3775|7332|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||3775||3775|7332||2
450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|APP|0|0|0|100|DKK|958|2499|lyfalmen|||1|30|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól||958||958|2499||1
450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|105026|136261|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||105026||105026|136261||1
450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|1|BOE|0|0|0|100|DKK|312013|393695|lyfsjukr|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||312013||312013|393695||1
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2009|3246|lyfalmen|V0313|2653|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1501||1501|3246||1
450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|7198|12406|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||7198||7198|12406||2
450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|16625|24063|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||16625|24063||5
451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|31485|42581|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||31485||31485|42581||2
451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|UKA|0|0|0|100|DKK|37944|50751|lyfalmen|||1|1|0|30,0800|Lundbeck Export A/S|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||37944||37944|50751||1
451378|H02AB0605|Prednisolone Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|582|1982|lyfalmen|||2|25|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Prednisólón||582||582|1982||1
451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|35005|47033|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||35005||35005|47033||2
451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|46674|61792|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||46674||46674|61792||2
451751|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|7097|10949|lyfalmen|V0610|10949|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||7097||7097|10949||1
451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|35462|47611|lyfalmen|||1|100|0||Artasan ehf|Aspen Pharma Trading Limited|Búsúlfan||35462||35462|47611||1
452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1
452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1
452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|6407|9999|lyfalmen|||1|120|0|60,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||6407||6407|9999||2
452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1129|2734|lyfalmen|V0800|2734|1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1129||1129|2734||2
452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8680|14961|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||8680||8680|14961||2
452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5495||1
452500|L01XE3801|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01XE38|01.02.2016||R|1|0|0|1|0|1|RRL|0|1|0|100|DKK|754481|944001|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration Limited|Cobimetinib||||754481|944001||2
452814|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|1391|2602|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||1324||1324|2602||1
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|7422|11396|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóð||7422||7422|11396||1
452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|6411|10005|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||6411||6411|10005||2
452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1081|2668|lyfalmen|V0597|2213|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1081||1081|2668||2
452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3244|5646|lyfalmen|V0598|4385|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||3244||3244|5646||2
452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2066|4024|lyfalmen|V0584|2944|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2066||2066|4024||2
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1147|1977|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1147||1147|1977||1
453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6226|9750|lyfalmen|V0585|7161|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||6226||6226|9750||2
453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3476|5965|lyfalmen|V0586|4404|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||3476||3476|5965||2
453559|N03AX1604|Brieka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1683|1720|lyfalmen|V0685|1199|2|56|0|4,6667|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||392||392|1720||1
453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|11613|17165|lyfalmen|V0587|11637|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||11613||11613|17165||2
453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2144|4131|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2144||2144|4131||1
454036|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.07.2013||R|1|0|0|0|G|0|APR|0|0|0|100|DKK|2490|4608|lyfalmen|V0706|4608|1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||2490||2490|4608||1
454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|8075|12295|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||8075||8075|12295||1
454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|0|Bel|1|0|0|100|DKK|4134|8014|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||4134||4134|8014||2
454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|9421|14148|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||9421||9421|14148||1
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|32201|34846|lyfalmen|V0342|6380|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||25369||25369|34846||1
454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|WAS|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group PTC ehf|Weifa AS|Paracetamól|||||||1
454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|OPH|0|0|0|100|DKK|46169|61087|lyfsjukr|||1|1|0||Artasan ehf|Novartis Europharm Ltd|Tópótecan||46116||46116|61087||1
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|894|1757|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||894||894|1757||1
455171|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3775|6376|lyfsjukr|||1|4000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3775||3775|6376||1
455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5566|8842|lyfalmen|V0713|7916|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||5566||5566|8842||1
455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1069317|1335569|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1069317||1069317|1335569||2
455492|G04BE0310|Sildenafil LYFIS|filmhtfl|50|mg|24|stk|1|þpakki||G04BE03|01.09.2016||R|0|0|0|0|0|0|LYF|0|0|0|100|IKR|9504|7374|lyfalmen|V0143|7374|2|24|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||4500||4500|7374||2
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGH|0|0|1|100|XEU|407|1741|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||407||407|1741||1
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGH|0|0|1|100|XEU|704|2149|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||704||704|2149||1
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGH|0|0|1|100|XEU|1438|3160|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1438||1438|3160||1
456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|5630|5585|lyfalmen|V0277|5585|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||3200||3200|5585||2
456989|R03AK0604|Relanio|innönddu|550|mcg/sk|180|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014|30.09.2016|R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|26905|27346|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||19010||19010|27346||2
457149|N06AB1007|Escitalopram Bluefish|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4950|2832|lyfalmen|V0327|2832|2|98|0|196,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1200||1200|2832||2
457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|41824|47968|lyfalmen|V0451|47968|2|1|0|83,7200|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||35744||35744|47968||1
457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5470|3383|lyfalmen|V0326|3383|2|98|0|147,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1600||1600|3383||2
457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MHS|0|0|1|100|XEU|1230|2873|lyfalmen|V0561|2873|2|100|0||Icepharma hf|Mylan Hospital AS|Lídókaín||1230||1230|2873||2
457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|PHH|0|0|0|100|GBP|5111|8215|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||5111||5111|8215||1
457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2444|4544|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2444||2444|4544||2
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|2116|1865|lyfalmen|V0003|1865|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||497||497|1865||1
457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8680|14961|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||8680||8680|14961||2
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|891|2407|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||891||891|2407||1
458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|BGB|0|0|0|100|DKK|315678|398253|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Regorafenib||315678||315678|398253||2
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1027|2594|lyfalmen|V0577|2244|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1027||1027|2594||1
458491|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1064|2645|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1064||1064|2645||2
458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|99021|128001|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||99021|128001||3
458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|8194|11451|lyfalmen|V0653|11337|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||7462||7462|11451||1
459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|761802|953107|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||761802||761802|953107||1
459225|M05BA0805|Zoledronic Acid Hospira|irl|5|mg|100|ml|1|poki|lausn|M05BA08|01.01.2016||R|0|1|0|1|0|0|VOG|0|0|0|100|IKR|39258|52413|lyfalmen|V0715|52413|2|100|0|1,2500|Alvogen HS|Hospira UK Ltd.|Zoledronsýra||39258||39258|52413||1
459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|100171|130223|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||100171||100171|130223||2
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|667|2099|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||667||667|2099||1
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1222|2862|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1222||1222|2862||1
459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|16523|31518|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||16523||16523|31518||2
459678|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|2204|2257|lyfalmen|V0692|2257|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||782||782|2257||2
459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|2500|2213|lyfalmen|V0284|2013|2|100|0|6,2500|Medical ehf|Teva Sweden AB|Quetíapín||750||750|2213||2
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|1249|2900|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||1249||1249|2900||1
460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|1|0|1|ACC|0|1|0|100|DKK|58753|77070|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare Limited|Bendamústín||58753||58753|77070||1
460170|J07BC0202|Avaxim|stl|||0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPA|0|0|0|100|XEU|3127|5484|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur Europe|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3127||3127|5484||2
460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|6410|10003|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||6410||6410|10003||2
460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|189735|241615|lyfsjukr|||1|5|0||Icepharma hf|Roche|Trastuzumab||189735||189735|241615||2
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|4884|9436|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||4884||4884|9436||2
461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|4345|7161|lyfalmen|V0585|7161|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||4345||4345|7161||1
461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|67942|88692|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||67942||67942|88692||1
461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|435259|546979|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||435259||435259|546979||1
461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyfalmen|V0554|1975|2|1|0|0,7500|LYFIS ehf|ratiopharm GmbH|Flúkónazól|||||1975||2
461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1102383|1376694|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1102383||1102383|1376694||2
461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|262563|332193|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||262563||262563|332193||1
461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|202|1459|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||202||202|1459||1
461774|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr||M09AX01|01.08.2015||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|5652|8960|lyfalmen|V0209|8960|2|2|0|5,7222|Vistor hf|Takeda Pharma A/S|Natríumhýalúrónat||5652||5652|8960||1
461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|344|1654|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||344||344|1654||1
462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|383|1708|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||383||383|1708||1
462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2236|4258|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer Pharma AG|Nífedipín||||2236|4258||2
462070|A10BX0901|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BX09|01.09.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|15466|22468|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||15466||15466|22468||1
462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|3395|5853|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||3395||3395|5853||1
462358|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|G|0|TTT|0|0|0|100|SEK|4847|7852|lyfalmen|V0730|7852|1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||4847||4847|7852||2
462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|PAA|0|0|1|100|DKK|12965|19026|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12965||12965|19026||1
462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|5221|10076|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||||5221|10076||2
463197|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.10.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1770|lyfalmen|V0108|1770|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1770||2
463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|5577|4538|lyfalmen|V0605|4538|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Memantín||2439||2439|4538||2
463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2698|2006|lyfalmen|V0325|2006|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||600||600|2006||2
463378|J01DH0203|Meropenem Mylan|stl/irs|500|mg/hgl|10|hgl|1|pakki|lausn|J01DH02|01.07.2016||R|0|0|0|0|0|1|MHS|0|0|0|100|DKK|10936|16233|lyfsjukr|||2|10|0|2,5000|Icepharma hf|Mylan Hospital AS|Meropenem||10936||10936|16233||2
463642|J01XA0107|Vancomycin Xellia|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.2013|31.10.2016|R|0|0|0|0|0|1|PAA|0|0|0|100|XEU|579|1977|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||579||579|1977||1
463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|42475|56481|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||42475|56481||1
463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1698|3518|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1698||1698|3518||1
463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2
463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1
464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|2614|4778|lyfalmen|||2|100|0|33,3300|LYFIS ehf|ratiopharm GmbH|Carvedílól||2614||2614|4778||2
464335|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|12786|18779|lyfalmen|V0718|18779|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||12786||12786|18779||1
464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|7428|11404|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||7428||7428|11404||2
464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|1756|3597|lyfalmen|||2|14|0|7,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||1756||1756|3597||2
464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016||L|0|0|0|0|G|0|GPA|0|0|1|100|XEU|||lyfalmen|V0677|2429|2|140|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Mómetasón|||||2429||1
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|DKK|1469|3202|lyfalmen|||2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1469||1469|3202|30.11.2016|1
465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|GPB|0|0|0|100|DKK|1510|3259|lyfalmen|||1|98|0|49,0000|Vistor hf|BGP Products AB|Verapamíl||1510||1510|3259||
465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2708|4908|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2708||2708|4908||2
466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|1540|1869|lyfalmen|V0038|1854|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Flúoxetín||500||500|1869||2
466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3844|2832|lyfalmen|V0039|2754|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Flúoxetín||1200||1200|2832||2
466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|487|1851|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||487||487|1851||1
466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1518|3270|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||1518||1518|3270||1
466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1006|2565|lyfalmen|V0545|1866|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||||1006|2565||2
466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1151|2765|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1151||1151|2765||1
466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|3989|6671|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||3989||3989|6671||1
466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|220314|279647|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||220314||220314|279647||2
466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|15399|22376|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||15399||15399|22376||1
466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2140|4126|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2140||2140|4126||1
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|5821|9193|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||5821||5821|9193||1
466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1
466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|3521|6027|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||3521||3521|6027||1
466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5
466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|16541|23948|lyfalmen|V0728|21841|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||16541||16541|23948||1
466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|2558|4701|lyfalmen|V0063|4064|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíð||2558||2558|4701||1
467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5042|8120|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5042||5042|8120||2
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|11390|16858|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||11390||11390|16858||1
467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|4838|7840|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||4838||4838|7840||2
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|21763|30285|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||21763||21763|30285||1
467756|A10BX1001|Lyxumia|stl|20|mcg|2|áf-penni|1|pakki||A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|8333|12650|lyfalmen|||1|2|0|2,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||8333||8333|12650||1
467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|66038|86284|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Ceftarólin||66038||66038|86284||1
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|339|1647|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||339||339|1647||1
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4808|5629|lyfalmen|V0317|3313|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3232||3232|5629||1
468103|H05BX0104|Cinacalcet Mylan|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|12503|18390|lyfalmen|V0720|18390|2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||12503||12503|18390||2
468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|228|1494|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||228||228|1494||1
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|7267|5601|lyfalmen|V0318|4520|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3212||3212|5601||1
468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|1828|3151|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||1828||1828|3151||2
468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011|30.09.2016|R|1|0|0|0|G|0|GRP|0|0|0|100|IKR|4530|2598|lyfalmen|||2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||1030||1030|2598||1
468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|4848|9368|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|||4848||4848|9368||2
468932|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5700|9026|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5700||5700|9026||1
468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|IKR|4172|5304|lyfalmen|V0467|4566|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5304||1
469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5566|8842|lyfalmen|V0712|7916|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||5566||5566|8842||1
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3175|5551|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3175||3175|5551||1
469422|G03AB0501|Gracial|töflur|||66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|0|APP|0|0|0|100|DKK|1945|3858|lyfalmen|||1|66|0|66,0000|Artasan ehf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||1945||1945|3858||1
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6027|9476|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6027||6027|9476||1
469794|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|4772|7749|lyfalmen|V0228|7424|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||4772||4772|7749||2
469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|1956|2383|lyfalmen|V0037|2383|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||874||874|2383||1
469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|3969|6643|lyfalmen|V0227|5791|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||3969||3969|6643||2
469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|2531|4664|lyfalmen|V0226|4240|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||2531||2531|4664||2
470148|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|7214|5891|lyfalmen|V0622|4957|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3422||3422|5891||1
470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3217|5608|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3217||3217|5608||1
470397|N05CM1801|Dexdor|irþ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|21163|29526|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||21163||21163|29526||1
470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|4773|7750|lyfalmen|||1|5|0|10,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||4773||4773|7750||1
470551|H05BX0103|Cinacalcet Sandoz|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|17859|22945|lyfalmen|V0720|18390|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Cinacalcet||15813||15813|22945||1
470933|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadælur|QJ51RC20|01.03.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|3495|6801|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||3495||3495|6801||2
471042|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|867|1704|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||867||867|1704||2
471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|718|2169|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíð||718||718|2169||1
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|3708|7205|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||3708||3708|7205||1
472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1468|3201|lyfalmen|V0048|2433|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1468||1468|3201||1
472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2300|4346|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2300||2300|4346||1
472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|9227|13881|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||9227||9227|13881||1
472599|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6868|5475|lyfalmen|V0012|5048|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5475||2
472756|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.10.2015||R|1|0|0|0|0|0|SHS|0|0|1|100|DKK|896|1984|lyfalmen|V0231|1984|2|300|0|50,0000|Artasan ehf|Sandoz A/S|Paracetamól||584||584|1984||1
472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|2544|4682|lyfalmen|V0670|3815|1|5|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníð og brinzolamið||2544||2544|4682||1
473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1129|2734|lyfalmen|V0800|2734|1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1129||1129|2734||2
474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|8589|13002|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||8589||8589|13002||1
474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|GPA|0|0|0|100|XEU|2178|4178|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||2178||2178|4178||1
474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2
474120|N03AX1604|Brieka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|6525|5410|lyfalmen|V0687|4890|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3073||3073|5410||1
474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2
474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|23676|45089|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||23676||23676|45089||2
474628|N05AH0313|Olanzapin Sandoz|filmhtfl|10|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|25042|10455|lyfalmen|||2|250|0|250,0000|Artasan ehf|Sandoz A/S|Olanzapín||6738||6738|10455||1
474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|622|2037|lyfalmen|V0266|2030|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||622||622|2037||2
474855|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|849|2349|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||849||849|2349||2
475338|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.10.2014||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2
475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|GRP|0|0|0|100|IKR|1100|2695|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2695||1
475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|497|1865|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||497||497|1865||1
475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|627|2043|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||627||627|2043||1
475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|GPA|0|0|1|100|IKR|1364|3058|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||1364||1364|3058||1
475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2
476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5695||5695|10975||2
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|51546|67954|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||51546|67954||1
476580|R03AC0206|Ventoline|innönd.l|2|mg/ml|20|lykjur|1|pakki|lausn f. eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|1146|2758|lyfalmen|||1|20|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||1146||1146|2758||1
476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3641|6192|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||3641|6192||2
477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|13719|20063|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||13719||13719|20063||1
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|GBP|3548|6064|lyfalmen|||1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||3548||3548|6064||1
477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|0|0|100|XEU|46052|61006|lyfsjukr|||1|27|0||Celgene AB|Celgene Europe Limited|Apremilast||46052||46052|61006||2
477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|28055|33747|lyfalmen|V0272|33747|2|100|0|75,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||24500||24500|33747||2
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3083||2
477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3161||2
477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|dreifa|H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|572|1968|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||572||572|1968||1
477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3083||1
477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|500|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2913||1
477786|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stl|V07AB|01.11.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|1000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2612||1
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|356|1670|lyfalmen|V0500|1600|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||356||356|1670||1
478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|5904|11372|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||5904||5904|11372||2
479310|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|20162|28260|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||20162||20162|28260||2
479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PIZ|0|0|0|100|DKK|95298|123292|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd|Bósútíníb||95298||95298|123292||1
480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|9965|6510|lyfalmen|V0341|6380|2|98|0|65,3333|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||3872||3872|6510||2
481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GPH|0|0|0|100|GBP|10210|15234|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||10210||10210|15234||1
481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|581|1980|lyfalmen|||0|30|0||Vistor hf|Galenica AB|Mómetasón||581||581|1980||1
481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|3753|6346|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||3753||3753|6346||1
481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|111|1333|lyfalmen|V0055|1333|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||111||111|1333||1
482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|12686|18641|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||12686||12686|18641||2
482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1
483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|53517|59543|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||44896||44896|59543||1
483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|25838|35439|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||25838|35439||2
483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|5130|8241|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||5130||5130|8241||2
483477|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|1765|2557|lyfalmen|V0467|2557|2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2557||2
483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2159|4152|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2159||2159|4152||1
483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|5290|8462|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||5290||5290|8462||1
483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|1548|3311|lyfalmen|V0374|3311|2|2,5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1548||1548|3311||1
483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|791|2269|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||791||791|2269||1
483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|1|100|XEU|226|1492|lyfalmen|V0055|1333|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||226||226|1492||1
484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|44531|59082|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||44531||44531|59082||1
484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|4289|7084|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríð||4289||4289|7084||1
484271|L01XE3101|Ofev|hylki|150|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|290041|366368|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||290041||290041|366368||1
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|105110|136366|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||105110||105110|136366||1
484618|A01AD0201|Andolex|munnskol|1,5|mg/ml|300|ml|1|glas|lausn|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|966|2510|lyfalmen|||1|300|0|50,0000|Vistor hf|Meda AB (V)|Benzýdamín||966||966|2510||1
484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|8079|12300|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||8079||8079|12300||2
484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|39526|52751|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||39526||39526|52751||1
484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|7782|11892|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||7782||7782|11892||1
485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|966|2510|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||966||966|2510||2
485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|8183|12444|lyfalmen|V0714|12444|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||8183||8183|12444||2
485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|318889|402247|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer Pharma AG|Riociguatum||318889||318889|402247||1
485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|11359|16815|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||11359||11359|16815||1
485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VIH|0|0|0|100|GBP|63858|83527|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Dolutegravír||63858||63858|83527||1
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2
486821|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|11698|12916|lyfalmen|V0691|12916|2|90|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||8526||8526|12916||1
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|436|1781|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||436||436|1781||1
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|519|1895|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||519||519|1895||1
487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|9677|14500|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||9677||9677|14500||1
487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|2077|4039|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||2077||2077|4039||1
487650|N04BD0204|Rasagiline Mylan|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.11.2016||R|0|0|0|0|G|0|ASD|0|0|0|100|SEK|31826|43013|lyfalmen|V0711|43013|2|112|0|112,0000|Icepharma hf|Mylan S.A.S.|Rasagilín||31826||31826|43013||2
487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|25730|35302|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||25730||25730|35302||1
487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|43180|57373|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||43180||43180|57373||1
487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|24025|29389|lyfalmen|V0453|29389|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||21055||21055|29389||2
487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RAT|0|0|1|100|IKR|1033|2006|lyfalmen|V0469|1889|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Díklófenak||600||600|2006||2
488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|218865|277845|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||218865||218865|277845||1
488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|GRP|0|0|0|100|DKK|5455|8689|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||5455||5455|8689||1
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|GRP|0|0|0|100|DKK|8729|13195|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||8729||8729|13195||1
488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
489050|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|2700|2695|lyfalmen|V0331|2695|2|96|0|96,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||1100||1100|2695||2
489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|5198|8335|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||5198||5198|8335||3
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|70330|91712|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||70330|91712||1
489348|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|13783|14329|lyfalmen|V0684|13871|2|56|0|56,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||9553||9553|14329||1
489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|706|1694|lyfalmen|V0188|1526|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||373||373|1694||1
490198|N03AX1606|Pregabalin Mylan|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|5628|5085|lyfalmen|V0734|5085|2|56|0|42,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||2837||2837|5085||2
490417|G03FB0504|Evorel Sequi|forðapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1652|3454|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1652||1652|3454||1
490425|G03FA0104|Evorel Conti|forðapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1530|3286|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1530||1530|3286||1
490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|4170|6547|lyfalmen|V0133|6547|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||3899||3899|6547||1
490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3270|5681|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3270||3270|5681||1
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8431|8703|lyfalmen|V0112|2557|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5465||5465|8703||1
490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3121|5476|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3121||3121|5476||1
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|10292|11652|lyfalmen|V0113|2626|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7608||7608|11652||1
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12085|14395|lyfalmen|V0114|2732|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9601||9601|14395||1
491230|J05AX0001|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AX|01.10.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|2022109|2520576|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvír og Velpatasvír||2022109||2022109|2520576||2
491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|105464|136806|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||105464|136806||1
491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|3156|3500|lyfalmen|V0693|3029|2|28|0|28,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||1685||1685|3500||2
491753|C10AC0103|Questran Loc|mixtduft|4|g|50|skpokar|1|pakki||C10AC01|01.12.2014|31.10.2016|R|0|0|0|0|0|0|BBB|0|0|0|100|DKK|3088|5431|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb AB|Kólestýramín||3088||3088|5431||1
492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PIZ|0|0|0|100|DKK|428841|538996|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd|Bósútíníb||428841||428841|538996||1
492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2355|4422|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2355||2355|4422||2
492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5431|8656|lyfalmen|V0002|4261|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||5431||5431|8656||1
492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1
492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|13586|19880|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||13586||13586|19880||1
493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|21750|30268|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||21750||21750|30268||1
493226|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|14|0|14,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1
493313|G04BD0704|Tolterodin Actavis|forðahlk|2|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2993|5300|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||2993||2993|5300||1
493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|76571|99606|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||76571||76571|99606||1
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|898|2416|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||898||898|2416||1
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1921|3825|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||1921||1921|3825||1
494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|56238|73889|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||56238||56238|73889||2
494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|140594|180498|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||140594||140594|180498||2
494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1762|3606|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1762||1762|3606||1
494574|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|þpakki||N03AX11|01.03.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|8353|12678|lyfalmen|||2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||8353||8353|12678|31.10.2016|2
494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól|||||||1
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1759|3602|lyfalmen|V0128|1921|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1759||1759|3602||1
494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2556|4699|lyfalmen|V0410|3893|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2556||2556|4699||1
494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2139|4204|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|Magnesíum súlfat||2139||2139|4204||2
494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1422|3138|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1422||1422|3138||1
494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|RAP|0|0|0|100|XEU|712982|892388|lyfsjukr|||1|250|0|9,3700|Raptor Pharmaceuticals Europe B.V.|Raptor Pharmaceuticals Europe B.V.|Mecaptamín||712982||712982|892388||3
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|17108|6107|lyfalmen|V0384|4376|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3579||3579|6107||1
495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|6654|6213|lyfalmen|V0389|6213|1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3656||3656|6213||1
495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5022|8093|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||5022||5022|8093||1
495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2077|4039|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Zanamivír||2077||2077|4039||1
496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|33707|lyfalmen|||3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33707||2
496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3563|6930|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3563||3563|6930||2
496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|6044|6149|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||3610||3610|6149|30.9.2016|1
496648|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|407|1741|lyfalmen|||2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||407||407|1741||1
496925|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.12.2016||L|1|0|0|0|0|0|SDF|0|0|1|100|DKK|||lyfalmen|V0807|4370|0|100|0|50,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Klemastín|||||4370||1
496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|1|0|G|0|PLS|0|0|0|100|DKK|365|1683|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||365||365|1683||1
496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|659|2088|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||659||659|2088||1
497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|153395|196419|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||153395||153395|196419||2
497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|192569|245140|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||192569||192569|245140||1
497065|M01AE0219|Alpoxen|töflur|500|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|GPA|0|0|1|100|SEK|1314|2821|lyfalmen|V0127|2821|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||1192||1192|2821||1
497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2513|4639|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||2513||2513|4639||1
497107|M01AE0219|Alpoxen|töflur|250|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|GPA|0|0|1|100|SEK|651|2077|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||651||651|2077||1
497286|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|2096|lyfalmen|V0056|1829|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2096||2
497290|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.01.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|NOK|7650|3957|lyfalmen|||1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2017||2017|3957||1
497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|529|1909|lyfalmen|V0448|1909|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||529||529|1909||1
497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|962|2505|lyfalmen|V0449|2505|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||962||962|2505||1
497885|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1358|2669|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1358||1358|2669||2
497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|980|2529|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||980||980|2529||1
498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|4346|lyfalmen|V0472|4346|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4346||2
498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|12534|14738|lyfalmen|V0683|13871|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||9850||9850|14738||2
498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|0|SAS|0|0|0|100|NOK|64477|103937|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||64477||64477|103937||1
498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|13202|19352|lyfalmen|V0608|9501|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||13202||13202|19352||1
498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|13648|19966|lyfalmen|V0609|10702|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||13648||13648|19966||1
499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|15071|21924|lyfalmen|V0610|10949|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||15071||15071|21924||1
499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|20698|28938|lyfalmen|V0718|18779|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||20698||20698|28938||1
499070|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|823|2313|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||823||823|2313||1
499109|N05AH0410|Quetiapin Actavis|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|9946|11396|lyfalmen|V0275|11396|2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||7422||7422|11396||
499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|7541|11560|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||7541|11560||2
499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|4884|7903|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||4884||4884|7903||2
499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|9681|14505|lyfalmen|||1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||9681||9681|14505||1
500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|57215|75125|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|emtricitabine og tenofovir alafenamide||57215||57215|75125||2
501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4880|3965|lyfalmen|||2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||2023||2023|3965||2
501277|N06AX2109|Duloxetine ratiopharm|sþ-hylki|60|mg|100|stk|1|glas||N06AX21|01.12.2015||R|0|0|0|0|0|0|RAT|0|0|0|100|IKR|11839|9852|lyfalmen|V0694|9573|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Duloxetín||6300||6300|9852||2
501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|4605|7519|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||4605||4605|7519||1
501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas||N06BA04|01.11.2015||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|9306|13989|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||9306||9306|13989||1
501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|21977|30556|lyfalmen|||1|168|0|21,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||21977||21977|30556||2
501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2212|4225|lyfalmen|V0434|3859|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2212||2212|4225||2
502888|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|3522|6028|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||3522||3522|6028||2
502904|A10BX0901|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BX09|01.11.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|4786|7768|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||4786||4786|7768||1
502956|A11DA0101|Tiacur|stl|25|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|11258|16676|lyfalmen|||1|10|0|5,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||11258|16676||2
503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|16297|23612|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||16297||16297|23612||1
503265|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|28|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|2090|4057|lyfalmen|||2|28|0|42,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2090||2090|4057||2
503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|17378|25100|lyfalmen|||1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||17378||17378|25100||1
503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|4101|6825|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4101||4101|6825||1
503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6070|8418|lyfalmen|||3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||5258||5258|8418||2
504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|3344|5783|lyfsjukr|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||3344||3344|5783||2
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1286|2027|lyfalmen|V0494|1869|2|90|0|180,0000|Actavis Group hf|Actavis hf|Glímepíríð||615||615|2027||1
504120|R03AL0301|ANORO|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|5574|8853|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og umeclidinium bromide||5574||5574|8853||1
504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|29543|40125|lyfsjukr|||1|112|0|22,4000|Icepharma hf|Pfizer Limited|Síldenafíl||29543||29543|40125||1
504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|þpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|904|2425|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||904||904|2425||2
504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|10901|20852|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||10901||10901|20852||1
505495|J01CE0107|Benzylpenicillin Panpharma|sts/irs|3|g/hgl|10|hgl|1|pakki|lausn|J01CE01|01.02.2016|30.11.2016|R|0|0|0|0|0|1|PAP|0|0|0|100|DKK|4242|7019|lyfsjukr|||2|10|0|8,3300|Icepharma hf|Panpharma S.A.|Benzýlpenicillín||||4242|7019||2
505503|J01CE0107|Benzylpenicillin Panpharma|sts/irs|0,6|g/hgl|10|hgl|1|pakki|lausn|J01CE01|01.02.2016|30.11.2016|R|0|0|0|0|0|1|PAP|0|0|0|100|DKK|1134|2741|lyfsjukr|||2|10|0|1,6700|Icepharma hf|Panpharma S.A.|Benzýlpenicillín||||1134|2741||2
505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|300|skammtar|1|fl|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|1405|3114|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1405||1405|3114||1
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|2806|5043|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||2806||2806|5043||1
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|6403|9994|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||6403||6403|9994||1
506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|17378|25100|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||17378||17378|25100||1
506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1995|3926|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||1995||1995|3926||2
506809|N05AX1207|Lemilvo|töflur|5|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|40890|24769|lyfalmen|V0682|24769|2|100|0|33,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||17138||17138|24769||1
506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1919|3822|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||1919||1919|3822||1
506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1
507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|312|1610|lyfalmen|V0808|1610|1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||312||312|1610||1
507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|513|884|vetorma|||0|24|0||Icepharma hf|Zoetis Finland OY|||513||513|884||2
507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|100509|130643|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||100509||100509|130643||1
507758|R03AK0604|Relanio|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014|30.09.2016|R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|9000|9852|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||6300||6300|9852||2
507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RPO|0|0|0|100|IKR|3105|5454|lyfalmen|||2|100|0|66,6700|LYFIS ehf|ratiopharm Oy|Betahistín||3105||3105|5454||2
507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|1519|3271|lyfalmen|V0092|3271|2|100|0|66,6600|Alvogen|Orion Corporation|Spírónólaktón||1519||1519|3271||1
507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|0|G|0|AML|0|0|1|100|DKK|833|2327|lyfalmen|||1|5|0||Vistor hf|Amdipharm Limited|Fúsidínsýra||833||833|2327||1
508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|7973|5398|lyfalmen|V0687|4890|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3064||3064|5398||2
508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|612|1955|lyfalmen|V0555|1900|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1955||1
508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|1991|3921|lyfalmen|V0710|3921|1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1991||1991|3921||1
508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3978|7718|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||3978|7718||2
508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3584|6970|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3584||3584|6970||2
508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|10618|20315|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||10618||10618|20315||2
508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SAA|0|1|0|100|NOK|474146|595343|lyfsjukr|||1|1|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||474146||474146|595343||1
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|7432|11410|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||7432||7432|11410||1
509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||||5425|10463||2
509359|N06AX1611|Duofaxin|forðatfl|75|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|858|2235|lyfalmen|V0336|2235|2|28|0|21,0000|Vistor hf|MediLink A/S|Venlafaxín||766||766|2235||1
509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2
509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|0|BGB|0|0|0|100|DKK|1713|3538|lyfalmen|V0134|2857|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Cýpróterón og östrógen||1713||1713|3538||2
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|GBP|35203|47284|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||35203||35203|47284||1
510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|67098|87625|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||67098|87625||2
510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|12953|19009|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||12953||12953|19009||2
510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|19390|27869|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||19390||19390|27869||2
510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|31805|42986|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||31805||31805|42986||2
510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|49158|64934|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||49158||49158|64934||2
510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|375|1697|lyfalmen|V0601|1547|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||375||375|1697||1
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|128466|165414|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||128466|165414||1
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|3241|4206|lyfalmen|V0445|4206|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríð||2198||2198|4206||1
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2096|4065|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2096||2096|4065||1
511361|A10BB1203|Glimepirid Bluefish|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|593|1456|lyfalmen|V0021|1456|2|90|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||200||200|1456||2
511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|16353|23689|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||16353||16353|23689||1
511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|10230|15261|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||10230||10230|15261||1
511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|12638|18575|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||12638||12638|18575||2
512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4091|6811|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||4091||4091|6811||1
513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|2096|lyfalmen|V0057|2096|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2096||2
513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1899|lyfalmen|V0109|1899|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1899||2
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1
513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|5462|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||2789||2789|5462||2
513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|21524|29983|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||21524||21524|29983||1
513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2095|4118|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2095||2095|4118||2
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1648|3239|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||1648||1648|3239||2
513947|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8268|15857|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8268||8268|15857||2
514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3933|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3933||2
514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1283|2946|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1283||1283|2946||1
514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|0|0|1|0|0|DAN|0|0|0|100|XEU|15927|23102|lyfalmen|||1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||15927|23102||2
514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|3800|2419|lyfalmen|V0692|2418|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||900||900|2419||2
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PLS|0|0|0|100|IKR|4026|4444|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4444||1
515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|10461|15579|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||10461||10461|15579||3
516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|0|0|100|DKK|124098|159981|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||124098|159981||2
516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|4183|6138|lyfsjukr|||1|10|0|1,0000|Alvogen|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||3602||3602|6138||1
516630|D06BX0201|Picato|hlaup|500|mcg/g|0,47|g|2|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LEP|0|0|1|100|DKK|14845|21613|lyfalmen|||1|0,94|0||Vistor hf|LEO Pharma A/S|Ingenol mebutate||||14845|21613||1
516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|8700|8751|lyfalmen|V0384|8751|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||5500||5500|8751||2
517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|18600|22102|lyfalmen|V0273|21009|2|100|0|50,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||15200||15200|22102||2
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2300|4346|lyfalmen|V0462|3424|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2300||2300|4346||
517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|25625|35170|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||25625||25625|35170||1
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2504|4627|lyfalmen|V0471|3485|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2504||2504|4627||1
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2692|4886|lyfalmen|V0472|3260|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2692||2692|4886||1
517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|25202|34634|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||25202||25202|34634||2
517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1
518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|48669|44877|lyfalmen|V0711|43013|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||33300||33300|44877||2
518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|AGH|0|0|1|100|DKK|870|2378|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||870||870|2378||1
518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|0|G|0|AGH|0|0|1|100|DKK|3220|5612|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3220||3220|5612|30.11.2016|1
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1623|3414|lyfalmen|V0590|2498|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel||1623||1623|3414||1
518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|985|2484|lyfalmen|V0004|2484|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||947||947|2484||1
518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|14991|21814|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||14991||14991|21814||1
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|MAB|0|0|1|100|SEK|775|2247|lyfalmen|||1|125|0|3,1250|Vistor hf|Meda AB|Fenoxýmetýlpenicillín||775||775|2247||1
519061|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|G|0|BAB|0|0|1|100|IKR|||lyfalmen|V0362|1987|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8422||2
519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|792|2088|lyfalmen|V0564|1953|2|100|0|50,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||659||659|2088||2
519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|||||2463|4841||2
519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3110|5461|lyfalmen|||2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíð||3110||3110|5461||1
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|APP|0|0|1|100|SEK|1160|2777|lyfalmen|||1|100|0|2,5000|Artasan ehf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1160||1160|2777||1
519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|5652|8960|lyfalmen|V0209|8960|2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||5652||5652|8960||1
520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|6598|3692|lyfalmen|V0515|3662|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||1825||1825|3692||1
520160|J01XA0108|Vancomycin Actavis|st/irþ|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.03.2016||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|699|1610|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||312||312|1610||1
520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|17538|25320|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||17538|25320||1
520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3674|6237|lyfalmen|||1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||3674||3674|6237||1
520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|4940|7980|lyfalmen|V0143|1229|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4940||4940|7980||1
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|13946|20376|lyfalmen|V0143|3687|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||13946||13946|20376||1
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|4538|7427|lyfalmen|V0144|1344|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4538||4538|7427||1
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12556|18463|lyfalmen|V0144|4031|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||12556||12556|18463||1
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1355|2144|lyfalmen|V0056|1829|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2144||1
520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|9564|14344|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||9564||9564|14344||1
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|2163|2144|lyfalmen|V0057|2096|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2144||1
520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|254|1530|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||254||254|1530||1
520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2
522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|7532|14460|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín í blöndum með öðrum sýklalyfjum||7532||7532|14460||1
522327|N03AX1604|Brieka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|8607|6134|lyfalmen|V0688|5616|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3599||3599|6134||1
522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|100171|130223|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||100171||100171|130223||2
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|137342|176453|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||137342||137342|176453||1
522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|2033|3979|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2033||2033|3979||1
523008|G03AA1208|Cleosensa|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|1965|3885|lyfalmen|V0192|3885|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||1965||1965|3885||1
523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|982|2532|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||982||982|2532||1
523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3959|3720|lyfalmen|V0285|3520|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||1845||1845|3720||1
523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1599||1
523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|148634|190497|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||148634||148634|190497||1
523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|255694|323650|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||255694||255694|323650||1
523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|831|2324|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||831||831|2324||1
523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|1281|2944|lyfalmen|V0584|2944|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1281||1281|2944||1
524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|289|1578|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||289||289|1578||1
524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1797|3654|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1797||1797|3654||1
524257|L02BB0401|Xtandi|hylki|40|mg|112|stk|1|þpakki||L02BB04|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|379957|478198|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||379957||379957|478198||1
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|6184|lyfalmen|V0010|3658|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6184||1
524351|L01XX2401|Oncaspar|stl/irl|750|ein/ml|5|ml|1|hgl||L01XX24|01.10.2016||R|0|0|0|1|0|1|ALT|0|0|0|100|SEK|184033|234524|lyfsjukr|||1|5|0||Lyfjaver ehf|Baxalta Innovations GmbH|Pegaspargase||184033||184033|234524||3
524937|N05AX1209|Aripiprazole Sandoz|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|14886|14329|lyfalmen|V0683|13871|2|56|0|37,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||9553||9553|14329||1
524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|0|GAL|0|0|0|100|XEU|5908|9312|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||5908||5908|9312||2
525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|542|1926|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||542||542|1926||1
525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|602|2009|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S|Díklófenak||602||602|2009||1
525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|TCA|0|0|1|100|XEU|1334|3017|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1334||1334|3017||1
525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|TCA|0|0|1|100|XEU|3865|6500|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||3865||3865|6500||1
525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|1|0|0|1|0|0|TBP|0|0|0|100|DKK|5818|7604|lyfalmen|V0657|7604|1|30|0|10,0000|Vistor hf|Teva Pharma B.V.|Modafinil||4667||4667|7604||1
525219|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|10966|20975|vetalmen|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||10966||10966|20975||2
525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|26714|36547|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||26714|36547||2
525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|4215|6982|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||4215||4215|6982||1
525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|3838|6463|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||3838||3838|6463||1
525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2008|3944|lyfsjukr|||2|1000|0|4,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2008|3944||2
525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4546||1
526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4608||1
526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3358|5802|lyfalmen|V0435|5802|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3358||3358|5802||2
526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|4834|7834|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4834||4834|7834||1
526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|13147|11428|lyfalmen|V0111|11228|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||7445||7445|11428||2
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|3064|5398|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3064||3064|5398||1
527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|þpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1
527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|10051|15015|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||10051||10051|15015||1
527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|14720|5403|lyfalmen|V0516|5396|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3068||3068|5403||1
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1153|2767|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Emedastín||1153||1153|2767||1
527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|206594|262583|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||206594||206594|262583||1
527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|0|RPG|0|0|0|100|XEU|1418|2787|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|||1418||1418|2787||2
528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|780|1939|lyfalmen|V0046|1939|2|100|0|33,3333|Alvogen|Orion Corporation|Spírónólaktón||551||551|1939||1
528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|12319|13981|lyfalmen|V0635|13664|2|100|0|20,8000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||9300||9300|13981||2
528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||||1
528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|8450|5495|lyfalmen|V0011|5246|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3135||3135|5495||1
528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|590|1856|lyfalmen|V0562|1635|2|100|0|33,3300|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||491||491|1856||2
528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1668|3476|lyfalmen|||0|100|0||Vistor hf|Galenica AB|Mómetasón||1668||1668|3476||1
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|5094|8192|lyfalmen|V0356|7160|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||5094||5094|8192||3
528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|5348|8541|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||5348||5348|8541||1
528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|3635|3518|lyfalmen|V0621|3518|2|18|0|18,0000|LYFIS ehf|ratiopharm GmbH|Rizatriptan||1698||1698|3518||2
529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982|30.11.2016|L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|53344|70228|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||53344||53344|70228||1
529787|L01XC1801|KEYTRUDA|irþ|50|mg|1|hgl|1|pakki||L01XC18|01.10.2015||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|220889|280362|lyfsjukr|||1|1|0||Vistor hf|Merck Sharp & Dohme Limited|Pembrolizumab||220889||220889|280362||1
529993|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1563|3072|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1563||1563|3072||2
530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|10127|lyfalmen|||2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|10127||2
530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1
530172|J05AX1601|Exviera|filmhtfl|250|mg|56|stk|1|þpakki||J05AX16|01.10.2015||R|1|0|0|1|0|1|ABV|0|1|0|100|DKK|133380|171526|lyfsjukr|||1|56|0|28,0000|Vistor hf|AbbVie Ltd.|Dasabuvir||133380||133380|171526||1
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|5195|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||5769||1
530322|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2
530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1267|2490|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1267||1267|2490||2
530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2221|4237|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2221||2221|4237||1
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4946|7988|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||4946||4946|7988||1
531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985|30.09.2016|R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2271|4306|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2271||2271|4306||1
531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|3732|6317|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||3732||3732|6317||3
531829|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1869|lyfalmen|V0329|1869|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1869||2
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|525|1903|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||525||525|1903||1
532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|36019|39433|lyfalmen|V0711|38404|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||28996||28996|39433||2
532821|L01XX3203|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.02.2016||R|0|1|0|1|0|1|WEH|0|0|0|100|XEU|91533|118530|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomíb||91533||91533|118530||2
532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1614|3402|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||1614||1614|3402||2
533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1412|3124|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1412||1412|3124||1
533779|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3
534141|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2178|2419|lyfalmen|V0006|2282|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||900||900|2419||1
534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|14545|21200|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||14545||14545|21200||1
534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|PHH|0|0|0|100|DKK|45659|60509|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||45659||45659|60509||1
534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|1674|3290|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|||1674||1674|3290||2
534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7700|6755|lyfalmen|V0117|6699|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||4050||4050|6755||2
534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|4326|7135|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||4326||4326|7135||2
535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|1747|3585|lyfalmen|V0092|3271|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1747||1747|3585||1
535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2
535777|N06AX2108|Aritavi|sþ-hylki|30|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1562|2257|lyfalmen|V0692|2257|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||782||782|2257||1
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|334|1640|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||334||334|1640||1
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|348|1659|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||348||348|1659||1
536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|þpakki||A10BA02|01.11.2012|30.09.2016|R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|340|1511|lyfalmen|||2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||240||240|1511||1
536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|23217|32124|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||23217||23217|32124||1
536384|N03AX1609|Pregabalin Sandoz GmbH|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|5279|6043|lyfalmen|V0733|4282|2|56|0|28,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||3533||3533|6043||1
536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|75672|98469|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||75672||75672|98469||1
536712|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|8489|12865|lyfalmen|V0690|12865|2|28|0|9,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||8489||8489|12865||1
536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2163|4158|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2163||2163|4158||2
536875|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|6918|10702|lyfalmen|V0609|10702|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||6918||6918|10702||1
536963|D06BX0201|Picato|hlaup|150|mcg/g|0,47|g|3|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LEP|0|0|1|100|DKK|14683|21390|lyfalmen|||1|1,41|0||Vistor hf|LEO Pharma A/S|Ingenol mebutate||||14683|21390||1
537029|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|13378|12263|lyfalmen|V0624|12263|2|90|0|108,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||8052||8052|12263||1
537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|57215|75125|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|emtricitabine og tenofovir alafenamide||57215||57215|75125||2
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4834|7834|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||4834||4834|7834||1
537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1928||1
538138|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|6045|9501|lyfalmen|V0608|9501|2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||6045||6045|9501||1
538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2
538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|86509|112176|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||86509||86509|112176||2
538555|L01BA0110|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2318|4371|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2318||2318|4371||2
538696|C09CA0305|Valsartan ratiopharm|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3328|3520|lyfalmen|V0678|3441|2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan||1700||1700|3520||2
538713|R03BB0701|Incruse|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|3765|6363|lyfalmen|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Umeclidiniumbrómið||3765||3765|6363||1
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNO|0|0|0|100|NOK|5743|9085|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||5743||5743|9085||1
539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|67657|88332|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||67657||67657|88332||1
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGH|0|0|1|100|DKK|493|1859|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||493||493|1859||1
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGH|0|0|0|100|DKK|639|2060|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||639||639|2060||1
539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1397|3103|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1397||1397|3103||1
540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|17058|24659|lyfsjukr|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||17058||17058|24659||1
540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|35592|27238|lyfalmen|V0721|27238|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||18932||18932|27238||2
540544|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|1250|2397|lyfalmen|V0621|1173|2|6|0|6,0000|LYFIS ehf|ratiopharm GmbH|Rizatriptan||884||884|2397||2
540648|N05AX1207|Lemilvo|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|18290|14277|lyfalmen|V0684|13871|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||9515||9515|14277||1
540709|N04BD0204|Rasagiline Mylan|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.11.2016||R|0|0|0|0|G|0|ASD|0|0|0|100|SEK|9355|14057|lyfalmen|V0726|14057|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Rasagilín||9355||9355|14057||2
540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|567326|711233|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||||567326|711233||2
541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1
541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|158304|202524|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer Pharma AG|Riociguatum||158304||158304|202524||1
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|4565|7464|lyfsjukr|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||4565||4565|7464||1
542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|0|0|WEH|0|0|0|100|XEU|16052|14391|lyfalmen|V0682|13871|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||9598||9598|14391||2
542634|N05AX1207|Lemilvo|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|20018|14277|lyfalmen|V0683|13871|2|56|0|37,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||9515||9515|14277||1
542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5910|9315|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||5910|9315||2
543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|þpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|463|1818|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||463||463|1818||1
543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|12162|17920|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||12162|17920||1
543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2954|2609|lyfalmen|V0203|2609|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||1038||1038|2609||2
543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2262|4294|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S|Pindólól||2262||2262|4294||1
543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|875|2385|lyfalmen|V0373|1379|2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||875||875|2385||1
543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|57437|75405|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||||57437|75405||2
543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|MAB|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Meda AB|Semen psyllii (ispaghula)|||||||1
543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1
544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|2932|3852|lyfalmen|V0143|3687|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||1941||1941|3852||2
544374|L01XX4701|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|441957|555309|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Science International Limited|Idelalisib||441957||441957|555309||2
544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|209761|266522|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||209761||209761|266522||2
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|10105|15089|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||10105||10105|15089||1
545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|32957|29573|lyfalmen|V0636|29012|2|100|0|84,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||21200||21200|29573||2
545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|201944|256800|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration Limited|Rítúxímab||201944||201944|256800||2
545110|H05BX0103|Cinacalcet Sandoz|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|49058|38706|lyfalmen|V0722|38679|2|28|0|42,0000|Artasan ehf|Sandoz A/S|Cinacalcet||28421||28421|38706||1
545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|0|RAT|0|0|0|100|XEU|1346|2857|lyfalmen|V0134|2857|2|63|0|84,0000|LYFIS ehf|ratiopharm GmbH|Cýpróterón og östrógen||1218||1218|2857||2
545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|681|2118|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||681||681|2118||1
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1661|3467|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1661||1661|3467||1
545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23516|32502|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||23516||23516|32502||1
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18960|27277|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||18960||18960|27277||1
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23655|32678|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||23655||23655|32678||1
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|20096|28176|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||20096||20096|28176||1
546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1
546151|A02BC0510|Eradizol|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Alvogen|Alvogen|Esómeprazól|||||||1
546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|984|2535|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól||984||984|2535||1
546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3218|2832|lyfalmen|V0580|2776|2|98|0|98,0000|LYFIS ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||1200||1200|2832||2
546838|J01CE0107|Benzylpenicillin Panpharma|sts/irs|1,2|g/hgl|10|hgl|1|pakki|lausn|J01CE01|01.02.2016|30.11.2016|R|0|0|0|0|0|1|PAP|0|0|0|100|DKK|1790|3644|lyfsjukr|||2|10|0|3,3300|Icepharma hf|Panpharma S.A.|Benzýlpenicillín||||1790|3644||2
546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|IKR|3931|4433|lyfalmen|V0010|3733|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2363||2363|4433||1
547519|N03AX1209|Gabapentin Sandoz|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2593|2802|lyfalmen|V0251|2776|2|100|0|22,2200|Artasan ehf|Sandoz A/S|Gabapentín||1178||1178|2802||1
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5017||1
547659|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2267|2557|lyfalmen|V0004|2484|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2557||2
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|RGO|0|0|0|100|GBP|7517|11527|lyfsjukr|||1|100|0|0,3800|Vistor hf|Glaxo Group Limited|Eptifibatíð||7517||7517|11527||1
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|RGO|0|0|0|100|GBP|2417|4507|lyfsjukr|||1|10|0|0,1000|Vistor hf|Glaxo Group Limited|Eptifibatíð||2417||2417|4507||1
547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8223|12499|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||8223|12499||2
548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|BYP|0|0|0|100|DKK|83038|107785|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer Pharma AG|Interferón beta-1b||83038||83038|107785||2
548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2
548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|516|1891|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||516||516|1891||1
548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||1724||1
548722|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|11678|9894|lyfalmen|V0694|9382|2|98|0|98,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||6331||6331|9894||2
548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|1|0|1|BAA|0|0|0|100|SEK|123961|159811|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Blöndur||123961||123961|159811||2
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|6298|9849|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||6298||6298|9849||1
549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|25838|35439|lyfalmen|||1|98|0|73,5000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||25838|35439||2
550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|TCA|0|0|1|100|IKR|1567|1852|lyfalmen|V0551|1841|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||488||488|1852||1
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2518|4646|lyfalmen|V0471|4646|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4646||2
551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1342|3028|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1342||1342|3028||1
551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1
551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6348|9918|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||6348||6348|9918||2
551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|3839|6464|lyfalmen|||1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||3839||3839|6464||1
551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1282|2945|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1282||1282|2945||
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2052|4005|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||2052||2052|4005||1
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1958|lyfalmen|V0466|1958|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1958||1
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3752|3648|lyfalmen|V0467|2557|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3648||1
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1209|lyfalmen|V0003|932|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1209||1
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1958|lyfalmen|V0003|1865|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1958||1
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7272|3648|lyfalmen|V0010|2090|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3648||1
552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1361|3054|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1361||1361|3054||2
552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1
552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|12859|20729|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||12859||12859|20729||1
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2503|4626|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||2503||2503|4626||1
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|9338|14033|lyfalmen|V0237|14033|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||9338|14033||1
553231|C10AA0506|Atorvaratio|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|3260|2557|lyfalmen|V0112|2557|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1000||1000|2557||2
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3194|5577|lyfalmen|V0237|4678|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||3194||3194|5577||1
553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|435259|546979|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||435259||435259|546979||1
553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|33761|45460|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||33761|45460||2
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|5829|11229|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||5829||5829|11229||1
554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5493|5723|lyfalmen|V0029|5710|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||3300||3300|5723||1
554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1085911|1356208|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1085911||1085911|1356208||2
554721|J01XA0108|Vancomycin Actavis|st/irþ|1000|mg/hgl|1|hgl|1|pakki||J01XA01|01.07.2016||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|1214|1938|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||550||550|1938||1
555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|127263|141004|lyfsjukr|||1|2|0||Vistor hf|Novartis Europharm Ltd|Secukinumab||108839||108839|141004||1
555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1768|3614|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1768||1768|3614||1
555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2015|3954|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2015||2015|3954||1
555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1521|3274|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1521||1521|3274||1
555572|S01XA2201|JETREA|stþ|0,5|mg/hgl|0,2|ml|1|hgl||S01XA22|01.12.2014||R|0|1|0|1|0|1|THO|0|0|0|100|USD|454834|571324|lyfsjukr|||1|0,2|0||Vistor hf|ThromboGenics NV|Ocriplasmínum||454834||454834|571324||1
555864|G04BD0804|Solifenacin Actavis|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|11426|15075|lyfalmen|V0440|15075|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||10095||10095|15075||1
556377|R01AD0903|Mometason Evolan|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.06.2016||L|0|0|0|0|G|0|EVO|0|0|1|100|IKR|||lyfalmen|V0677|2429|2|140|0|35,0000|LYFIS ehf|Evolan Pharma AB|Mómetasón|||||2806||2
556694|C10A00001|Praluent|stl|150|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|58677|76974|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||58677|76974||1
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|15940|23120|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||15940||15940|23120||2
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3793|6401|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3793||3793|6401||1
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|7395|11359|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7395||7395|11359||1
557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1
557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2231|4041|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2078||2078|4041||2
558175|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|3543|6892|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||3543||3543|6892||2
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|190927|243098|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||190927|243098||1
558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2
559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1158|2774|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1158||1158|2774||2
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2
559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|3850|6480|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||3850||3850|6480||1
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1527||1
560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|1|0|1|CLC|0|1|0|100|XEU|37993|50813|lyfsjukr|||1|100|0||Celgene AB|Celgene Europe Limited|Paklítaxel||37993||37993|50813||2
560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|942|2394|lyfalmen|V0044|2195|1|25|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||882||882|2394||1
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1
560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|1115|2715|lyfalmen|||1|4,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||1115||1115|2715||1
560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|3811|6426|lyfalmen|||1|125|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||3811||3811|6426||1
560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|4193|6952|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4193||4193|6952||1
560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|76372|99354|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||76372||76372|99354||1
560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|351312|442572|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||351312||351312|442572||1
560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|POF|0|1|0|100|DKK|132768|108560|lyfsjukr|||2|60|0||Alvogen|Alvogen|Imatiníb||83650||83650|108560||1
561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1266|2923|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1266||1266|2923||2
561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|158304|202524|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer Pharma AG|Riociguatum||158304||158304|202524||1
562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1530|2481|lyfalmen|V0098|2386|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||945||945|2481||1
562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|38742|51760|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuþáttur IX||38742||38742|51760||1
562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|3481|5972|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||3481||3481|5972||1
562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|208357|264776|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||208357||208357|264776||2
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|66970|87463|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||66970||66970|87463||1
563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|88269|114402|lyfalmen|V0484|114402|1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||88269||88269|114402||2
563184|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|60|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|4705|7656|lyfalmen|V0705|6933|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||4705||4705|7656||1
563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|501|1870|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||501||501|1870||1
563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|498|1866|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||498||498|1866||1
563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1075|2660|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1075||1075|2660||1
563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|19440|18741|lyfalmen|V0720|18390|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||12758||12758|18741||2
563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2683|4873|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2683||2683|4873||2
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2781|5008|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2781||2781|5008||2
563653|A10BB1203|Glimepirid Bluefish|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1522|1869|lyfalmen|V0494|1869|2|90|0|180,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|1869||2
563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1486|2921|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1486|2921||2
563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|361109|454757|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||361109||361109|454757||1
563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10463||10463|18034||2
563918|N02AA0505|Oxycodone ratiopharm|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|521|1898|lyfalmen|V0596|1829|2|28|0|1,8600|LYFIS ehf|ratiopharm GmbH|Oxýcódon||521||521|1898||2
564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|54196|71306|lyfsjukr|||1|168|0|33,6000|Vistor hf|Merck Sharp & Dohme Limited|Ribavirin||54196||54196|71306||1
564110|A02BX1302|Galieve Cool Mint|mixtúra|||150|ml|1|glas|dreifa|A02BX13|01.10.2014|30.11.2016|L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|17420|25157|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||17420||17420|25157||3
564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|828|2320|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||828||828|2320||1
564918|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1
565046|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2060|4016|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2060||2060|4016||1
565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|7600|6411|lyfalmen|V0286|6353|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Quetíapín||3800||3800|6411||2
565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|8183|12444|lyfalmen|V0714|12444|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||8183||8183|12444||1
565625|M01AE0102|Ibufen|mixtúra|20|mg/ml|100|ml|1|glas||M01AE01|01.08.2016||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|100|0|1,6700|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1
565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|6735|12948|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||6735|12948||
565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|19089|27455|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||19089||19089|27455||1
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1287|2952|lyfalmen|V0444|2006|1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíð||1287||1287|2952||1
566243|G03AA1207|Cleonita|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|2391|4471|lyfalmen|V0193|4471|2|84|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2391||2391|4471||1
566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|11521|17038|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||11521||11521|17038||1
567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|190203|242198|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||190203||190203|242198||1
567259|A10BB1203|Glimepirid Bluefish|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|907|1593|lyfalmen|V0022|1593|2|90|0|90,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||300||300|1593||2
567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|13441|19681|lyfalmen|V0651|19681|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||13441||13441|19681||1
567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|0|G|0|APP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól|||||2623||
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|4516|7396|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||4516|7396||1
567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2131|4114|lyfalmen|V0291|2419|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2131||2131|4114||1
567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|2117|4094|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||2117||2117|4094||1
567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4129|6864|lyfalmen|V0292|3864|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||4129||4129|6864||1
567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1
567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2
567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|GBP|801|2283|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||801||801|2283||1
568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|4345|7161|lyfalmen|||1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||4345||4345|7161||1
568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2255|2484|lyfalmen|V0058|2484|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||947||947|2484||1
568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|3041|3786|lyfalmen|V0059|3786|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||1893||1893|3786||1
568945|N05AX1206|Aripiprazole ratiopharm|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|20454|14119|lyfalmen|V0684|13871|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Aripiprazól||9400||9400|14119||2
569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|1|0|1|0|1|VII|0|0|0|100|GBP|103947|134919|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír, dolutegravír og lamivudín||103947||103947|134919||1
569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|8679|13126|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||8679||8679|13126||2
569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|4800|2901|lyfalmen|V0001|2769|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1250||1250|2901||2
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|11970|17656|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||11970||11970|17656||1
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|13765|20127|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||13765||13765|20127||1
570258|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.11.2015||R|1|0|0|1|0|0|BLP|0|0|0|100|IKR|7200|7787|lyfalmen|V0657|7604|2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||4800||4800|7787||2
570421|L01BA0110|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2221|4237|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2221||2221|4237||2
571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|2638|5175|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||2638||2638|5175||1
571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|3100|5447|lyfalmen|V0384|4376|2|15|0|7,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||3100||3100|5447||2
571181|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|64404|84217|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||64404||64404|84217||1
571217|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014|30.11.2016|R|0|0|0|1|0|1|BER|0|1|0|100|SEK|34848|46835|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||34848|46835||3
571285|L01XE1301|Giotrif|filmhtfl|40|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|231089|293048|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||231089||231089|293048||1
571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|424477|533569|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Obinutuzumab||424477||424477|533569||2
571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
571628|N06AX2109|Duloxetine ratiopharm|sþ-hylki|30|mg|100|stk|1|glas||N06AX21|01.12.2015||R|0|0|0|0|0|0|RAT|0|0|0|100|IKR|7600|8062|lyfalmen|||2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Duloxetín||5000||5000|8062||2
572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|62117|81325|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||62117||62117|81325||1
572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1
573065|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|3828|5475|lyfalmen|V0011|5141|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5475||2
573069|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.05.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2476|3091|lyfalmen|V0248|3065|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1388||1388|3091||2
573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|TCA|0|0|0|100|IKR|5300|3608|lyfalmen|V0245|3585|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||1764||1764|3608||1
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3303|5727|lyfalmen|V0464|4461|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||3303||3303|5727||1
573382|J05AX6501|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AX65|01.09.2015||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|1961798|2445566|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir og ledipasvir||||1961798|2445566||
573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|66729|87158|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||66729||66729|87158||2
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|12477|18354|lyfsjukr|||1|10|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||12477||12477|18354||1
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|20456|28632|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||20456||20456|28632||1
573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1918|2532|lyfalmen|V0189|2059|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||982||982|2532||1
573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|4280|4265|lyfalmen|V0144|4031|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||2241||2241|4265||2
574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2
574357|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|0|0|WEH|0|0|0|100|XEU|64608|39323|lyfalmen|||2|500|0|500,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||28909||28909|39323||2
574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|325142|410024|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||325142||325142|410024||2
574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|8326|12640|lyfalmen|V0388|12640|1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||8326||8326|12640||1
574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
574900|N05AH0410|Quetiapin Actavis|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|17579|21009|lyfalmen|V0273|21009|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||14406||14406|21009||
575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1924|2060|lyfalmen|V0151|2060|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||639||639|2060||1
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|5996|5841|lyfalmen|V0322|2338|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||3386||3386|5841||1
575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3549|2060|lyfalmen|V0152|2060|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||639||639|2060||1
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|10805|5841|lyfalmen|V0323|3018|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||3386||3386|5841||1
575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|670495|839546|lyfsjukr|||1|1|0|0,1600|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||670495||670495|839546||1
575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1117|2006|lyfalmen|V0159|1972|2|20|0|10,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||600||600|2006||2
575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1285|2419|lyfalmen|V0160|2324|2|30|0|15,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||900||900|2419||2
575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1453|2419|lyfalmen|V0158|2396|2|20|0|15,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||900||900|2419||2
576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|TCA|0|0|0|100|IKR|945|1643|lyfalmen|V0243|1454|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||336||336|1643||1
576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1052798|1315024|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1052798||1052798|1315024||2
576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|7903|12058|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Merkaptópúrín||7903||7903|12058||1
577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|16541|23948|lyfalmen|V0727|21841|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||16541||16541|23948||1
577455|C10AA0506|Atorvaratio|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4000|2626|lyfalmen|V0113|2626|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1050||1050|2626||2
577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|9347|14046|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||9347||9347|14046||2
578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|USD|3818|6436|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||3818||3818|6436||2
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|5292|9121|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||5292||5292|9121||2
578794|A06AB0202|Toilax|sþ-tfl|5|mg|100|stk|1|glas||A06AB02|01.12.2016||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|312|1610|lyfalmen|V0808|1610|1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||312||312|1610||1
579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|15443|22436|lyfalmen|||2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||15443||15443|22436||2
579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|874|2383|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||874||874|2383||1
579171|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|GPB|0|0|0|100|DKK|1991|3921|lyfalmen|V0710|3921|1|98|0|98,0000|Vistor hf|BGP Products AB|Verapamíl||1991||1991|3921||
579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|168799|215577|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||168799||168799|215577||1
579421|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|1671|2557|lyfalmen|V0005|2484|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2557||2
579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|284|1571|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||284||284|1571||1
579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|0|0|OPE|0|0|0|100|DKK|8006|12200|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||8006||8006|12200||1
579932|C03DA0402|Eplerenone Portfarma|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|6316|3398|lyfalmen|V0107|3374|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||1611||1611|3398||1
579972|C03DA0403|Eplerenon  Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|11228|lyfalmen|V0111|11228|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||7300||7300|11228||2
580042|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|þpakki||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|580|1979|lyfalmen|||1|10|0||Icepharma hf|Bayer AB|Flúókortólón||580||580|1979||2
580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6665|10354|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||6665||6665|10354||1
580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|1|0|1|PLC|0|0|0|100|DKK|5878|9271|lyfsjukr|||1|8|0||Icepharma hf|Fresenius Kabi Oncology Plc.|Docetaxel||5878||5878|9271||2
580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1288|2953|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1288||1288|2953||2
581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2529|4661|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2529||2529|4661||2
581661|N02CC0403|Rizatriptan Portfarma|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2822|4515|lyfalmen|V0620|4515|2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||2423||2423|4515||1
581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|20533|lyfalmen|V0421|20450|2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||14060||14060|20533||1
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|11184|21389|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||11184||11184|21389||2
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|ASN|0|0|0|100|USD|2149|4138|lyfalmen|V0669|3555|0|2,5|0|25,0000|Alcon Nordic A/S|Alcon Laboratories Ltd.|Travóprost||2149||2149|4138||1
581991|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5395|10406|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||5395||5395|10406||2
582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|16982|24555|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||16982||16982|24555||2
582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|33232|44791|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||33232||33232|44791||2
582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|14238|20778|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||14238||14238|20778||3
582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|66464|86823|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||66464||66464|86823||2
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|20699|28939|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||20699||20699|28939||2
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|23744|32790|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||23744||23744|32790||2
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|53916|70952|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||53916||53916|70952||2
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21048|29381|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||21048||21048|29381||2
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|27062|36987|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||27062||27062|36987||2
583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1963|3365|lyfalmen|V0376|2624|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1587||1587|3365||1
583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|42999|57144|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||42999||42999|57144||2
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|770|2240|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||770||770|2240||2
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|72616|94604|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||72616||72616|94604||2
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|23006|31857|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||23006||23006|31857||2
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|36809|49315|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||36809||36809|49315||2
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|69017|90052|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||69017||69017|90052||2
583776|L01XE2301|Tafinlar|hylki|50|mg|28|stk|1|glas||L01XE23|01.11.2013|30.09.2016|R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|168755|215522|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||168755||168755|215522||1
583806|G04BE0310|Sildenafil LYFIS|filmhtfl|100|mg|24|stk|1|þpakki||G04BE03|01.09.2016||R|0|0|0|0|0|0|LYF|0|0|0|100|IKR|10000|8062|lyfalmen|V0144|8062|2|24|0|48,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||5000||5000|8062||2
584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|14395|20994|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||14395||14395|20994||1
584610|N03AX1609|Pregabalin Sandoz GmbH|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|1543|1622|lyfalmen|V0731|1622|2|56|0|4,6667|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||321||321|1622||1
585516|A10BX1201|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|16079|23312|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||16079||16079|23312||1
585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|4698|7647|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||4698||4698|7647||1
585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|3503|6002|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3503||3503|6002||1
585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2500|2832|lyfalmen|V0006|2282|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1200||1200|2832||2
585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|3245|5647|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3245||3245|5647||
585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|þpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|364|1507|lyfalmen|V0541|1507|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||237||237|1507||2
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|23939|33037|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||23939||23939|33037||1
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|10983|16297|lyfsjukr|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||10983||10983|16297||1
586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|293895|371161|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||293895||293895|371161||1
586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|54379|71538|lyfalmen|||1|2|0||Vistor hf|Amgen Europe B.V.|Evolocumab||54379||54379|71538||1
586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|22917|31744|lyfalmen|V0652|31744|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban 	||||22917|31744||1
587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|7012|6258|lyfalmen|V0196|6258|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||3689||3689|6258||1
587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|123655|159430|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||123655||123655|159430||1
587613|A02BC0112|Omezolmyl|sþ-hylki|40|mg|100|stk|1|þpakki||A02BC01|01.03.2015||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|5232|2769|lyfalmen|V0001|2769|2|100|0|200,0000|Icepharma hf|Mylan AB|Ómeprazól||1154||1154|2769||2
587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3594|6127|lyfalmen|V0095|6127|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||3594||3594|6127||1
588001|A10BB1203|Glimepirid Bluefish|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1522|1869|lyfalmen|V0494|1869|2|90|0|180,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|1869||2
588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|16052|14391|lyfalmen|V0683|13871|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||9598||9598|14391||2
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1697|3516|lyfalmen|V0461|3515|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1697||1697|3516||1
588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|6302|9855|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||6302||6302|9855||1
588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|17378|25100|lyfalmen|||1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||17378||17378|25100||1
588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7265|5194|lyfalmen|V0282|5194|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2916||2916|5194||1
588912|N03AX1609|Pregabalin Sandoz GmbH|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|6984|5690|lyfalmen|V0734|5085|2|56|0|42,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||3276||3276|5690||1
588982|R03AK0604|Relanio|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014|30.09.2016|R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|6000|7787|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||4800||4800|7787||2
589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|507868|637284|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||507868||507868|637284||1
589382|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004|30.09.2016|R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2658|4581|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2658||2658|4581||2
589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|9157|13784|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||9157||9157|13784||2
590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|112956|146124|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||112956||112956|146124||1
590135|C10AA0107|Simvastatin LYFIS|filmhtfl|10|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|1800|1869|lyfalmen|V0108|1770|2|100|0|33,3400|LYFIS ehf|LYFIS ehf|Simvastatín||500||500|1869||2
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2
590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2379|2540|lyfalmen|V0041|2445|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||988||988|2540||1
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|132497|170427|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||132497||132497|170427||1
591110|C10AA0507|Atorvastatin Hexal|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.10.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1940|2732|lyfalmen|V0113|2626|2|100|0|100,0000|Artasan ehf|Hexal A/S|Atorvastatín||1127||1127|2732||1
591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|10060|15027|lyfalmen|V0347|15027|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||10060||10060|15027||3
591317|C03DA0403|Eplerenon  Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.10.2014|31.10.2016|R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|12054|lyfalmen|||2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||7700||7900|12054||2
591445|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|5750|9095|lyfalmen|V0409|9095|2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||5750||5750|9095||2
591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|1215|2853|lyfalmen|V0168|2853|1|21|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||1215||1215|2853||1
592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|2953|5773|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||2953||2953|5773||1
592534|L04AD0104|Ciqorin|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|12500|14256|lyfalmen|||2|50|0|10,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||9500||9500|14256||2
592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|556086|697254|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||556086||556086|697254||1
593200|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014|30.11.2016|R|0|0|0|1|0|1|BER|0|1|0|100|SEK|18401|26508|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||18401|26508||3
593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|401|1732|lyfalmen|V0238|718|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||401||401|1732||2
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|707|2154|lyfalmen|V0238|2154|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||707||707|2154||2
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1035|2605|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1035||1035|2605||2
593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|12663|9382|lyfalmen|V0694|9382|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||5959||5959|9382||2
593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
594099|A10BB1203|Glimepirid Bluefish|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|960|1869|lyfalmen|V0023|1869|2|90|0|135,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|1869||2
594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|14454|21075|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||14454||14454|21075||1
594542|N03AX1604|Brieka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|8563|6125|lyfalmen|V0689|5604|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3592||3592|6125||1
594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|262|452|vetorma|||0|10|0||Icepharma hf|Zoetis Finland OY|||262||262|452||2
595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|ESS|0|0|0|100|DKK|4391|7224|lyfsjukr|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||4391||4391|7224||2
595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|13441|19681|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||13441||13441|19681||1
595250|D01BA0206|Terbinafin Bluefish|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.02.2016||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7265|9439|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Terbínafín||6000||6000|9439||2
595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|18118|26118|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||18118||18118|26118||1
595991|J07BB0201|Fluarix|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|453|1804|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir  mótefnavakar||453||453|1804||1
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|42955|57088|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||42955|57088||1
596881|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|13226|19385|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||13226||13226|19385||1
597041|R06AX2702|Aerius (Lyf og heilsa)|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.06.2016||R|1|0|0|0|G|0|HOL|0|0|1|100|NOK|2811|5050|lyfalmen|V0458|3177|3|90|0|90,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||2811||2811|5050||2
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1814|3677|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1814||1814|3677||1
597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|500337|627917|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||500337||500337|627917||1
597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|100171|130223|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||100171||100171|130223||2
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1
598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|1956|3873|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíð||1956||1956|3873||2
598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|298|1591|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||298||298|1591||1
598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2
598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1
598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||1776||1
599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|479095|601498|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd|Axitinib||479095||479095|601498||1
599052|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|14|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|6168|9670|lyfalmen|V0690|6433|2|14|0|4,6600|Artasan ehf|Sandoz GmbH|Aripiprazól||6168||6168|9670||1
599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|3511|6832|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||3511||3511|6832||2
599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2021||1
599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|22348|31025|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||22348|31025||1
599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3245|lyfalmen|V0334|3240|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3245||2
954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|1|0|1|GEL|0|0|0|100|NOK|103803|134740|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||103803||103803|134740||2
957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|21992|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|21992||2
957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2610|4773|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||2610||2610|4773||2
962234|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||300|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1610|3396|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1610||1610|3396||2
962242|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||100|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1030|2598|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1030||1030|2598||2
967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|þpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|25000|9439|lyfalmen|||2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||6000||6000|9439|30.9.2016|2
968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1522|3275|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1522||1522|3275||2
968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27153|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27153||2
968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|10906|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|10906||2
968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5212|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5212||2
968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6204|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6204||2
970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3988|6670|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||3988||3988|6670||2
980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|4995|8056|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||4995||4995|8056||2